<SEC-DOCUMENT>0001140361-26-018777.txt : 20260504
<SEC-HEADER>0001140361-26-018777.hdr.sgml : 20260504
<ACCEPTANCE-DATETIME>20260504115347
ACCESSION NUMBER:		0001140361-26-018777
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		16
FILED AS OF DATE:		20260504
DATE AS OF CHANGE:		20260504

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TORONTO DOMINION BANK
		CENTRAL INDEX KEY:			0000947263
		STANDARD INDUSTRIAL CLASSIFICATION:	COMMERCIAL BANKS, NEC [6029]
		ORGANIZATION NAME:           	02 Finance
		EIN:				135640479
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			1031

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-283969
		FILM NUMBER:		26935641

	BUSINESS ADDRESS:	
		STREET 1:		66 WELLINGTON STREET WEST
		STREET 2:		12TH FLOOR, TD TOWER
		CITY:			TORONTO, ONTARIO
		STATE:			A6
		ZIP:			M5K 1A2
		BUSINESS PHONE:		416-944-6367

	MAIL ADDRESS:	
		STREET 1:		66 WELLINGTON STREET WEST
		STREET 2:		12TH FLOOR, TD TOWER
		CITY:			TORONTO, ONTARIO
		STATE:			A6
		ZIP:			M5K 1A2
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>ef20072128_424b2.htm
<DESCRIPTION>TERM SHEET
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 26.3.2.5342
         Copyright 1995 - 2026 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: Arial; font-size: 9pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="border-collapse: collapse; margin: 0px 0px 8pt; width: 100%; color: #000000; font-family: Arial; font-size: 9pt; text-align: left;" id="z068a8feac52d4cb1ba92bea55ed8b66a">

            <tr>
              <td style="width: 32.9%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">&#160;</td>
              <td style="width: 30%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">&#160;</td>
              <td style="width: 35.51%; vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0);">
                <div style="text-align: right; font-size: 7pt; font-weight: bold;">Filed Pursuant to Rule 424(b)(2)<br>
                  Registration Statement No. 333-283969<br>
                  (To Prospectus dated February 26, 2025<br>
                </div>
                <div style="text-align: right; font-size: 7pt; font-weight: bold;">and Product Supplement EQUITY LIRN-1 dated March</div>
                <div style="text-align: right; font-size: 7pt; font-weight: bold;"> 3, 2025)</div>
              </td>
              <td colspan="1" style="width: 1%; vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">&#160;</td>
            </tr>

        </table>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z09290738303646e1852e1d3605b8ea7e">

          <tr>
            <td colspan="1" rowspan="2" style="width: 1%; vertical-align: top; background-color: rgb(31, 73, 125);">&#160;</td>
            <td colspan="2" rowspan="2" style="vertical-align: top; background-color: rgb(31, 73, 125);">
              <div style="color: rgb(255, 255, 255);">443,109 Units</div>
              <div style="color: rgb(255, 255, 255);">$10 principal amount per unit</div>
              <div style="color: rgb(255, 255, 255);">CUSIP No. 89116V295</div>
              <div><img height="52" width="58" src="image0.jpg"></div>
            </td>
            <td style="vertical-align: top; background-color: rgb(31, 73, 125);">
              <div style="color: rgb(255, 255, 255);">Pricing Date</div>
              <div style="color: rgb(255, 255, 255);">Settlement Date</div>
              <div style="color: rgb(255, 255, 255);">Maturity Date</div>
            </td>
            <td style="width: 24.26%; vertical-align: top; background-color: #1F497D;">
              <div style="text-align: right; color: rgb(255, 255, 255);">April 30, 2026</div>
              <div style="text-align: right; color: rgb(255, 255, 255);">May 7, 2026</div>
              <div style="text-align: right; color: rgb(255, 255, 255);">April 28, 2028</div>
            </td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top; background-color: rgb(31, 73, 125);"><br>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(4, 110, 135); font-size: 2pt;">&#160;</td>
            <td style="width: 25.69%; vertical-align: top; background-color: rgb(4, 110, 135); font-size: 2pt;">&#160;</td>
            <td style="width: 25.36%; vertical-align: top; background-color: rgb(200, 125, 14); font-size: 2pt;">&#160;</td>
            <td style="width: 24.51%; vertical-align: top; background-color: rgb(92, 37, 92); font-size: 2pt;">&#160;</td>
            <td style="vertical-align: top; background-color: rgb(97, 150, 26); font-size: 2pt;">&#160;</td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(31, 73, 125);">&#160;</td>
            <td colspan="4" style="vertical-align: top; background-color: rgb(31, 73, 125);">
              <div style="color: rgb(255, 255, 255); font-size: 21pt; font-weight: bold;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Linked to the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF</div>
              <div style="text-indent: -18pt; margin-left: 18pt; margin-top: 5pt; margin-bottom: 5pt;"><font style="color: rgb(255, 255, 255); font-size: 6pt;">&#9632;</font><font style="text-indent: 0px; font-size: 6pt;" class="TRGRRTFtoHTMLTab">&#160;&#160;&#160; &#160; </font><font style="font-size: 8pt; color: rgb(255, 255, 255);">Maturity of approximately 2 years</font></div>
              <div style="text-indent: -18pt; margin-left: 18pt; margin-top: 5pt; margin-bottom: 5pt;"><font style="color: rgb(255, 255, 255); font-size: 6pt;">&#9632;</font><font style="text-indent: 0px; font-size: 6pt;" class="TRGRRTFtoHTMLTab">&#160; &#160; &#160; </font><font style="font-size: 8pt; color: rgb(255, 255, 255);">2-to-1 leveraged upside exposure to increases in the Underlying Fund, subject to a capped return of 25.60%</font></div>
              <div style="text-indent: -18pt; margin-left: 18pt; margin-top: 5pt; margin-bottom: 5pt;"><font style="color: rgb(255, 255, 255); font-size: 6pt;">&#9632;</font><font style="text-indent: 0px; font-size: 6pt;" class="TRGRRTFtoHTMLTab">&#160;&#160;&#160; &#160; </font><font style="font-size: 8pt;"><font style="color: rgb(255, 255, 255);">If the Underlying Fund declines, but not by more than 5.00%</font>,<font style="color: rgb(255, 255, 255);"> a return of principal</font></font></div>
              <div style="text-indent: -18pt; margin-left: 18pt; margin-top: 5pt; margin-bottom: 5pt;"><font style="color: rgb(255, 255, 255); font-size: 6pt;">&#9632;</font><font style="text-indent: 0px; font-size: 6pt;" class="TRGRRTFtoHTMLTab">&#160; &#160;&#160; </font><font style="font-size: 8pt; color: rgb(255, 255, 255);">1-to-1 downside exposure to decreases in the Underlying Fund beyond a 5.00% decline, with up to 95.00% of your principal at risk</font></div>
              <div style="text-indent: -18pt; margin-left: 18pt; margin-top: 5pt; margin-bottom: 5pt;"><font style="color: rgb(255, 255, 255); font-size: 6pt;">&#9632;</font><font style="text-indent: 0px; font-size: 6pt;" class="TRGRRTFtoHTMLTab">&#160;&#160; &#160;&#160; </font><font style="font-size: 8pt; color: rgb(255, 255, 255);">All payments occur at maturity and are subject to the credit risk of The Toronto-Dominion Bank</font></div>
              <div style="text-indent: -18pt; margin-left: 18pt; margin-top: 5pt; margin-bottom: 5pt;"><font style="color: rgb(255, 255, 255); font-size: 6pt;">&#9632;</font><font style="text-indent: 0px; font-size: 6pt;" class="TRGRRTFtoHTMLTab">&#160; &#160; &#160; </font><font style="font-size: 8pt; color: rgb(255, 255, 255);">No periodic interest payments</font></div>
              <div style="text-indent: -18pt; margin-left: 18pt; margin-top: 5pt; margin-bottom: 5pt;"><font style="color: rgb(255, 255, 255); font-size: 6pt;">&#9632;</font><font style="text-indent: 0px; font-size: 6pt;" class="TRGRRTFtoHTMLTab">&#160; &#160; &#160; </font><font style="font-size: 8pt; color: rgb(255, 255, 255);">In addition to the underwriting discount set forth below, the notes include a hedging-related charge of $0.05 per unit. See &#8220;Structuring the Notes&#8221;</font></div>
              <div style="text-indent: -18pt; margin-left: 18pt; margin-top: 5pt; margin-bottom: 5pt;"><font style="color: rgb(255, 255, 255); font-size: 6pt;">&#9632;</font><font style="text-indent: 0px; font-size: 6pt;" class="TRGRRTFtoHTMLTab">&#160;&#160;&#160;&#160;&#160; </font><font style="font-size: 8pt; color: rgb(255, 255, 255);">Limited secondary market liquidity, with no exchange listing</font></div>
              <div style="margin-top: 5pt; margin-bottom: 5pt; text-indent: -18pt; margin-left: 18pt;"><font style="color: rgb(255, 255, 255); font-size: 6pt;">&#9632;</font><font style="font-size: 6pt;" class="TRGRRTFtoHTMLTab">&#160;&#160; &#160; &#160; </font><font style="font-size: 8pt; color: rgb(255, 255, 255);">The notes are unsecured debt securities and are not savings accounts or insured deposits of TD. The notes are not insured or guaranteed by the Canada Deposit Insurance Corporation (the
                  &#8220;CDIC&#8221;), the U.S. Federal Deposit Insurance Corporation (the &#8220;FDIC&#8221;), or any other governmental agency of Canada, the United States or any other jurisdiction</font></div>
            </td>
          </tr>
          <tr>
            <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(184, 204, 228); font-size: 3pt;">&#160;</td>
            <td colspan="4" style="vertical-align: top; background-color: rgb(184, 204, 228); font-size: 3pt;">&#160;</td>
          </tr>

      </table>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 3pt; font-size: 8pt; font-weight: bold;">The notes are being issued by The Toronto-Dominion Bank (&#8220;TD&#8221;). There are important differences between the notes and a conventional debt
        security, including different investment risks and certain additional costs. See &#8220;Risk Factors&#8221; beginning on page TS-6 of this term sheet, &#8220;Additional Risk Factors&#8221; on page TS-7 of this term sheet and &#8220;Risk Factors&#8221; beginning on page PS-7 of
        product supplement EQUITY LIRN-1 and page 1 of the prospectus.</div>
      <div style="margin: 0px 0px 6pt; font-size: 8pt;"><font style="font-weight: bold;">The initial estimated value of the notes at the time the terms of the notes were set on the pricing date was $9.647 per unit, which is less than the public offering
          price listed below.</font> See &#8220;Summary&#8221; on the following page, &#8220;Risk Factors&#8221; beginning on page TS-6 of this term sheet and &#8220;Structuring the Notes&#8221; on page TS-13 of this term sheet for additional information. The actual value of your notes at
        any time will reflect many factors and cannot be predicted with accuracy.</div>
      <div style="margin: 3pt 0px 6pt; font-size: 8pt; text-align: justify;">
        <hr noshade="noshade" align="center" style="height: 1px; width: 20%; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">None of the U.S. Securities and Exchange Commission (the
        &#8220;SEC&#8221;), any state securities commission, or any other regulatory body has approved or disapproved of these notes or passed upon the adequacy or accuracy of this document, product supplement EQUITY LIRN-1 or the prospectus. Any representation to the
        contrary is a criminal offense.</div>
      <div style="text-align: center; margin-bottom: 9pt; font-size: 8pt; font-weight: bold;">
        <hr noshade="noshade" align="center" style="height: 1px; width: 20%; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;"></div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z061b26aa83e043b297803cd94b0c416c">

          <tr>
            <td style="width: 33%; vertical-align: top;"><br>
            </td>
            <td style="width: 33%; vertical-align: top;">
              <div style="text-align: center; margin-top: 3pt; margin-bottom: 3pt; font-size: 8pt;"><u>Per Unit</u></div>
            </td>
            <td style="width: 32.74%; vertical-align: top;">
              <div style="text-align: center; margin-top: 3pt; margin-bottom: 3pt; font-size: 8pt;"><u>Total</u></div>
            </td>
          </tr>
          <tr>
            <td style="width: 33%; vertical-align: top;">
              <div style="margin-top: 3pt; margin-bottom: 3pt; font-size: 8pt;">Public offering price</div>
            </td>
            <td style="width: 33%; vertical-align: top;">
              <div style="text-align: center; margin-top: 3pt; margin-bottom: 3pt; font-size: 8pt;">$&#160; 10.00</div>
            </td>
            <td style="width: 32.74%; vertical-align: top;">
              <div style="text-align: center; margin-top: 3pt; margin-bottom: 3pt; font-size: 8pt;"><font style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 9pt; font-style: normal; font-variant: normal; text-transform: none;"><font style="font-size: 8pt;">&#160;$4,431,090.00 </font><br>
                </font> </div>
            </td>
          </tr>
          <tr>
            <td style="width: 33%; vertical-align: top;">
              <div style="margin-top: 3pt; margin-bottom: 3pt; font-size: 8pt;">Underwriting discount</div>
            </td>
            <td style="width: 33%; vertical-align: top;">
              <div style="text-align: center; margin-top: 3pt; margin-bottom: 3pt; font-size: 8pt;">$&#160;&#160;&#160; 0.20</div>
            </td>
            <td style="width: 32.74%; vertical-align: top;">
              <div style="text-align: center; margin-top: 3pt; margin-bottom: 3pt; font-size: 8pt;">$88,621.80</div>
            </td>
          </tr>
          <tr>
            <td style="width: 33%; vertical-align: top;">
              <div style="margin-top: 3pt; margin-bottom: 3pt; font-size: 8pt;">Proceeds, before expenses, to TD</div>
            </td>
            <td style="width: 33%; vertical-align: top;">
              <div style="text-align: center; margin-top: 3pt; margin-bottom: 3pt; font-size: 8pt;">$&#160;&#160;&#160; 9.80</div>
            </td>
            <td style="width: 32.74%; vertical-align: top;">
              <div style="text-align: center; margin-top: 3pt; margin-bottom: 3pt; font-size: 8pt;">&#160;$4,342,468.20</div>
            </td>
          </tr>

      </table>
      <div style="text-align: center; text-indent: -46.35pt; margin-left: 46.35pt; margin-top: 3pt; margin-bottom: 3pt; font-weight: bold;">The notes:</div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z52b361e7c21f4ee5bf30e5ed749f4ae4">

          <tr>
            <td style="width: 33.15%; vertical-align: top; border-left: #000000 1px solid; border-right: #000000 1px solid; border-top: #000000 1px solid; border-bottom: #000000 1px solid;">
              <div style="text-align: center; margin-top: 3pt; margin-bottom: 3pt; font-weight: bold;">Are Not FDIC Insured</div>
            </td>
            <td style="width: 34.12%; vertical-align: top; border-left: #000000 1px solid; border-right: #000000 1px solid; border-top: #000000 1px solid; border-bottom: #000000 1px solid;">
              <div style="text-align: center; margin-top: 3pt; margin-bottom: 3pt; font-weight: bold;">Are Not Bank Guaranteed</div>
            </td>
            <td style="width: 32.72%; vertical-align: top; border-left: #000000 1px solid; border-right: #000000 1px solid; border-top: #000000 1px solid; border-bottom: #000000 1px solid;">
              <div style="text-align: center; margin-top: 3pt; margin-bottom: 3pt; font-weight: bold;">&#160;May Lose Value</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div>
        <div style="text-align: center; margin-top: 5pt; font-size: 14pt; font-weight: bold;">BofA Securities</div>
        <div style="text-align: center; font-size: 10pt;">April 30, 2026</div>
      </div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                  <tr>
                    <td style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 100%;">
                      <div style="color: rgb(91, 134, 43); font-size: 16pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                      <div style="color: rgb(91, 134, 43);">Linked to the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF due April 28, 2028</div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
      </div>
      <div style="margin-top: 6pt; margin-bottom: 6pt; color: rgb(91, 134, 43); font-size: 20pt;">Summary</div>
      <div style="text-align: justify; margin-top: 5pt; font-size: 8pt;">The Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Linked to the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF due April 28, 2028 (the &#8220;notes&#8221;) are our senior unsecured debt securities, Series
        H. The notes are not guaranteed or insured by the CDIC, the FDIC or any other governmental agency, and are not, either directly or indirectly, an obligation of any third party. The notes are not bail-inable debt securities (as defined in the
        prospectus) under the CDIC Act.<font style="font-weight: bold;"> The notes will rank equally with all of our other senior unsecured debt. Any payments due on the notes, including any repayment of principal, will be subject to the credit risk of TD.</font>
        The notes provide you a leveraged return, subject to a cap, if the Ending Value of the Market Measure, which is the shares of the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF (the &#8220;Underlying Fund&#8221;), is greater than the Starting Value. If the Ending Value is
        equal to or less than the Starting Value but greater than or equal to the Threshold Value, you will receive the principal amount of your notes. If the Ending Value is less than the Threshold Value, you will lose a portion, which could be
        significant, of the principal amount of your notes. Any payments on the notes will be calculated based on the $10 principal amount per unit and will depend on the performance of the Underlying Fund, subject to our credit risk. See &#8220;Terms of the
        Notes&#8221; below.</div>
      <div style="text-align: justify; margin-top: 5pt; font-size: 8pt;">The economic terms of the notes (including the Capped Value) are based on our internal funding rate (which is our internal borrowing rate based on variables such as market benchmarks
        and our appetite for borrowing) and several factors, including selling concessions, discounts, commissions or fees expected to be paid in connection with the offering of the notes, the estimated profit that we expect to earn in connection with
        structuring the notes, estimated costs which we may incur in connection with the notes and the economic terms of certain related hedging arrangements as discussed further below and under &#8220;Structuring the Notes&#8221; on page TS-13.</div>
      <div style="text-align: justify; margin-top: 5pt; font-size: 8pt;">On the cover page of this term sheet, we have provided the initial estimated value for the notes. The initial estimated value of your notes on the pricing date is less than their
        public offering price. The initial estimated value was determined by reference to our internal pricing models, which take into account a number of variables, typically including expected volatility of the Market Measure, interest rates (forecasted,
        current and historical rates), price-sensitivity analysis, time to maturity of the notes and our internal funding rate which take into account a number of variables and are based on a number of subjective assumptions, which are not evaluated or
        verified on an independent basis and may or may not materialize. Because our internal funding rate generally represents a discount from the levels at which our benchmark debt securities trade in the secondary market, the use of an internal funding
        rate for the notes rather than the levels at which our benchmark debt securities trade in the secondary market is expected, assuming all other economic terms are held constant, to have increased the initial estimated value of the notes and to have
        had an adverse effect on the economic terms of the notes. For more information about the initial estimated value and the structuring of the notes, see the related discussion under &#8220;Risk Factors&#8221; and &#8220;Structuring the Notes&#8221; herein.</div>
      <div class="BRPFTCL" style="float: left; width: 48%;">
        <div>
          <div>
            <div style="margin-top: 6pt; margin-bottom: 6pt; color: rgb(91, 134, 43); font-size: 18pt;">Terms of the Notes</div>
          </div>
          <table cellspacing="0" cellpadding="1" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

              <tr>
                <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(242, 242, 242);">&#160;</td>
                <td style="width: 30%; vertical-align: top; background-color: rgb(242, 242, 242);">
                  <div style="margin-top: 1.5pt; margin-bottom: 1.5pt; color: rgb(91, 134, 43); font-size: 7.5pt; font-weight: bold;">Issuer:</div>
                </td>
                <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
                <td style="width: 68%; vertical-align: top;">
                  <div style="text-align: justify; margin-top: 1.5pt; margin-bottom: 1.5pt; font-size: 7.5pt;">The Toronto-Dominion Bank (&#8220;TD&#8221;)</div>
                </td>
              </tr>
              <tr>
                <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(242, 242, 242);">&#160;</td>
                <td style="width: 30%; vertical-align: top; background-color: rgb(242, 242, 242);">
                  <div style="margin-top: 1.5pt; margin-bottom: 1.5pt; color: rgb(91, 134, 43); font-size: 7.5pt; font-weight: bold;">Principal Amount:</div>
                </td>
                <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
                <td style="width: 68%; vertical-align: top;">
                  <div style="text-align: justify; margin-top: 1.5pt; margin-bottom: 1.5pt; font-size: 7.5pt;">$10.00 per unit</div>
                </td>
              </tr>
              <tr>
                <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(242, 242, 242);">&#160;</td>
                <td style="width: 30%; vertical-align: top; background-color: rgb(242, 242, 242);">
                  <div style="margin-top: 1.5pt; margin-bottom: 1.5pt; color: rgb(91, 134, 43); font-size: 7.5pt; font-weight: bold;">Term:</div>
                </td>
                <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
                <td style="width: 68%; vertical-align: top;">
                  <div style="text-align: justify; margin-top: 1.5pt; margin-bottom: 1.5pt; font-size: 7.5pt;">Approximately 2 years</div>
                </td>
              </tr>
              <tr>
                <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(242, 242, 242);">&#160;</td>
                <td style="width: 30%; vertical-align: top; background-color: rgb(242, 242, 242);">
                  <div style="margin-top: 1.5pt; margin-bottom: 1.5pt; color: rgb(91, 134, 43); font-size: 7.5pt; font-weight: bold;">Market Measure:</div>
                </td>
                <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
                <td style="width: 68%; vertical-align: top;">
                  <div style="text-align: justify; margin-top: 1.5pt; margin-bottom: 1.5pt; font-size: 7.5pt;">The iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF (Bloomberg symbol: &#8220;EFA&#8221;)</div>
                </td>
              </tr>
              <tr>
                <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(242, 242, 242);">&#160;</td>
                <td style="width: 30%; vertical-align: top; background-color: rgb(242, 242, 242);">
                  <div style="margin-top: 1.5pt; margin-bottom: 1.5pt; color: rgb(91, 134, 43); font-size: 7.5pt; font-weight: bold;">Starting Value:</div>
                </td>
                <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
                <td style="width: 68%; vertical-align: top;">
                  <div style="text-align: justify; margin-top: 1.5pt; margin-bottom: 1.5pt; font-size: 7.5pt;">$102.32</div>
                </td>
              </tr>
              <tr>
                <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(242, 242, 242);">&#160;</td>
                <td style="width: 30%; vertical-align: top; background-color: rgb(242, 242, 242);">
                  <div style="margin-top: 1.5pt; margin-bottom: 1.5pt; color: rgb(91, 134, 43); font-size: 7.5pt; font-weight: bold;">Ending Value:</div>
                </td>
                <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
                <td style="width: 68%; vertical-align: top;">
                  <div style="text-align: justify; margin-top: 1.5pt; margin-bottom: 1.5pt; font-size: 7.5pt;">The average of the Closing Market Price of the Market Measure multiplied by the Price Multiplier on each calculation day occurring during the
                    Maturity Valuation Period. The scheduled calculation days are subject to postponement in the event of Market Disruption Events, as described beginning on page PS-28 of product supplement EQUITY LIRN-1.</div>
                </td>
              </tr>
              <tr>
                <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(242, 242, 242);">&#160;</td>
                <td style="width: 30%; vertical-align: top; background-color: rgb(242, 242, 242);">
                  <div style="margin-top: 1.5pt; margin-bottom: 1.5pt; color: rgb(91, 134, 43); font-size: 7.5pt; font-weight: bold;">Threshold Value:</div>
                </td>
                <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
                <td style="width: 68%; vertical-align: top;">
                  <div style="text-align: justify; margin-top: 1.5pt; margin-bottom: 1.5pt; font-size: 7.5pt;">$97.20 (95.00% of the Starting Value, rounded to two decimal places).</div>
                </td>
              </tr>
              <tr>
                <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(242, 242, 242);">&#160;</td>
                <td style="width: 30%; vertical-align: top; background-color: rgb(242, 242, 242);">
                  <div style="margin-top: 1.5pt; margin-bottom: 1.5pt; color: rgb(91, 134, 43); font-size: 7.5pt; font-weight: bold;">Price Multiplier:</div>
                </td>
                <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
                <td style="width: 68%; vertical-align: top;">
                  <div style="text-align: justify; margin-top: 1.5pt; margin-bottom: 1.5pt; font-size: 7.5pt;">1, subject to adjustment for certain corporate events relating to the Underlying Fund, as described beginning on page PS-31 of product supplement
                    EQUITY LIRN-1.</div>
                </td>
              </tr>
              <tr>
                <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(242, 242, 242);">&#160;</td>
                <td style="width: 30%; vertical-align: top; background-color: rgb(242, 242, 242);">
                  <div style="margin: 1.5pt 0px 0px; color: rgb(91, 134, 43); font-size: 7.5pt; font-weight: bold;">Participation</div>
                  <div style="margin: 0px 0px 1.5pt; color: rgb(91, 134, 43); font-size: 7.5pt; font-weight: bold;"> Rate:</div>
                </td>
                <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
                <td style="width: 68%; vertical-align: top;">
                  <div style="text-align: justify; margin-top: 1.5pt; margin-bottom: 1.5pt; font-size: 7.5pt;">200.00%</div>
                </td>
              </tr>
              <tr>
                <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(242, 242, 242);">&#160;</td>
                <td style="width: 30%; vertical-align: top; background-color: rgb(242, 242, 242);">
                  <div style="margin-top: 1.5pt; margin-bottom: 1.5pt; color: rgb(91, 134, 43); font-size: 7.5pt; font-weight: bold;">Capped Value:</div>
                </td>
                <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
                <td style="width: 68%; vertical-align: top;">
                  <div style="text-align: justify; margin-top: 1.5pt; margin-bottom: 1.5pt; font-size: 7.5pt;">$12.56 per unit, which represents a return of 25.60% over the principal amount.</div>
                </td>
              </tr>
              <tr>
                <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(242, 242, 242);">&#160;</td>
                <td style="width: 30%; vertical-align: top; background-color: rgb(242, 242, 242);">
                  <div style="margin: 1.5pt 0px 0px; color: rgb(91, 134, 43); font-size: 7.5pt; font-weight: bold;">Maturity Valuation </div>
                  <div style="margin: 0px 0px 1.5pt; color: rgb(91, 134, 43); font-size: 7.5pt; font-weight: bold;">Period:</div>
                </td>
                <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
                <td style="width: 68%; vertical-align: top;">
                  <div style="text-align: justify; margin-top: 1.5pt; margin-bottom: 1.5pt; font-size: 7.5pt;">April 19, 2028, April 20, 2028, April 21, 2028, April 24, 2028 and April 25, 2028</div>
                </td>
              </tr>
              <tr>
                <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(242, 242, 242);">&#160;</td>
                <td style="width: 30%; vertical-align: top; background-color: rgb(242, 242, 242);">
                  <div style="margin: 1.5pt 0px 0px; color: rgb(91, 134, 43); font-size: 7.5pt; font-weight: bold;">Fees and </div>
                  <div style="margin: 0px 0px 1.5pt; color: rgb(91, 134, 43); font-size: 7.5pt; font-weight: bold;">Charges:</div>
                </td>
                <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
                <td style="width: 68%; vertical-align: top;">
                  <div style="text-align: justify; margin-top: 1.5pt; margin-bottom: 1.5pt; font-size: 7.5pt;">The underwriting discount of $0.20 per unit listed on the cover page and the hedging related charge of $0.05 per unit described in &#8220;Structuring
                    the Notes&#8221; on page TS-13.</div>
                </td>
              </tr>
              <tr>
                <td colspan="1" style="width: 1%; vertical-align: top; background-color: rgb(242, 242, 242);">&#160;</td>
                <td style="width: 30%; vertical-align: top; background-color: rgb(242, 242, 242);">
                  <div style="margin: 1.5pt 0px 0px; color: rgb(91, 134, 43); font-size: 7.5pt; font-weight: bold;">Calculation</div>
                  <div style="margin: 0px 0px 1.5pt; color: rgb(91, 134, 43); font-size: 7.5pt; font-weight: bold;"> Agents:</div>
                </td>
                <td colspan="1" style="width: 1%; vertical-align: top;">&#160;</td>
                <td style="width: 68%; vertical-align: top;">
                  <div style="margin-top: 1.5pt; margin-bottom: 1.5pt; font-size: 7.5pt;">BofA Securities, Inc. (&#8220;BofAS&#8221;) and TD, acting jointly.</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div class="BRPFTCR" style="float: right; width: 48%;">
        <div>
          <div style="margin-top: 6pt; margin-bottom: 6pt; color: rgb(91, 134, 43); font-size: 18pt;">Redemption Amount Determination</div>
          <div style="margin-top: 6pt; margin-bottom: 6pt; color: rgb(91, 134, 43); font-size: 18pt;">
            <div style="text-align: justify; margin-top: 1.5pt; margin-bottom: 1.5pt; font-size: 7.5pt; color: rgb(0, 0, 0);">On the maturity date, you will receive a cash payment per unit determined as follows:</div>
            <div style="text-align: justify; margin-top: 1.5pt; margin-bottom: 1.5pt; font-size: 7.5pt; color: rgb(0, 0, 0);">
              <div style="text-align: center; margin-top: 5pt;"><img src="image1.jpg"></div>
            </div>
          </div>
        </div>
      </div>
      <div style="clear: both;"><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div style="clear: both;">
              <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                  <tr>
                    <td style="width: 50%; vertical-align: top;">
                      <div style="color: rgb(91, 134, 43); font-size: 8pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                    </td>
                    <td style="width: 50%; vertical-align: top;">
                      <div style="text-align: right; color: rgb(91, 134, 43); font-size: 8pt;">TS-<font class="BRPFPageNumber">2</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                  <tr>
                    <td style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 100%;">
                      <div style="color: rgb(91, 134, 43); font-size: 16pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                      <div style="color: rgb(91, 134, 43);">Linked to the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF due April 28, 2028</div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
      </div>
      <div style="margin-top: 3pt; margin-bottom: 3pt;">The terms and risks of the notes are contained in this term sheet and in the following:</div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="za2ee9a310cb8458f8981d0ab35b3bbd5">

          <tr>
            <td style="width: 18pt; vertical-align: top; color: rgb(91, 143, 34); font-size: 7pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top;">
              <div>Product supplement EQUITY LIRN-1 dated March 3, 2025:</div>
            </td>
          </tr>

      </table>
      <div style="text-indent: -18pt; margin-left: 36pt; margin-top: 5pt;"><a href="https://www.sec.gov/Archives/edgar/data/947263/000114036125006726/ef20044383_424b3.htm">http://www.sec.gov/Archives/edgar/data/947263/000114036125006726/ef20044383_424b3.htm</a></div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="zdac500fdf7ad4cdbb96b1358f1a53992">

          <tr>
            <td style="width: 18pt; vertical-align: top; color: rgb(91, 143, 34); font-size: 7pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top;">
              <div>Prospectus dated February 26, 2025:</div>
            </td>
          </tr>

      </table>
      <div style="text-indent: -18pt; margin-left: 36pt; margin-top: 5pt;"><a href="https://www.sec.gov/Archives/edgar/data/947263/000119312525036639/d931193d424b5.htm">http://www.sec.gov/Archives/edgar/data/947263/000119312525036639/d931193d424b5.htm</a></div>
      <div style="text-align: justify; margin-top: 5pt;">These documents, including this term sheet (together, the &#8220;Note Prospectus&#8221;), have been filed as part of a registration statement with the SEC and may, without cost, be accessed on the SEC website as
        indicated above or obtained from Merrill Lynch, Pierce, Fenner &amp; Smith Incorporated (&#8220;MLPF&amp;S&#8221;) or BofAS by calling 1-800-294-1322.</div>
      <div style="text-align: justify; margin-top: 5pt; font-size: 8pt;"><font style="font-size: 9pt;">You should read the Note Prospectus, including this term sheet, for information about us and this offering. Any prior or contemporaneous oral statements
          and any other written materials you may have received are superseded by the Note Prospectus. Capitalized terms used but not defined in this term sheet have the meanings set forth in product supplement EQUITY LIRN-1. In the event of any conflict
          the following hierarchy will govern: first, this term sheet; second, product supplement EQUITY LIRN-1; and last, the prospectus. Unless otherwise indicated or unless the context requires otherwise, all references in this document to &#8220;we,&#8221; &#8220;us,&#8221;
          &#8220;our,&#8221; or similar references are to TD.</font></div>
      <div style="margin-top: 6pt; margin-bottom: 6pt; color: rgb(91, 134, 43); font-size: 20pt;">Investor Considerations</div>
      <div class="BRPFTCL" style="float: left; width: 48%;">
        <div>
          <div style="font-weight: bold;">You may wish to consider an investment in the notes if:</div>
          <div style="font-weight: bold;">
            <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="za4e4578d03d24fa38d65fe1dd6c0d21c">

                <tr>
                  <td style="width: 18pt; vertical-align: top; color: rgb(91, 143, 34); font-size: 7pt;">&#9632;</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div>You anticipate that the price of the Underlying Fund will increase moderately from the Starting Value to the Ending Value.</div>
                  </td>
                </tr>

            </table>
            <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="zf57678731bce4f2681ba1c4735a224ef">

                <tr>
                  <td style="width: 18pt; vertical-align: top; color: rgb(91, 143, 34); font-size: 7pt;">&#9632;</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div>You are willing to risk a substantial loss of principal if the price of the Underlying Fund decreases from the Starting Value to an Ending Value that is below the Threshold Value.</div>
                  </td>
                </tr>

            </table>
            <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="zd71194ca050b4afe949c5d33719e7631">

                <tr>
                  <td style="width: 18pt; vertical-align: top; color: rgb(91, 143, 34); font-size: 7pt;">&#9632;</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div>You accept that the return on the notes will be capped.</div>
                  </td>
                </tr>

            </table>
            <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="zc7e32355307942038c8a84812243cdbb">

                <tr>
                  <td style="width: 18pt; vertical-align: top; color: rgb(91, 143, 34); font-size: 7pt;">&#9632;</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div>You are willing to forgo interest payments that are paid on conventional interest-bearing debt securities.</div>
                  </td>
                </tr>

            </table>
            <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="zedfcb045999d4a1b930fda674b342c45">

                <tr>
                  <td style="width: 18pt; vertical-align: top; color: rgb(91, 143, 34); font-size: 7pt;">&#9632;</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div>You are willing to forgo the benefits of directly owning the Underlying Fund or the securities held by the Underlying Fund, including dividends and other distributions.</div>
                  </td>
                </tr>

            </table>
            <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="z82d42e7efe8a486aae47c005b5bab413">

                <tr>
                  <td style="width: 18pt; vertical-align: top; color: rgb(91, 143, 34); font-size: 7pt;">&#9632;</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div>You are willing to accept that a limited market or no market exists for sales of the notes prior to maturity, and understand that the market price for the notes in any secondary market may be adversely affected by various factors,
                      including, but not limited to, our actual and perceived creditworthiness, our internal funding rate and fees and charges on the notes, as described on page TS-2.</div>
                  </td>
                </tr>

            </table>
            <div>
              <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="zf361f95dbdd0471d97bb76d72128ca22">

                  <tr>
                    <td style="width: 18pt; vertical-align: top; color: rgb(91, 143, 34); font-size: 7pt;">&#9632;</td>
                    <td style="width: auto; vertical-align: top; text-align: justify;">
                      <div>You are willing to assume our credit risk, as issuer of the notes, for all payments under the notes, including the Redemption Amount.</div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
      </div>
      <div class="BRPFTCR" style="float: right; width: 48%;">
        <div>
          <div style="font-weight: bold;">The notes may not be an appropriate investment for you if:</div>
          <div style="font-weight: bold;">
            <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="z3172b57e4138424cbec65d72fe270f6b">

                <tr>
                  <td style="width: 18pt; vertical-align: top; color: rgb(91, 143, 34); font-size: 7pt;">&#9632;</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div>You believe that the price of the Underlying Fund will decrease from the Starting Value to the Ending Value or that it will not increase sufficiently over the term of the notes to provide you with your desired return.</div>
                  </td>
                </tr>

            </table>
            <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="zde8ba0cad386402c8766e13d78bc041b">

                <tr>
                  <td style="width: 18pt; vertical-align: top; color: rgb(91, 143, 34); font-size: 7pt;">&#9632;</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div>You seek 100% principal repayment or preservation of capital.</div>
                  </td>
                </tr>

            </table>
            <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="z000c568dbf924344beaf5aab4d09f063">

                <tr>
                  <td style="width: 18pt; vertical-align: top; color: rgb(91, 143, 34); font-size: 7pt;">&#9632;</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div>You seek an uncapped return on your investment.</div>
                  </td>
                </tr>

            </table>
            <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="zd9bb37150c59434a8c9f93718d73ec7f">

                <tr>
                  <td style="width: 18pt; vertical-align: top; color: rgb(91, 143, 34); font-size: 7pt;">&#9632;</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div>You seek interest payments or other current income on your investment.</div>
                  </td>
                </tr>

            </table>
            <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="zce8866bc38434487a257d61c0f09fdfc">

                <tr>
                  <td style="width: 18pt; vertical-align: top; color: rgb(91, 143, 34); font-size: 7pt;">&#9632;</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div>You want to receive the benefits of directly owning the Underlying Fund or the securities held by the Underlying Fund, including dividends and other distributions.</div>
                  </td>
                </tr>

            </table>
            <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="zd5fea95f50c14b2bb073b6d23cc1519d">

                <tr>
                  <td style="width: 18pt; vertical-align: top; color: rgb(91, 143, 34); font-size: 7pt;">&#9632;</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div>You seek an investment for which there will be a liquid secondary market.</div>
                  </td>
                </tr>

            </table>
            <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="z6359d3e0d13643e2865a6ba6782bba2c">

                <tr>
                  <td style="width: 18pt; vertical-align: top; color: rgb(91, 143, 34); font-size: 7pt;">&#9632;</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">You are unwilling or are unable to take market risk on the notes or to accept the credit risk of TD as issuer of the notes.</td>
                </tr>

            </table>
          </div>
        </div>
      </div>
      <div style="clear: both;">
        <table cellspacing="0" cellpadding="0" border="0" id="z7723d2d583c8400193a54d1ca5fc3f47" style="font-family: Arial; font-size: 9pt; color: rgb(0, 0, 0); width: 100%;">

            <tr>
              <td style="width: 100.00%;">
                <div style="text-align: left; margin-top: 5pt;">We urge you to consult your investment, legal, tax, accounting, and other advisors concerning an investment in the notes.</div>
              </td>
            </tr>

        </table>
      </div>
      <div> <br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div style="clear: both;">
              <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                  <tr>
                    <td style="width: 50%; vertical-align: top;">
                      <div style="color: rgb(91, 134, 43); font-size: 8pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                    </td>
                    <td style="width: 50%; vertical-align: top;">
                      <div style="text-align: right; color: rgb(91, 134, 43); font-size: 8pt;">TS-<font class="BRPFPageNumber">3</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                  <tr>
                    <td style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 100%;">
                      <div style="color: rgb(91, 134, 43); font-size: 16pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                      <div style="color: rgb(91, 134, 43);">Linked to the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF due April 28, 2028</div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
      </div>
      <div style="margin: 5pt 0px; color: #5B862B; font-size: 20pt;">Hypothetical Payout Profile</div>
      <div class="BRPFTCL" style="float: left; width: 48%;">
        <div>
          <div style="margin: 0px 0px 6pt; font-weight: bold; text-align: center;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
        </div>
        <div>
          <div style="text-align: center; margin-top: 5pt; margin-bottom: 6pt;"><img src="image2.jpg"></div>
        </div>
      </div>
      <div class="BRPFTCR" style="float: right; width: 48%;">
        <div>
          <div style="background-color: #F2F2F2; margin: 0px 0px 0px; text-align: justify;">This graph reflects the returns on the notes, based on the Participation Rate of 200.00%, the Threshold Value of 95.00% of the Starting Value and the Capped Value
            of $12.56 per unit. The green line reflects the returns on the notes, while the dotted gray line reflects the returns of a direct investment in the Market Measure, excluding dividends or distributions.</div>
          <div style="background-color: rgb(242, 242, 242); margin: 0px; text-align: justify;"> <br>
          </div>
          <div style="background-color: rgb(242, 242, 242); margin: 0px 0px 6pt; text-align: justify;">
            <div style="background-color: #F2F2F2; margin: 0px 0px 0px;">This graph has been prepared for purposes of illustration only. See the below table for a further illustration of the range of hypothetical payments at maturity.</div>
          </div>
        </div>
      </div>
      <div style="clear: both;"><br>
      </div>
      <div style="text-align: justify; color: rgb(91, 134, 43); font-size: 20pt;">Hypothetical Payments at Maturity</div>
      <div style="text-align: justify; margin-top: 6pt;">The following table and examples are for purposes of illustration only. They are based on <font style="font-weight: bold;">hypothetical</font> values and show <font style="font-weight: bold;">hypothetical</font>
        returns on the notes. They illustrate the calculation of the Redemption Amount and total rate of return based on a hypothetical Starting Value of 100.00, a hypothetical Threshold Value of 95.00, the Participation Rate of 200.00%, the Capped Value
        of $12.56 per unit and a range of hypothetical Ending Values. <font style="font-weight: bold;">The actual amount you receive and the resulting total rate of return will depend on the actual Starting Value, Threshold Value, and Ending Value and
          whether you hold the notes to maturity.</font> The following examples do not take into account any tax consequences from investing in the notes.</div>
      <div style="text-align: justify; margin-top: 5pt; margin-bottom: 5pt;">For recent actual prices of the Underlying Fund, see &#8220;The Underlying Fund&#8221; section below. In addition, all payments on the notes are subject to issuer credit risk. If TD, as
        issuer, becomes unable to meet its obligations as they become due, you could lose some or all of your investment.</div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="zce813338a8c7428c9ad5b3267c943898">

          <tr>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center; font-weight: bold;">Ending Value</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center; font-weight: bold;">Percentage Change from the </div>
              <div style="text-align: center; font-weight: bold;">Starting Value to the Ending</div>
              <div style="text-align: center; font-weight: bold;"> Value</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center; font-weight: bold;">Redemption Amount per</div>
              <div style="text-align: center; font-weight: bold;"> Unit</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center; font-weight: bold;">Total Rate of Return on the</div>
              <div style="text-align: center; font-weight: bold;"> Notes</div>
            </td>
          </tr>
          <tr>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">0.00</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">-100.00%</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">$0.50</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">-95.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">25.00</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">-75.00%</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">$3.00</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">-70.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">50.00</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">-50.00%</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">$5.50</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">-45.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">60.00</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">-40.00%</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">$6.50</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">-35.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">70.00</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">-30.00%</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">$7.50</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">-25.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">80.00</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">-20.00%</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">$8.50</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">-15.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">90.00</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">-10.00%</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">$9.50</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">-5.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">&#160;&#160; 95.00<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">-5.00%</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">$10.00</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">0.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">97.00</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">-3.00%</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">$10.00</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">0.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">&#160;&#160; 100.00<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">0.00%</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">$10.00</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">0.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">102.00</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">2.00%</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">$10.40</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">4.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">105.00</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">5.00%</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">$11.00</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">10.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">110.00</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">10.00%</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">$12.00</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">20.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">112.80</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">12.80%</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">&#160;&#160; $12.56<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup></div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">25.60%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">120.00</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">20.00%</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">$12.56</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">25.60%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">130.00</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">30.00%</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">$12.56</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">25.60%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">140.00</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">40.00%</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">$12.56</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">25.60%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">150.00</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">50.00%</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">$12.56</div>
            </td>
            <td style="width: 25%; vertical-align: bottom;">
              <div style="text-align: center;">25.60%</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="z5501e0c1c29343e48d5b2b3ec2356677">

          <tr>
            <td style="width: 27pt; vertical-align: top;">(1)</td>
            <td style="width: auto; vertical-align: top;">
              <div>This is the <font style="font-weight: bold;">hypothetical</font> Threshold Value.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="z77cb4acb467945ff95389453875785cc">

          <tr>
            <td style="width: 27pt; vertical-align: top;">(2)</td>
            <td style="width: auto; vertical-align: top;">
              <div>The <font style="font-weight: bold;">hypothetical</font> Starting Value of 100.00 used in these examples has been chosen for illustrative purposes only. The actual Starting Value is $102.32, which was the Closing Market Price of the
                Underlying Fund on the pricing date.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="z79e0e3bf7b6a48c4a2b36579312683aa">

          <tr>
            <td style="width: 27pt; vertical-align: top;">(3)</td>
            <td style="width: auto; vertical-align: top;">
              <div>The Redemption Amount per unit cannot exceed the<font style="font-weight: bold;">&#160;</font>Capped Value.</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div style="clear: both;">
              <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                  <tr>
                    <td style="width: 50%; vertical-align: top;">
                      <div style="color: rgb(91, 134, 43); font-size: 8pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                    </td>
                    <td style="width: 50%; vertical-align: top;">
                      <div style="text-align: right; color: rgb(91, 134, 43); font-size: 8pt;">TS-<font class="BRPFPageNumber">4</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                  <tr>
                    <td style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 100%;">
                      <div style="color: rgb(91, 134, 43); font-size: 16pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                      <div style="color: rgb(91, 134, 43);">Linked to the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF due April 28, 2028</div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
      </div>
      <div style="margin-top: 5pt; margin-bottom: 5pt; font-weight: bold;">Redemption Amount Calculation Examples</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="zc8a6e184e6c64211983783d3334b5660">

          <tr>
            <td rowspan="1" colspan="3" style="vertical-align: top;">
              <div style="margin-top: 5pt; font-weight: bold;">Example 1</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="3" style="vertical-align: top;">
              <div style="margin-top: 5pt;">The Ending Value is 60.00, or 60.00% of the Starting Value:</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="margin-top: 5pt;">Starting Value:<font style="text-indent: 0px; font-size: 5.14pt;" class="TRGRRTFtoHTMLTab"><br>
                </font></div>
            </td>
            <td style="width: 5%; vertical-align: bottom;">100.00</td>
            <td style="width: 83%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="margin-top: 5pt;">Threshold Value:<font style="text-indent: 0px; font-size: 5pt;" class="TRGRRTFtoHTMLTab"><br>
                </font></div>
            </td>
            <td style="width: 5%; vertical-align: top;">95.00</td>
            <td style="width: 83%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="margin-top: 5pt;">Ending Value:</div>
            </td>
            <td style="width: 5%; vertical-align: top;">60.00</td>
            <td style="width: 83%; vertical-align: top;">&#160;</td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="width: 29.04%; vertical-align: top;">
              <div style="text-align: center;"><img height="28" width="134" src="image3.jpg"></div>
            </td>
            <td style="width: 70.84%; vertical-align: middle;">
              <div style="margin-top: 5pt;"><font style="font-weight: bold;">= $6.50</font> Redemption Amount per unit</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td colspan="2" style="vertical-align: top;">
              <div style="margin-top: 5pt; font-weight: bold;">Example 2</div>
            </td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top;">
              <div style="margin-top: 5pt;">The Ending Value is 95.00, or 95.00% of the Starting Value:</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="margin-top: 5pt;">Starting Value:<font style="text-indent: 0px; font-size: 5.14pt;" class="TRGRRTFtoHTMLTab"> <br>
                </font></div>
            </td>
            <td style="width: 88%; vertical-align: bottom;">100.00</td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="margin-top: 5pt;">Threshold Value:</div>
            </td>
            <td style="width: 88%; vertical-align: bottom;">95.00</td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="margin-top: 5pt;">Ending Value:<font style="text-indent: 0px; font-size: 5.14pt;" class="TRGRRTFtoHTMLTab"> <br>
                </font></div>
            </td>
            <td style="width: 88%; vertical-align: bottom;">95.00</td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top;">
              <div style="margin-top: 5pt;">Redemption Amount per unit <font style="font-weight: bold;">= $10.00</font>, the principal amount, since the Ending Value is less than the Starting Value but equal to or greater than the Threshold Value.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td colspan="2" style="vertical-align: top;">
              <div style="margin-top: 5pt; font-weight: bold;">Example 3</div>
            </td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top;">
              <div style="margin-top: 5pt;">The Ending Value is 102.00, or 102.00% of the Starting Value:</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="margin-top: 5pt;">Starting Value:<font style="text-indent: 0px; font-size: 5.14pt;" class="TRGRRTFtoHTMLTab"><br>
                </font></div>
            </td>
            <td style="width: 88%; vertical-align: top;">100.00</td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="margin-top: 5pt;">Ending Value:<font style="text-indent: 0px; font-size: 5.14pt;" class="TRGRRTFtoHTMLTab"><br>
                </font></div>
            </td>
            <td style="width: 88%; vertical-align: top;">102.00</td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="width: 32%; vertical-align: top;">
              <div style="text-align: center;"><img height="27" width="212" src="image4.jpg"></div>
            </td>
            <td style="width: 68%; vertical-align: middle;">
              <div style="margin-top: 5pt;"><font style="font-weight: bold;">= $10.40 </font>Redemption Amount per unit</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td colspan="2" style="vertical-align: top;">
              <div style="margin-top: 5pt; font-weight: bold;">Example 4</div>
            </td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top;">
              <div style="margin-top: 5pt;">The Ending Value is 130.00, or 130.00% of the Starting Value:</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="margin-top: 5pt;">Starting Value:</div>
            </td>
            <td style="width: 88%; vertical-align: bottom;">100.00</td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="margin-top: 5pt;">Ending Value:</div>
            </td>
            <td style="width: 88%; vertical-align: bottom;">130.00</td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td colspan="1" style="width: 12%; vertical-align: top;">&#160;</td>
            <td style="width: 35%; vertical-align: top;">
              <div><img height="27" width="212" src="image4.jpg"></div>
            </td>
            <td style="width: 53%; vertical-align: middle;">
              <div style="text-align: justify; margin-top: 5pt; font-weight: bold;">= $16.00, however, because the Redemption Amount for the notes cannot exceed the Capped Value, the Redemption Amount will be $12.56 per unit</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div style="clear: both;">
              <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                  <tr>
                    <td style="width: 50%; vertical-align: top;">
                      <div style="color: rgb(91, 134, 43); font-size: 8pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                    </td>
                    <td style="width: 50%; vertical-align: top;">
                      <div style="text-align: right; color: rgb(91, 134, 43); font-size: 8pt;">TS-<font class="BRPFPageNumber">5</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                  <tr>
                    <td style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 100%;">
                      <div style="color: rgb(91, 134, 43); font-size: 16pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                      <div style="color: rgb(91, 134, 43);">Linked to the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF due April 28, 2028</div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
      </div>
      <div style="margin-top: 6pt; margin-bottom: 6pt; color: rgb(91, 134, 43); font-size: 20pt;">Risk Factors</div>
      <div style="text-align: justify; margin-top: 5pt; font-style: italic;">There are important differences between the notes and a conventional debt security. An investment in the notes involves significant risks, including those listed below. You should
        carefully review the more detailed explanation of risks relating to the notes in the &#8220;Risk Factors&#8221; sections beginning on page PS-7 of product supplement EQUITY LIRN-1 and page 1 of the prospectus. We also urge you to consult your investment,
        legal, tax, accounting, and other advisors as to the risks entailed by an investment in the notes and the suitability of the notes in light of your particular circumstances.</div>
      <div style="margin-top: 5pt; font-weight: bold;"><u>Structure-Related Risks</u></div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="z524591c499324920aeac629fb5638109">

          <tr>
            <td style="width: 17.45pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(91, 134, 43); font-size: 7pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Depending on the performance of the Underlying Fund as measured shortly before the maturity date, your investment may result in a loss; there is no guaranteed return of principal.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="z8e755e439314417da21fa57917fd66dd">

          <tr>
            <td style="width: 17.45pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(91, 134, 43); font-size: 7pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Your return on the notes may be less than the yield you could earn by owning a conventional fixed or floating rate debt security of comparable maturity.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="z595c212ed0f04567b4965f1174ea07b1">

          <tr>
            <td style="width: 17.45pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(91, 134, 43); font-size: 7pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Your investment return is limited to the return represented by the Capped Value and may be less than a comparable investment directly in the Underlying Fund or the securities held by the Underlying Fund.</div>
            </td>
          </tr>

      </table>
      <div style="text-indent: -18pt; margin-left: 18pt; margin-top: 5pt; font-weight: bold;"><u>Market Measure-Related Risks</u></div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="ze17c0b9a947c4f33b01faddc4d7428bf">

          <tr>
            <td style="width: 17.45pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(91, 134, 43); font-size: 7pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The sponsor and investment advisor of the Underlying Fund may adjust the Underlying Fund in a way that may adversely affect the value of the notes and the amount payable on the notes, and these entities have no obligation to consider
                your interests.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="z8d833afaeb614e149c37d4a8cfd91e09">

          <tr>
            <td style="width: 17.45pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(91, 134, 43); font-size: 7pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The sponsor of the MSCI EAFE<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index (the &#8220;Underlying Index&#8221;), described below, may adjust the Underlying Index in a way that affects its level, and has no obligation to consider your interests.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="za57e60a62a6b48d79293378179b56835">

          <tr>
            <td style="width: 17.45pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(91, 134, 43); font-size: 7pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>You will have no rights of a holder of the Underlying Fund or the securities held by the Underlying Fund, and you will not be entitled to receive any shares of the Underlying Fund or the securities held by the Underlying Fund, or any
                dividends or other distributions in respect of the Underlying Fund or the securities held by the Underlying Fund.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="zb2c2ba55230848e897bf95bf7c5ea473">

          <tr>
            <td style="width: 17.45pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(91, 134, 43); font-size: 7pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>While we, MLPF&amp;S, BofAS or our or their respective affiliates may from time to time own shares of the Underlying Fund or the securities held by the Underlying Fund, none of us, MLPF&amp;S, BofAS or our or their respective affiliates
                control the Underlying Fund or any company held by the Underlying Fund, and have not verified any disclosure made by the Underlying Fund or any other company.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="z0df4bcae06744d0db0e7274c54669115">

          <tr>
            <td style="width: 17.45pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(91, 134, 43); font-size: 7pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>There are liquidity and management risks associated with the Underlying Fund.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="z47e8ae06d0e141f19780606234a95614">

          <tr>
            <td style="width: 17.45pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(91, 134, 43); font-size: 7pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The performance of the Underlying Fund may not correlate with the performance of its Underlying Index as well as the net asset value per share of the Underlying Fund, especially during periods of market volatility when the liquidity and
                the market price of the shares of the Underlying Fund and/or the securities held by the Underlying Fund may be adversely affected, sometimes materially.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="z2d17e140f44e4f64b931d4e05beea126">

          <tr>
            <td style="width: 17.45pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(91, 134, 43); font-size: 7pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The Redemption Amount will not be adjusted for all corporate events that could affect the Underlying Fund. See &#8220;Description of LIRNs&#8212;Anti-Dilution and Discontinuance Adjustments Relating to Underlying Funds&#8221; beginning on page PS-31 of
                product supplement EQUITY LIRN-1.</div>
            </td>
          </tr>

      </table>
      <div style="text-indent: -18pt; margin-left: 18pt; margin-top: 5pt; font-weight: bold;"><u>Valuation- and Market-Related Risks</u></div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="z43b55757019c483ab807600cc7263b16">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(118, 147, 60); font-size: 7pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The initial estimated value of your notes on the pricing date is less than their public offering price. The difference between the public offering price of your notes and the initial estimated value of the notes reflects costs and
                expected profits associated with selling and structuring the notes, as well as hedging our obligations under the notes (including, but not limited to, the hedging related charge, as further described under &#8220;Structuring the Notes&#8221; on page
                TS-13). Because hedging our obligations entails risks and may be influenced by market forces beyond our control, this hedging may result in a profit that is more or less than expected, or a loss and the amount of any such profit or loss
                will not be known until the maturity date.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="z68c82a38fd5746c7a34fbd81a930e8b4">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(118, 147, 60); font-size: 7pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The initial estimated value of your notes is based on our internal funding rate. The internal funding rate used in the determination of the initial estimated value of the notes generally represents a discount from the credit spreads for
                our conventional fixed-rate debt securities and the borrowing rate we would pay for our conventional fixed-rate debt securities. This discount is based on, among other things, our view of the funding value of the notes as well as the higher
                issuance, operational and ongoing liability management costs of the notes in comparison to those costs for our conventional fixed-rate debt, as well as estimated financing costs of any hedge positions (including, but not limited to, the
                hedging related charge, as further described under &#8220;Structuring the Notes&#8221; on page TS-13), taking into account regulatory and internal requirements. If the interest rate implied by the credit spreads for our conventional fixed-rate debt
                securities, or the borrowing rate we would pay for our conventional fixed-rate debt securities were to be used, we would expect the economic terms of the notes to be more favorable to you. Additionally, assuming all other economic terms are
                held constant, the use of an internal funding rate for the notes is expected to have increased the initial estimated value of the notes and have had an adverse effect on the economic terms of the notes.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="zd419145a19b7407796735d8a03286cfc">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(118, 147, 60); font-size: 7pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The initial estimated value of the notes is based on our internal pricing models, which may prove to be inaccurate and may be different from the pricing models of other financial institutions, including BofAS and MLPF&amp;S. The initial
                estimated value of your notes when the terms of the notes were set on the pricing date is based on our internal pricing models, which take into account a number of variables, typically including the expected volatility of the Market
                Measure, interest rates (forecasted, current and</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div style="clear: both;">
              <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                  <tr>
                    <td style="width: 50%; vertical-align: top;">
                      <div style="color: rgb(91, 134, 43); font-size: 8pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                    </td>
                    <td style="width: 50%; vertical-align: top;">
                      <div style="text-align: right; color: rgb(91, 134, 43); font-size: 8pt;">TS-<font class="BRPFPageNumber">6</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                  <tr>
                    <td style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 100%;">
                      <div style="color: rgb(91, 134, 43); font-size: 16pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                      <div style="color: rgb(91, 134, 43);">Linked to the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF due April 28, 2028</div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable">

            <tr>
              <td style="width: 18pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; color: rgb(118, 147, 60);"><br>
              </td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>historical rates), price-sensitivity analysis, time to maturity of the notes and our internal funding rate, and are based on a number of subjective assumptions, which are not evaluated or verified on an independent basis and may or may
                  not materialize. Further, our pricing models may be different from other financial institutions&#8217; pricing models, including those of BofAS and MLPF&amp;S, and the methodologies used by us to estimate the value of the notes may not be
                  consistent with those of other financial institutions that may be purchasers or sellers of notes in any secondary market. As a result, the secondary market price of your notes, if any, may be materially less than the initial estimated
                  value of the notes determined by reference to our internal pricing models. In addition, market conditions and other relevant factors in the future may change and any assumptions may prove to be incorrect.</div>
              </td>
            </tr>

        </table>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="ze4d9543ad5364fb2b328e243cc92d9ea">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(118, 147, 60); font-size: 7pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The initial estimated value of your notes is not a prediction of the prices at which you may sell your notes in the secondary market, if any exists, and such secondary market prices, if any, will likely be less than the public offering
                price of your notes, may be less than the initial estimated value of your notes and could result in a substantial loss to you. The initial estimated value of the notes will not be a prediction of the prices at which MLPF&amp;S, BofAS, or
                our or their respective affiliates or third parties may be willing to purchase the notes from you in secondary market transactions (if they are willing to purchase, which they are not obligated to do). The price at which you may be able to
                sell your notes in the secondary market at any time, if any, will be influenced by many factors that cannot be predicted, such as market conditions, and any bid and ask spread for similar sized trades, and may be substantially less than the
                initial estimated value of the notes. Further, as secondary market prices of your notes take into account the levels at which our debt securities trade in the secondary market, and do not take into account our various costs and expected
                profits associated with selling and structuring the notes, as well as hedging our obligations under the notes, secondary market prices of your notes will likely be less than the public offering price of your notes. As a result, the price at
                which MLPF&amp;S, BofAS, or our or their respective affiliates or third parties may be willing to purchase the notes from you in secondary market transactions, if any, will likely be less than the price you paid for your notes, and any sale
                prior to maturity could result in a substantial loss to you.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="z38a993b0d3d1485b8c7739e8e67a4f70">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(118, 147, 60); font-size: 7pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>A trading market is not expected to develop for the notes. None of us, MLPF&amp;S, BofAS or our or their respective affiliates is obligated to make a market for, or to repurchase, the notes. There is no assurance that any party will be
                willing to purchase your notes at any price in any secondary market.</div>
            </td>
          </tr>

      </table>
      <div style="text-indent: -18pt; margin-left: 18pt; margin-top: 5pt; font-weight: bold;"><u>Conflict-Related Risks</u></div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="zfaaf305b407e4720a45c7f128ad3de30">

          <tr>
            <td style="width: 17.45pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(91, 134, 43); font-size: 7pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Our business, hedging and trading activities, and those of MLPF&amp;S, BofAS and our and their respective affiliates (including trades in the Underlying Fund or the securities held by the Underlying Fund), and any hedging and trading
                activities we, MLPF&amp;S, BofAS or our or their respective affiliates engage in for our clients&#8217; accounts, may affect the market value of, and return on, the notes and may create conflicts of interest with you.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="z85a5d2ff62054922a4feb265332b31ee">

          <tr>
            <td style="width: 17.45pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(91, 134, 43); font-size: 7pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>There may be potential conflicts of interest involving the calculation agents, one of which is us and one of which is BofAS, as the determinations made by the calculation agents may be discretionary and could adversely affect any payment
                on the notes.</div>
            </td>
          </tr>

      </table>
      <div style="text-indent: -18pt; margin-left: 18pt; margin-top: 5pt; font-weight: bold;"><u>General Credit-Related Risks</u></div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="z37306e3179354345ab56d935a94574a7">

          <tr>
            <td style="width: 17.45pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(91, 134, 43); font-size: 7pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Payments on the notes are subject to our credit risk, and actual or perceived changes in our creditworthiness are expected to affect the value of the notes. If we become unable to meet our financial obligations as they become due, you
                may lose some or all of your investment.</div>
            </td>
          </tr>

      </table>
      <div style="text-indent: -18pt; margin-left: 18pt; margin-top: 5pt; font-weight: bold;"><u>Tax-Related Risks</u></div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="zab24ea895bc6434187667d4b26ee1b50">

          <tr>
            <td style="width: 17.45pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(91, 134, 43); font-size: 7pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The U.S. federal income tax consequences of the notes are uncertain and, because of this uncertainty, there is a risk that the U.S. federal income tax consequences of the notes could differ materially and adversely from the treatment
                described below in &#8220;Supplemental Discussion of U.S. Federal Income Tax Consequences&#8221;, as described further in product supplement EQUITY LIRN-1 under &#8220;Material U.S. Federal Income Tax Consequences &#8212; Alternative Treatments&#8221;. You should
                consult your tax advisors as to the tax consequences of an investment in the notes and the potential alternative treatments.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="ze59a63404bfe413693a420433d7243a7">

          <tr>
            <td style="width: 17.45pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(91, 134, 43); font-size: 7pt;">&#9632;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>For a discussion of the Canadian federal income tax consequences of investing in the notes, please see the discussion herein under &#8220;Canadian Taxation&#8221;. If you are not a Non-resident Holder (as that term is defined under &#8220;Canadian
                Taxation&#8221; herein) for Canadian federal income tax purposes or if you acquire the notes in the secondary market, you should consult your tax advisors as to the consequences of acquiring, holding and disposing of the notes and receiving the
                payments that might be due under the notes. We will not pay any additional amounts as a result of any withholding required by reason of the rules governing hybrid mismatch arrangements contained in sections 12.7 and 18.4 of the Canadian Tax
                Act, as such rules may be amended from time to time.</div>
            </td>
          </tr>

      </table>
      <div style="margin-top: 6pt; margin-bottom: 6pt; color: rgb(91, 134, 43); font-size: 20pt;">Additional Risk Factors</div>
      <div style="text-align: justify; margin-top: 5pt; font-weight: bold;">The notes are subject to foreign currency exchange rate risk.</div>
      <div style="text-align: justify; margin-top: 5pt;">&#160;The Underlying Fund holds securities traded outside of the United States. The Underlying Fund&#8217;s share price will fluctuate based upon its net asset value, which will in turn depend in part upon
        changes in the value of the currencies in which the securities held by the Underlying Fund are traded. Accordingly, investors in the notes will be exposed to currency exchange rate risk with respect to each of the currencies in which the securities
        held by the Underlying Fund are traded. An investor&#8217;s net exposure will depend on the extent to which these currencies strengthen or weaken against the U.S. dollar. If the dollar strengthens against these currencies, the net asset value of the
        Underlying Fund will be adversely affected and the price of the Underlying Fund may decrease.</div>
      <div style="text-align: justify; margin-top: 5pt; font-weight: bold;">The notes are subject to risks associated with foreign securities markets.</div>
      <div style="font-weight: bold; text-align: justify;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div style="clear: both;">
              <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                  <tr>
                    <td style="width: 50%; vertical-align: top;">
                      <div style="color: rgb(91, 134, 43); font-size: 8pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                    </td>
                    <td style="width: 50%; vertical-align: top;">
                      <div style="text-align: right; color: rgb(91, 134, 43); font-size: 8pt;">TS-<font class="BRPFPageNumber">7</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                  <tr>
                    <td style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 100%;">
                      <div style="color: rgb(91, 134, 43); font-size: 16pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                      <div style="color: rgb(91, 134, 43);">Linked to the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF due April 28, 2028</div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
      </div>
      <div style="text-align: justify; margin-top: 5pt;">The Underlying Fund includes certain foreign equity securities. You should be aware that investments in securities linked to the value of foreign equity securities involve particular risks. The
        foreign securities markets comprising the Underlying Fund may have less liquidity and may be more volatile than U.S. or other securities markets and market developments may affect foreign markets differently from U.S. or other securities markets.
        Direct or indirect government intervention to stabilize these foreign securities markets, as well as cross-shareholdings in foreign companies, may affect trading prices and volumes in these markets. Also, there is generally less publicly available
        information about foreign companies than about those U.S. companies that are subject to the reporting requirements of the SEC, and foreign companies are subject to accounting, auditing and financial reporting standards and requirements that differ
        from those applicable to U.S. reporting companies.</div>
      <div style="text-align: justify; margin-top: 5pt;">Prices of securities in foreign countries are subject to political, economic, financial and social factors that apply in those geographical regions. These factors, which could negatively affect those
        securities markets, include the possibility of recent or future changes in a foreign government&#8217;s economic and fiscal policies, the possible imposition of, or changes in, currency exchange laws or other laws or restrictions applicable to foreign
        companies or investments in foreign equity securities and the possibility of fluctuations in the rate of exchange between currencies, the possibility of outbreaks of hostility and political instability and the possibility of natural disaster or
        adverse public health developments in the region. Moreover, foreign economies may differ favorably or unfavorably from the U.S. economy in important respects such as growth of gross national product, rate of inflation, capital reinvestment,
        resources and self-sufficiency.</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div style="clear: both;">
              <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                  <tr>
                    <td style="width: 50%; vertical-align: top;">
                      <div style="color: rgb(91, 134, 43); font-size: 8pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                    </td>
                    <td style="width: 50%; vertical-align: top;">
                      <div style="text-align: right; color: rgb(91, 134, 43); font-size: 8pt;">TS-<font class="BRPFPageNumber">8</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                  <tr>
                    <td style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 100%;">
                      <div style="color: rgb(91, 134, 43); font-size: 16pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                      <div style="color: rgb(91, 134, 43);">Linked to the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF due April 28, 2028</div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
      </div>
      <div style="text-align: justify; margin-top: 6pt; color: rgb(91, 134, 43); font-size: 20pt;">The Underlying Fund</div>
      <div style="text-align: justify; margin-top: 5pt;">All disclosures contained in this term sheet regarding the Underlying Fund, including, without limitation, its make-up, method of calculation, and changes in its components, have been derived from
        publicly available sources. The information reflects the policies of, and is subject to change by, BlackRock Fund Advisors, the advisor to the Underlying Fund (the &#8220;sponsor&#8221; or &#8220;BFA&#8221;). The sponsor has no obligation to continue to publish, and may
        discontinue publication of, the Underlying Fund. The consequences of the sponsor discontinuing publication of the Underlying Fund are discussed in the section entitled &#8220;Description of LIRNs &#8212;Anti-Dilution and Discontinuance Adjustments Relating to
        Underlying Funds&#8221; beginning on page PS-31 of product supplement EQUITY LIRN-1. None of us, our affiliates, the calculation agents, MLPF&amp;S or BofAS accepts any responsibility for the calculation, maintenance or publication of the Underlying Fund
        or any successor Underlying Fund.</div>
      <div style="text-align: justify; margin-top: 5pt; font-weight: bold;">
        <table cellspacing="0" cellpadding="0" border="0" id="z726f0bde30b14c32b93d91caf6a3f514" style="font-family: Arial; font-size: 9pt; color: rgb(0, 0, 0); width: 5%;">

            <tr>
              <td nowrap="nowrap" style="width: 5%; border-bottom: 1px solid rgb(0, 0, 0);">
                <div style="font-weight: bold; text-align: justify;">The iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-align: justify; margin-top: 5pt;">The iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF (the &#8220;EFA Fund&#8221;) seeks to track the investment results, before fees and expenses, of an index composed of large- and mid-capitalization developed market
        equities, excluding the U.S. and Canada, which is currently the MSCI EAFE<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index. For more information about the MSCI EAFE<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index, see &#8220;The MSCI EAFE<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index&#8221; below. The iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF is an
        exchange-traded fund that trades on NYSE Arca under the ticker symbol &#8220;EFA.&#8221;</div>
      <div style="text-align: justify; margin-top: 5pt;">BFA uses a representative sampling indexing strategy to manage the EFA Fund. &#8220;Representative sampling&#8221; is an indexing strategy that involves investing in a representative sample of securities that
        collectively has an investment profile similar to that of an applicable Underlying Index. The securities selected are expected to have, in the aggregate, investment characteristics (based on factors such as market capitalization and industry
        weightings), fundamental characteristics (such as return variability and yield) and liquidity measures similar to those of an applicable Underlying Index. The EFA Fund may or may not hold all of the securities in its Underlying Index.</div>
      <div style="text-align: justify; margin-top: 5pt;">The EFA Fund&#8217;s Underlying Index is a financial calculation, based on a grouping of financial instruments, and is not an investment product, while the EFA Fund is an actual investment portfolio. The
        performance of the EFA Fund and its Underlying Index may vary for a number of reasons, including transaction costs, asset or currency valuations, corporate actions (such as mergers and spin-offs), timing variances and differences between the EFA
        Fund&#8217;s portfolio and its Underlying Index resulting from the EFA Fund&#8217;s use of representative sampling or from legal restrictions (such as diversification requirements) that apply to the EFA Fund but not to its Underlying Index. &#8220;Tracking error&#8221; is
        the divergence of the performance (return) of the EFA Fund&#8217;s portfolio from that of its Underlying Index. Because the EFA Fund uses a representative sampling indexing strategy, it can be expected to have a larger tracking error than if it used a
        replication indexing strategy. &#8220;Replication&#8221; is an indexing strategy in which a fund invests in substantially all of the securities in its Underlying Index in approximately the same proportions as in the Underlying Index.</div>
      <div style="text-align: justify; margin-top: 5pt;">iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>, Inc. is a registered investment company that consists of numerous separate investment portfolios, including the EFA Fund. Information provided to or filed with the SEC by iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>,
        Inc. pursuant to the Securities Act of 1933, as amended, and the Investment Company Act of 1940, as amended, can be located by reference to SEC file numbers 033-97598 and 811-09102, respectively, through the SEC&#8217;s website at http://www.sec.gov.</div>
      <div style="text-align: justify; margin-top: 5pt; font-style: italic; font-weight: bold;">The MSCI EAFE<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index</div>
      <div style="text-align: justify; margin-top: 5pt;">The MSCI EAFE<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index is a free float-adjusted market capitalization index that is designed to measure the equity market performance of the large- and mid-cap segments of certain developed
        markets, excluding the United States and Canada. The MSCI EAFE<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index currently consists of the following 21 developed market country indices: Australia, Austria, Belgium, Denmark, Finland, France, Germany, Hong Kong, Ireland, Israel,
        Italy, Japan, the Netherlands, New Zealand, Norway, Portugal, Singapore, Spain, Sweden, Switzerland and the United Kingdom. The MSCI EAFE<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index covers approximately 85% of the free float-adjusted market capitalization in each country.
        The U.S. dollar price return version of the MSCI EAFE<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index is reported by Bloomberg L.P. under the ticker symbol &#8220;MXEA.&#8221; For more information about the MSCI EAFE<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index, see &#8220;The MSCI Index&#8221; below.</div>
      <div style="text-align: justify; margin-top: 5pt; font-style: italic; font-weight: bold;">The MSCI Index</div>
      <div style="text-align: justify; margin-top: 5pt;">All information contained in this term sheet regarding the MSCI EAFE<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index (an &#8220;MSCI Index&#8221;), including, without limitation, their make-up, method of calculation and changes in their
        components, has been derived from publicly available information, without independent verification. This information reflects the policies of, and is subject to change by, MSCI Inc. (&#8220;MSCI&#8221;). The MSCI Index is calculated, maintained and published
        by MSCI. MSCI has no obligation to continue to publish, and may discontinue the publication of, the MSCI Index.</div>
      <div style="text-align: justify; margin-top: 5pt; font-weight: bold;">Constructing the MSCI Global Investable Market Indices</div>
      <div style="text-align: justify; margin-top: 5pt;">The MSCI Global Investable Market Indices, including the MSCI EAFE<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index, are constructed and maintained at an individual market level. MSCI undertakes an index construction process that
        involves: (i) defining the equity universe for each market; (ii) determining the market investable equity universe for each market; (iii) determining market capitalization size segments for each market; and (iv) applying index continuity rules for
        the Standard Index (as defined below).</div>
      <div style="text-align: justify; margin-top: 5pt; font-style: italic;">Defining the Equity Universe for the Relevant Market</div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="z41a16a8cd59846e7a74ecd568c0828b9">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">(i)</td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify;">Identifying Eligible Equity Securities: All listed equity securities, including real estate investment trusts and certain income trusts listed in Canada, are eligible for inclusion in the equity universe.
                Limited partnerships, limited liability companies and business trusts, which are listed in the United States and are not structured to be taxed as limited partnerships, are likewise eligible for inclusion in the equity universe. Conversely,
                mutual funds, exchange-traded funds, equity derivatives and most investment trusts<br>
              </div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div style="clear: both;">
              <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                  <tr>
                    <td style="width: 50%; vertical-align: top;">
                      <div style="color: rgb(91, 134, 43); font-size: 8pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                    </td>
                    <td style="width: 50%; vertical-align: top;">
                      <div style="text-align: right; color: rgb(91, 134, 43); font-size: 8pt;">TS-<font class="BRPFPageNumber">9</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                  <tr>
                    <td style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 100%;">
                      <div style="color: rgb(91, 134, 43); font-size: 16pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                      <div style="color: rgb(91, 134, 43);">Linked to the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF due April 28, 2028</div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable">

            <tr>
              <td style="width: 18pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;"><br>
              </td>
              <td style="width: auto; vertical-align: top;">
                <div style="text-align: justify;">are not eligible for inclusion in the equity universe. Preferred shares that exhibit characteristics of equity securities are eligible. Stapled securities are considered eligible if each of the underlying
                  components exhibit characteristics of equity securities.</div>
              </td>
            </tr>

        </table>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="z36e2a069733042d19b7e9c6b9d428f29">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">(ii)</td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify;">Country Classification of Eligible Securities: The equity universe initially looks at securities listed in any of the countries in the MSCI global index series, which will be classified as a developed market
                (&#8220;DM&#8221;), emerging market (&#8220;EM&#8221;) or frontier market. Each company and its securities (i.e., share classes) are classified in one and only one country, which allows for a distinctive sorting of each company by its respective country.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; margin-top: 5pt; font-style: italic;">Determining the Market Investable Equity Universes</div>
      <div style="text-align: justify; margin-top: 5pt;">A market investable equity universe for a market is derived by (i) identifying eligible listings for each security in the equity universe and (ii) applying investability screens to individual
        companies and securities in the equity universe that are classified in that market. A market is equivalent to a single country, except in DM Europe, where all DM countries in Europe are aggregated into a single market for index construction
        purposes. The global investable equity universe is the aggregation of all market investable equity universes.</div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="z62bec0a88de94fedb2e51e84d8258e59">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">(i)</td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify;">Identifying Eligible Listings: A security may have a listing that trades in the country where it is classified (a &#8220;local listing&#8221;) and/or a listing that trades in a different country (a &#8220;foreign listing&#8221;). A
                security may be represented by either a local listing or a foreign listing (including a depositary receipt) in the global investable equity universe as determined by MSCI.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="ze52001c0275141a4ac46acaffc0a6195">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">(ii)</td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify;">Applying Investability Screens: Some of the investability requirements are applied at the individual security level and some at the overall company level, represented by the aggregation of individual
                securities of the company. As such, the inclusion or exclusion of one security does not imply the automatic inclusion or exclusion of other securities of the same company.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; text-indent: 36pt; margin-top: 5pt;">The investability screens used to determine the investable equity universe in each market are as follows:</div>
      <div style="text-align: justify; margin-top: 5pt;">
        <div><br>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="z1545b7e243b343d585ec8f0249ee8d56">

            <tr>
              <td style="width: 54pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">a.</td>
              <td style="width: auto; vertical-align: top;">
                <div style="text-align: justify;">Equity Universe Minimum Size Requirement: This investability screen is applied at the company level. In order to be included in a market investable equity universe, a company must have the required minimum
                  full market capitalization. A company will meet this requirement if its cumulative free float-adjusted market capitalization is within the top 99% of the equity universe sorted in descending order by full market capitalization.</div>
              </td>
            </tr>

        </table>
        <div style="margin-top: 5pt;"> <br>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="zc341819076aa4f6c99ef1802d8152d9a">

            <tr>
              <td style="width: 54pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">b.</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>Equity Universe Minimum Free Float-Adjusted Market Capitalization Requirement: This investability screen is applied at the individual security level. To be eligible for inclusion in a market investable equity universe, a security must
                  have a free float-adjusted market capitalization equal to or higher than 50% of the equity universe minimum size requirement.</div>
              </td>
            </tr>

        </table>
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="zad8c03944adf41d38b37d077c64a6d96">

            <tr>
              <td style="width: 54pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">c.</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>DM and EM Minimum Liquidity Requirement: This investability screen is applied at the individual security level. To be eligible for inclusion in a market investable equity universe, a security must have adequate liquidity as measured by
                  the annualized traded value ratio (&#8220;ATVR&#8221;) and the frequency of trading. In addition to the ATVR and frequency of trading requirements, securities in the MSCI China equity universe will not be eligible for inclusion in the market
                  investable equity universe if the securities are suspended on the price cutoff date of the index review or have been suspended for 50 consecutive business days or more in the past 12 months.</div>
              </td>
            </tr>

        </table>
        <div style="margin-left: 72pt; margin-top: 5pt;">Only one listing per security may be included in the market investable equity universe. In instances when a security has two or more eligible listings that meet the above liquidity requirements, then
          the following priority rules are used to determine which listing will be used for potential inclusion of the security in the market investable equity universe: (i) local listing; (ii) foreign listing in the same geographical region and (iii)
          foreign listing in a different geographical region.</div>
        <div style="margin-left: 72pt; margin-top: 5pt;">Due to liquidity concerns relating to securities trading at very high stock prices, a security with a stock price above $10,000 will fail the liquidity screening and will not be included in any
          market investable equity universe. This limitation applies only for securities that are not currently constituents of the MSCI Global Investable Market Indices. Current constituents of the MSCI Global Investable Market Indices will remain in
          their respective indices even if their stock price passes $10,000.</div>
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="z3504ab5aae0d43e3b52e65460bc53785">

            <tr>
              <td style="width: 54pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">d.</td>
              <td style="width: auto; vertical-align: top;">
                <div style="text-align: justify;">Global Minimum Foreign Inclusion Factor Requirement: This investability screen is applied at the individual security level. To be eligible for inclusion in a market investable equity universe, a security&#8217;s
                  foreign inclusion factor (&#8220;FIF&#8221;) must reach a certain threshold. The FIF of a security is defined as the proportion of shares outstanding that is available for purchase in the public equity markets by international investors. This
                  proportion accounts for the available free float of and/or the foreign ownership limits applicable to a specific security (or company). In general, a security must have an FIF equal to or larger than 0.15 to be eligible for inclusion in a
                  market investable equity universe. Exceptions to this general rule are made only in the limited cases where the exclusion of securities of a very large company would compromise the Standard Index&#8217;s ability to fully and fairly represent
                  the characteristics of the underlying market.</div>
              </td>
            </tr>

        </table>
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="z54c40afc04ff4aefb6aff15ad79c5c48">

            <tr>
              <td style="width: 54pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">e.</td>
              <td style="width: auto; vertical-align: top;">
                <div style="text-align: justify;">Minimum Length of Trading Requirement: This investability screen is applied at the individual security level. For an initial public offering (&#8220;IPO&#8221;) to be eligible for inclusion in a market investable
                  equity universe, the new issue must have started trading at least three months before the implementation of an index review. This requirement is applicable to small new issues in all markets. Large IPOs and large primary/secondary
                  offerings of non-index constituents are not subject to this requirement and may be included in a market investable equity universe and the Standard Index outside of an index review.</div>
              </td>
            </tr>

        </table>
        <div> <br>
        </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
          <div class="BRPFPageFooter" style="width: 100%;">
            <div>
              <div style="clear: both;">
                <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                    <tr>
                      <td style="width: 50%; vertical-align: top;">
                        <div style="color: rgb(91, 134, 43); font-size: 8pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                      </td>
                      <td style="width: 50%; vertical-align: top;">
                        <div style="text-align: right; color: rgb(91, 134, 43); font-size: 8pt;">TS-<font class="BRPFPageNumber">10</font></div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>
          </div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          <div class="BRPFPageHeader" style="width: 100%;">
            <div>
              <div>
                <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                    <tr>
                      <td style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 100%;">
                        <div style="color: rgb(91, 134, 43); font-size: 16pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                        <div style="color: rgb(91, 134, 43);">Linked to the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF due April 28, 2028</div>
                      </td>
                    </tr>

                </table>
              </div>
            </div>
          </div>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="z7716f35b68014c81967725f58e8078b8">

            <tr>
              <td style="width: 54pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">f.</td>
              <td style="width: auto; vertical-align: top;">
                <div style="text-align: justify;">Minimum Foreign Room Requirement: This investability screen is applied at the individual security level. For a security that is subject to a foreign ownership limit to be eligible for inclusion in a market
                  investable equity universe, the proportion of shares still available to foreign investors relative to the maximum allowed (referred to as &#8220;foreign room&#8221;) must be at least 15%.</div>
              </td>
            </tr>

        </table>
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="z22bd5c2e290e4fdca365949e6d5a69fd">

            <tr>
              <td style="width: 54pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">g.</td>
              <td style="width: auto; vertical-align: top;">
                <div>Financial Reporting Requirement: This investability screen is applied at the company level. Companies classified as belonging to the United States must file a Form 10-K/10-Q to be eligible for inclusion in the United States investable
                  equity universe.</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-align: justify; margin-top: 5pt; font-style: italic;">Defining Market Capitalization Size Segments for Each Market</div>
      <div style="text-align: justify; margin-top: 5pt;">Once a market investable equity universe is defined, it is segmented into the following size-based indices (each, a &#8220;Size Segment Index&#8221;), with the following free float-adjusted market capitalization
        market coverage target ranges:</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="z9ca858c8460c4f23a22a47b2ab07943c">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">(i)</td>
            <td style="width: auto; vertical-align: top;">
              <div>Investable Market Index (Large + Mid + Small): 99%+1% or -0.5%</div>
            </td>
          </tr>

      </table>
      <div style="margin-top: 5pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="z0837df9fefcc49a99d10e75314821095">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">(ii)</td>
            <td style="width: auto; vertical-align: top;">
              <div>Standard Index (Large + Mid): 85% &#177; 5%</div>
            </td>
          </tr>

      </table>
      <div style="margin-top: 5pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="z2eedaa09652f4e948e0b3e91cfe81da7">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#160;(iii)</td>
            <td style="width: auto; vertical-align: top;">
              <div>Large Cap Index: 70% &#177; 5%</div>
            </td>
          </tr>

      </table>
      <div style="margin-top: 5pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="z344bb6afaedc47198d7c8371b16bac29">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">(iv)</td>
            <td style="width: auto; vertical-align: top;">
              <div>Mid Cap Index: The Mid Cap Index market coverage in each market is derived as the difference between the market coverage of the Standard Index and the Large Cap Index in that market.</div>
            </td>
          </tr>

      </table>
      <div style="margin-top: 5pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: rgb(0, 0, 0); margin-top: 5pt;" class="DSPFListTable" id="z778ea6ff2fe34f55a23e20c2d3581197">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">(v)</td>
            <td style="width: auto; vertical-align: top;">
              <div>Small Cap Index: The Small Cap Index market coverage in each market is derived as the difference between the free float-adjusted market capitalization coverage of the Investable Market Index and the Standard Index in that market.</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; margin-top: 5pt;">Creating the Size Segment Indices in each market involves the following steps: (i) defining the market coverage target range for each size segment; (ii) determining the global minimum size range for
        each size segment; (iii) determining the market size segment cutoffs and associated segment number of companies; (iv) assigning companies to the size segments; and (v) applying final size-segment investability requirements (which includes minimum
        free float market capitalization requirements, minimum foreign room requirements, and exclusions for securities that exhibit extreme price increases).</div>
      <div style="text-align: justify; margin-top: 5pt; font-style: italic;">Index Continuity Rules for the Standard Indices</div>
      <div style="text-align: justify; margin-top: 5pt;">In order to achieve index continuity, as well as provide some basic level of diversification within a market index, notwithstanding the effect of other index construction rules, a minimum number of
        five constituents will be maintained for a DM Standard Index and a minimum number of three constituents will be maintained for an EM Standard Index.</div>
      <div style="text-align: justify; margin-top: 5pt;">If, after the application of the index construction methodology, a Standard Index contains fewer than five securities in a DM or three securities in an EM, then the largest securities by free
        float-adjusted market capitalization among the securities included in the market investable equity universe are added to the Standard Index in order to reach five constituents in that DM or three in that EM. At subsequent index reviews, if the
        minimum number of securities described above is not met, then after the market investable equity universe is identified, the securities are ranked by free float-adjusted market capitalization, however, in order to increase stability the free
        float-adjusted market capitalization of the existing index constituents (prior to review) is multiplied by 1.5, and securities are added until the desired minimum number of securities is reached.</div>
      <div style="text-align: justify; margin-top: 5pt; font-style: italic;">Classifying Securities under the Global Industry Classification Standard</div>
      <div style="text-align: justify; margin-top: 5pt;">All securities in the global investable equity universe are assigned to the industry that best describes their business activities. To this end, MSCI has designed, in conjunction with S&amp;P Dow
        Jones Indices, the GICS<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>. The GICS<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> entails four levels of classification: (i) sector; (ii) industry groups; (iii) industries; and (iv) sub-industries. Under the GICS<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>, each company is assigned uniquely to one
        sub-industry according to its principal business activity. Therefore, a company can belong to only one industry grouping at each of the four levels of the GICS<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>. The GICS<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> classification of each security is used by MSCI to
        construct additional indices.</div>
      <div style="text-align: justify; margin-top: 5pt; font-style: italic;">Constructing and Calculating the Individual Global Investable Market Indices</div>
      <div style="text-align: justify; margin-top: 5pt;">After companies are allocated to their respective size segments and securities are reviewed for complying with the final size-segment requirements, the final list of constituents for each Size
        Segment Index is determined. The MSCI Investable Market Indices are composed of the MSCI Standard Indices and the MSCI Small Cap Indices. The MSCI Standard Indices are further subdivided into the MSCI Large Cap and the MSCI Mid Cap Indices. Two or
        more market indices can be combined to form composite indices. Market indices can be grouped either on the basis of market classification definition, geographical regions, economic regions or other criteria.</div>
      <div style="text-align: justify; margin-top: 5pt; font-weight: bold;">Maintenance of the MSCI Global Investable Market Indices</div>
      <div style="text-align: justify; margin-top: 5pt;">The MSCI Global Investable Market Indices are maintained with the objective of reflecting the evolution of the underlying equity markets and segments on a timely basis, while seeking to achieve index
        continuity, continuous investability of constituents and replicability of the indices and index stability and low index turnover.</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div style="clear: both;">
              <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                  <tr>
                    <td style="width: 50%; vertical-align: top;">
                      <div style="color: rgb(91, 134, 43); font-size: 8pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                    </td>
                    <td style="width: 50%; vertical-align: top;">
                      <div style="text-align: right; color: rgb(91, 134, 43); font-size: 8pt;">TS-<font class="BRPFPageNumber">11</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                  <tr>
                    <td style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 100%;">
                      <div style="color: rgb(91, 134, 43); font-size: 16pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                      <div style="color: rgb(91, 134, 43);">Linked to the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF due April 28, 2028</div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
      </div>
      <div style="text-align: justify; margin-top: 5pt;">In particular, index maintenance involves semi-annual index reviews in May and November and quarterly index reviews in February and August. Semi-annual index reviews include updating the indices on
        the basis of a fully refreshed equity universe; taking buffer rules into consideration for migration of securities across size and style segments; and updating FIFs and number of shares (&#8220;NOS&#8221;). Quarterly index reviews include adding significant
        new eligible securities (such as IPOs that were not eligible for earlier inclusion) in the index; allowing for significant moves of companies within the Size Segment Indices, using wider buffers than in the semi-annual index reviews; and reflecting
        the impact of significant market events on FIFs and updating NOS.</div>
      <div style="text-align: justify; margin-top: 5pt;">In addition, ongoing event-related changes to the indices are made as the result of mergers, acquisitions, spin-offs, bankruptcies, reorganizations and other similar corporate events. They can also
        result from capital reorganizations in the form of rights issues, bonus issues, public placements and other similar corporate actions that take place on a continuing basis. These changes generally are reflected in the indices at the time of the
        event. Significantly large IPOs are included in the indices after the close of the company&#8217;s tenth day of trading.</div>
      <div style="text-align: justify; margin-top: 5pt; font-weight: bold;">Calculation of the MSCI Global Investable Market Indices</div>
      <div style="text-align: justify; margin-top: 5pt;">The MSCI Global Investable Market Indices are calculated using the Laspeyres&#8217; concept of a weighted arithmetic average together with the concept of chain-linking. As a general principle, today&#8217;s
        index level is obtained by applying the change in the market performance to the previous period index level.</div>
      <div style="text-align: justify; margin-top: 5pt;"> <br>
      </div>
      <div style="text-align: justify; margin-top: 5pt; font-weight: bold;">Historical Data</div>
      <div style="text-align: justify; margin-top: 5pt;"><font style="font-weight: bold; font-style: italic;">The following graph shows the daily historical performance of the Underlying Fund</font><font style="font-size: 8pt;">&#160;</font><font style="font-weight: bold; font-style: italic;">on its primary exchange in the period from January 1, 2016 through April 30, 2026. We obtained this historical data from Bloomberg L.P. We have not independently verified the accuracy or completeness
          of the information obtained from Bloomberg L.P. On the pricing date, the Closing Market Price of the Underlying Fund</font><font style="font-size: 8pt;">&#160;</font><font style="font-weight: bold; font-style: italic;">was $102.32. The graph below may
          have been adjusted to reflect certain corporate actions such as stock splits and reverse stock splits.</font></div>
      <div style="text-align: center; margin-top: 5pt; font-weight: bold;">Historical Performance of the Underlying Fund</div>
      <div style="text-align: center; margin-top: 5pt;"><img src="image5.jpg"></div>
      <div style="text-align: justify; margin-top: 5pt;"><font style="font-weight: bold; font-style: italic;">This historical data on the Underlying Fund</font><font style="font-size: 8pt;">&#160;</font><font style="font-weight: bold; font-style: italic;">is
          not necessarily indicative of the future performance of the Underlying Fund</font><font style="font-size: 8pt;">&#160;</font><font style="font-weight: bold; font-style: italic;">or what the value of the notes may be. Any historical upward or downward
          trend in the price per share of the Underlying Fund</font><font style="font-size: 8pt;">&#160;</font><font style="font-weight: bold; font-style: italic;">during any period set forth above is not an indication that the price per share of the Underlying
          Fund</font><font style="font-size: 8pt;">&#160;</font><font style="font-weight: bold; font-style: italic;">is more or less likely to increase or decrease at any time over the term of the notes.</font></div>
      <div style="text-align: justify; margin-top: 5pt;">You should consult publicly available sources for the prices and trading patterns of the Underlying Fund<font style="font-size: 8pt;">.</font></div>
      <div style="text-align: justify;"><font style="font-size: 8pt;"> <br>
        </font></div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div style="clear: both;">
              <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                  <tr>
                    <td style="width: 50%; vertical-align: top;">
                      <div style="color: rgb(91, 134, 43); font-size: 8pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                    </td>
                    <td style="width: 50%; vertical-align: top;">
                      <div style="text-align: right; color: rgb(91, 134, 43); font-size: 8pt;">TS-<font class="BRPFPageNumber">12</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                  <tr>
                    <td style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 100%;">
                      <div style="color: rgb(91, 134, 43); font-size: 16pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                      <div style="color: rgb(91, 134, 43);">Linked to the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF due April 28, 2028</div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
      </div>
      <div style="margin-top: 6pt; margin-bottom: 6pt; color: rgb(91, 134, 43); font-size: 20pt;">Supplement to the Plan of Distribution (Conflicts of Interest)</div>
      <div style="text-align: justify; margin-top: 3pt;">Under our distribution agreement, we have appointed TDS, an affiliate of TD, and BofAS as agents for the sale of the notes. TDS will purchase the notes from us, and BofAS will purchase the notes from
        TDS, each at the public offering price less the indicated underwriting discount indicated on the cover hereof MLPF&amp;S will purchase the notes from BofAS for resale, and will receive a selling concession in connection with the sale of the notes
        in an amount up to the full amount of the underwriting discount indicated on the cover of this term sheet. BofAS and MLPF&amp;S will offer the notes at the public offering price set forth on the cover page hereof. We or one of our affiliates will
        also pay a fee to LFT Securities, LLC for providing certain electronic platform services with respect to this offering, which will have an adverse effect on the economic terms of the notes. An affiliate of each of TD and BofAS has an ownership
        interest in LFT Securities, LLC. TD will reimburse TDS for certain expenses in connection with its role in the offer and sale of the notes, and TD will pay TDS a fee in connection with its role in the offer and sale of the notes.</div>
      <div style="text-align: justify; margin-top: 3pt;">We will deliver the notes against payment therefor in New York, New York on a date that is greater than one business day following the pricing date. Under Rule 15c6-1 of the Securities Exchange Act
        of 1934, as amended, trades in the secondary market generally are required to settle in one business day, unless the parties to any such trade expressly agree otherwise. Accordingly, purchasers who wish to trade the notes more than one business day
        prior to the settlement date will be required to specify alternative settlement arrangements to prevent a failed settlement.</div>
      <div style="text-align: justify; margin-top: 3pt;">The notes will not be listed on any securities exchange. In the original offering of the notes, the notes will be sold in minimum investment amounts of 100 units. If you place an order to purchase
        the notes, you are consenting to MLPF&amp;S and/or one of its affiliates acting as a principal in effecting the transaction for your account.</div>
      <div style="text-align: justify; margin-top: 3pt;">MLPF&amp;S, BofAS or our or their affiliates may repurchase and resell the notes, with repurchases and resales being made at prices related to then-prevailing market prices or at negotiated prices,
        and these prices will include MLPF&amp;S&#8217; and BofAS&#8217; (or such other entity&#8217;s) trading commissions and mark-ups or mark-downs. MLPF&amp;S and BofAS (or such other entity) may act as principal or agent in these market-making transactions, but is not
        obligated to engage in any such transactions. At MLPF&amp;S&#8217; and BofAS&#8217; discretion, MLPF&amp;S and BofAS may offer to buy the notes in the secondary market at a price that may exceed TD&#8217;s initial estimated value of the notes for a short,
        undetermined initial period after the issuance of the notes. Notwithstanding the foregoing, any price offered by us, MLPF&amp;S, BofAS or our or their affiliates for the notes will be based on then-prevailing market conditions and other
        considerations, including the performance of the Underlying Fund and the remaining term of the notes. However, none of us, MLPF&amp;S, BofAS or any of our or their respective affiliates is obligated to purchase your notes at any price or at any
        time, and we cannot assure you that we, MLPF&amp;S, BofAS or any of our or their respective affiliates will purchase your notes at a price that equals or exceeds the initial estimated value of the notes.</div>
      <div style="text-align: justify; margin-top: 3pt;">BofAS has informed us that, as of the date hereof, it expects that if you hold your notes in a BofAS account, the value of the notes shown on your account statement will be based on BofAS&#8217; estimate
        of the value of the notes if BofAS or another of its affiliates were to make a market in the notes, which it is not obligated to do. That estimate will be based upon the price that BofAS may pay for the notes in light of then-prevailing market
        conditions, and other considerations, as mentioned above, and will include transaction costs. At certain times, this price may be higher than or lower than our initial estimated value of the notes.</div>
      <div style="text-align: justify; margin-top: 3pt;">TDS is an affiliate of TD and, as such, has a &#8220;conflict of interest&#8221; in this offering within the meaning of Financial Industry Regulatory Authority, Inc. (&#8220;FINRA&#8221;) Rule 5121. Additionally, TD will
        receive the net proceeds from the initial public offering of the notes, thus creating an additional conflict of interest within the meaning of FINRA Rule 5121. Consequently, this offering of the notes will be conducted in compliance with the
        provisions of FINRA Rule 5121 and TDS is not permitted to sell the notes to an account over which it exercises discretionary authority without the prior specific written approval of the account holder.</div>
      <div style="text-align: justify; margin-top: 3pt;">The distribution of the Note Prospectus in connection with these offers or sales will be solely for the purpose of providing investors with the description of the terms of the notes that was made
        available to investors in connection with their initial offering. Secondary market investors should not, and will not be authorized to, rely on the Note Prospectus for information regarding TD or for any purpose other than that described in the
        immediately preceding sentence.</div>
      <div style="margin-top: 6pt; margin-bottom: 6pt; color: rgb(91, 134, 43); font-size: 20pt;">Structuring the Notes</div>
      <div style="text-align: justify; margin-top: 5pt;">The notes are our senior unsecured debt securities, Series H, the return on which is linked to the performance of the Underlying Fund. As is the case for all of our debt securities, including our
        market-linked notes, the economic terms of the notes reflect our actual or perceived creditworthiness at the time of pricing. Our internal funding rate generally represents a discount from the credit spreads for our conventional fixed-rate debt
        securities and the borrowing rate we would pay for our conventional fixed-rate debt securities. If the interest rate implied by the credit spreads for our conventional fixed-rate debt securities, or the borrowing rate we would pay for our
        conventional fixed-rate debt securities were to be used, we would expect the economic terms of the notes to be more favorable to you. Therefore, due to these factors, the public offering price you pay to purchase the notes is greater than the
        initial estimated value of the notes.</div>
      <div style="text-align: justify; margin-top: 5pt;">At maturity, we are required to pay the Redemption Amount to holders of the notes, which will be calculated based on the performance of the Underlying Fund and the $10 per unit principal amount. In
        order to meet these payment obligations, at the time we issue the notes, we may choose to enter into certain hedging arrangements (which may include call options, put options or other derivatives) with BofAS, MLPF&amp;S or one of their affiliates.
        The terms of these hedging arrangements are determined by seeking bids from market participants, which may include MLPF&amp;S, BofAS and one or more of our or their affiliates, and take into account a number of factors, including our </div>
      <div style="text-align: justify;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div style="clear: both;">
              <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                  <tr>
                    <td style="width: 50%; vertical-align: top;">
                      <div style="color: rgb(91, 134, 43); font-size: 8pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                    </td>
                    <td style="width: 50%; vertical-align: top;">
                      <div style="text-align: right; color: rgb(91, 134, 43); font-size: 8pt;">TS-<font class="BRPFPageNumber">13</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                  <tr>
                    <td style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 100%;">
                      <div style="color: rgb(91, 134, 43); font-size: 16pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                      <div style="color: rgb(91, 134, 43);">Linked to the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF due April 28, 2028</div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
      </div>
      <div style="text-align: justify; margin-top: 5pt;">creditworthiness, interest rate movements, the volatility of the Underlying Fund, the tenor of the notes and the tenor of the hedging arrangements. The economic terms and initial estimated value of
        the notes depend, in part, on the terms of these hedging arrangements.</div>
      <div style="text-align: justify; margin-top: 5pt;">BofAS has advised us that the hedging arrangements will include a hedging related charge of approximately $0.05 per unit, reflecting an estimated profit to be credited to BofAS from these
        transactions. Since hedging entails risk and may be influenced by unpredictable market forces, additional profits and losses from these hedging arrangements may be realized by BofAS or any third party hedge providers.</div>
      <div style="text-align: justify; margin-top: 5pt;">For further information, see &#8220;Risk Factors&#8212;Conflict-Related Risks&#8221; herein and &#8220;Use of Proceeds and Hedging&#8221; on page PS-23 of product supplement EQUITY LIRN-1.</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div style="clear: both;">
              <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                  <tr>
                    <td style="width: 50%; vertical-align: top;">
                      <div style="color: rgb(91, 134, 43); font-size: 8pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                    </td>
                    <td style="width: 50%; vertical-align: top;">
                      <div style="text-align: right; color: rgb(91, 134, 43); font-size: 8pt;">TS-<font class="BRPFPageNumber">14</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                  <tr>
                    <td style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 100%;">
                      <div style="color: rgb(91, 134, 43); font-size: 16pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                      <div style="color: rgb(91, 134, 43);">Linked to the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF due April 28, 2028</div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
      </div>
      <div style="text-align: justify; margin-top: 6pt; color: rgb(91, 134, 43); font-size: 20pt;">Supplemental Discussion of U.S. Federal Income Tax Consequences</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">The U.S. federal income tax consequences of your investment in the notes are uncertain. No statutory, regulatory, judicial or administrative authority directly discusses how the
        notes should be treated for U.S. federal income tax purposes. Some of these tax consequences are summarized below, but we urge you to read the more detailed discussion under &#8220;Material U.S. Federal Income Tax Consequences&#8221; beginning on page PS-43 of
        product supplement EQUITY LIRN-1 and to discuss the tax consequences of your particular situation with your tax advisor. This discussion is based upon the U.S. Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), final, temporary and proposed
        U.S. Department of the Treasury (the &#8220;Treasury&#8221;) regulations, rulings and decisions, in each case, as available and in effect as of the date hereof, all of which are subject to change, possibly with retroactive effect. Tax consequences under state,
        local and non-U.S. laws are not addressed herein. No ruling from the U.S. Internal Revenue Service (the &#8220;IRS&#8221;) has been sought as to the U.S. federal income tax consequences of your investment in the notes, and the following discussion is not
        binding on the IRS. Except as discussed under the heading &#8220;Non-U.S. Holders&#8221;, this discussion is applicable only to a U.S. holder that acquires notes upon initial issuance and holds its notes as a capital asset for U.S. federal income tax purposes.</div>
      <div style="text-align: justify; margin-top: 6pt;"><font style="font-style: italic;">U.S. Tax Treatment. </font>Pursuant to the terms of the notes, TD and you agree, in the absence of a statutory or regulatory change or an administrative
        determination or judicial ruling to the contrary, to characterize your notes as prepaid derivative contracts with respect to the Underlying Fund. Holders are urged to consult their tax advisors concerning the significance, and the potential impact,
        of the above characterization. If your notes are so treated, upon the taxable disposition (including cash settlement) of a note, you generally should recognize gain or loss in an amount equal to the difference between the amount realized on such
        taxable disposition and your tax basis in the note. Your tax basis in a note generally should equal your cost for the note. Subject to the discussion below regarding Section 1260 of the Code, such gain or loss should generally be long-term capital
        gain or loss if you have held your notes for more than one year (otherwise such gain or loss should be short-term capital gain or loss if held for one year or less) The deductibility of capital losses is subject to limitations.</div>
      <div style="text-align: justify; margin-top: 5pt;"><font style="font-style: italic;">Section 1260</font>. Because the Underlying Fund would be treated as a &#8220;pass-thru entity&#8221; for purposes of Section 1260 of the Code, it is possible that an investment
        in the notes could be treated as a &#8220;constructive ownership transaction&#8221; within the meaning of Section 1260 of the Code. If the notes were treated as a constructive ownership transaction, certain adverse U.S. federal income tax consequences could
        apply (i.e., all or a portion of any long-term capital gain that you recognize upon the taxable disposition of your notes could be recharacterized as ordinary income and you could be subject to an interest charge on deferred tax liability with
        respect to such recharacterized gain). We urge you to read the discussion concerning the possible treatment of the notes as a constructive ownership transaction under &#8220;Material U.S. Federal Income Tax Consequences &#8212;&#8211; Section 1260&#8221; in product
        supplement EQUITY LIRN-1.</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">Based on certain factual representations received from us, our special U.S. tax counsel, Fried, Frank, Harris, Shriver &amp; Jacobson LLP, is of the opinion that it would be
        reasonable to treat your notes in the manner described above. However, because there is no authority that specifically addresses the tax treatment of the notes, it is possible that your notes could alternatively be treated for tax purposes as a
        single contingent payment debt instrument or pursuant to some other characterization (including possible treatment as a &#8220;constructive ownership transaction&#8221; under Section 1260 of the Code), such that the timing and character of your income from the
        notes could differ materially and adversely from the treatment described above, as described further under &#8220;Material U.S. Federal Income Tax Consequences &#8212; Alternative Treatments&#8221; on page PS-46 of product supplement EQUITY LIRN-1.</div>
      <div style="text-align: justify; margin-top: 6pt;"><font style="font-style: italic;">Notice 2008-2. </font>In 2007, the IRS released a notice that may affect the taxation of holders of the notes. According to Notice 2008-2, the IRS and the Treasury
        are considering whether a holder of an instrument such as the notes should be required to accrue ordinary income on a current basis. It is not possible to determine what guidance they will ultimately issue, if any. It is possible, however, that
        under such guidance, holders of the notes will ultimately be required to accrue income currently and this could be applied on a retroactive basis. According to the Notice, the IRS and the Treasury are also considering other relevant issues,
        including whether additional gain or loss from such instruments should be treated as ordinary or capital, whether non-U.S. holders of such instruments should be subject to withholding tax on any deemed income accruals, and whether the special
        &#8220;constructive ownership rules&#8221; of Section 1260 of the Code (discussed above)<font style="font-size: 8pt;">&#160;</font>should be applied to such instruments. Both U.S. and non-U.S. holders are urged to consult their tax advisors concerning the
        significance, and the potential impact, of the above considerations on their investments in the notes.</div>
      <div style="text-align: justify; margin-top: 6pt;"><font style="font-style: italic;">Proposed Legislation</font>. In 2007, legislation was introduced in Congress that, if it had been enacted, would have required holders of notes purchased after the
        bill was enacted to accrue interest income over the term of the notes despite the fact that there will be no interest payments over the term of the notes. It is impossible to predict what any such legislation or administrative or regulatory
        guidance might provide, and whether the effective date of any legislation or guidance will affect securities that were issued before the date that such legislation or guidance is issued. You are urged to consult your tax advisor as to the
        possibility that any legislative or administrative action may adversely affect the tax treatment of your notes.</div>
      <div style="text-align: justify; margin-top: 6pt;">Furthermore, in 2013 the House Ways and Means Committee released in draft form certain proposed legislation relating to financial instruments. If it had been enacted, the effect of this legislation
        generally would have been to require instruments such as the notes to be marked to market on an annual basis with all gains and losses to be treated as ordinary, subject to certain exceptions.</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div style="clear: both;">
              <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                  <tr>
                    <td style="width: 50%; vertical-align: top;">
                      <div style="color: rgb(91, 134, 43); font-size: 8pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                    </td>
                    <td style="width: 50%; vertical-align: top;">
                      <div style="text-align: right; color: rgb(91, 134, 43); font-size: 8pt;">TS-<font class="BRPFPageNumber">15</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                  <tr>
                    <td style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 100%;">
                      <div style="color: rgb(91, 134, 43); font-size: 16pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                      <div style="color: rgb(91, 134, 43);">Linked to the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF due April 28, 2028</div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
      </div>
      <div style="text-align: justify; margin-top: 6pt;">Except to the extent otherwise required by law, TD intends to treat your notes for U.S. federal income tax purposes in accordance with the treatment described above and under &#8220;Material U.S. Federal
        Income Tax Consequences&#8221; of the product supplement EQUITY LIRN-1, unless and until such time as the Treasury and the IRS determine that some other treatment is more appropriate.</div>
      <div style="text-align: justify; margin-top: 6pt;"><font style="font-style: italic;">Medicare Tax on Net Investment Income.</font> U.S. holders that are individuals, estates or certain trusts are subject to an additional 3.8% tax on all or a portion
        of their &#8220;net investment income,&#8221; or &#8220;undistributed net investment income&#8221; in the case of an estate or trust, which may include any income or gain realized with respect to the notes, to the extent of their net investment income or undistributed net
        investment income (as the case may be) that, when added to their other modified adjusted gross income, exceeds $200,000 for an unmarried individual, $250,000 for a married taxpayer filing a joint return (or a surviving spouse), $125,000 for a
        married individual filing a separate return or the dollar amount at which the highest tax bracket begins for an estate or trust. The 3.8% Medicare tax is determined in a different manner than the regular income tax. U.S. holders should consult
        their tax advisors as to the consequences of the 3.8% Medicare tax.</div>
      <div style="text-align: justify; margin-top: 6pt;"><font style="font-style: italic;">Specified Foreign Financial Assets</font>. Certain<font style="font-style: italic;">&#160;</font>U.S. holders that own &#8220;specified foreign financial assets&#8221; in excess of
        an applicable threshold may be subject to reporting obligations with respect to such assets with their tax returns, especially if such assets are held outside the custody of a U.S. financial institution. Significant penalties can apply if a U.S.
        holder is required to disclose its notes and fails to do so.</div>
      <div style="text-align: justify; margin-top: 6pt;"><font style="font-style: italic;">Backup Withholding and Information Reporting</font>. The proceeds received from a taxable disposition of the notes will be subject to information reporting unless
        you are an &#8220;exempt recipient&#8221; and may also be subject to backup withholding at the rate specified in the Code if you fail to provide certain identifying information (such as an accurate taxpayer number, if you are a U.S. holder) or meet certain
        other conditions.</div>
      <div style="text-align: justify; margin-top: 6pt;">Amounts withheld under the backup withholding rules are not additional taxes and may be refunded or credited against your U.S. federal income tax liability, provided the required information is
        furnished to the IRS.</div>
      <div style="text-align: justify; margin-top: 4pt;"><font style="font-style: italic;">Non-U.S. Holders.</font> If you are a non-U.S. holder, subject to Section 897 of the Code and Section 871(m) of the Code, and FATCA, each as discussed below, you
        should generally not be subject to generally applicable information reporting and backup withholding requirements with respect to payments on your notes if you comply with certain certification and identification requirements as to your non-U.S.
        status, including providing us (and/or the applicable withholding agent) a properly executed and fully completed applicable IRS Form W-8. Subject to Section 897 of the Code and Section 871(m) of the Code, discussed herein, gain realized from the
        taxable disposition of a note generally should not be subject to U.S. tax unless (i) such gain is effectively connected with a trade or business conducted by you in the U.S., (ii) you are a non-resident alien individual and are present in the U.S.
        for 183 days or more during the taxable year of such taxable disposition and certain other conditions are satisfied or (iii) you have certain other present or former connections with the U.S.</div>
      <div style="text-align: justify; margin-top: 6pt;"><font style="font-style: italic;">Section 897. </font>We will not attempt to ascertain whether the Underlying Fund<font style="font-size: 8pt;">&#160;</font>would be treated as a &#8220;United States real
        property holding corporation&#8221; (&#8220;USRPHC&#8221;) within the meaning of Section 897 of the Code. We also have not attempted to determine whether the notes should be treated as &#8220;United States real property interests&#8221; (&#8220;USRPI&#8221;) as defined in Section 897 of
        the Code. If the Underlying Fund and/or the notes were so treated, certain adverse U.S. federal income tax consequences could possibly apply, including subjecting any gain realized by a non-U.S. holder in respect of the notes upon a taxable
        disposition of the notes to U.S. federal income tax on a net basis, and the proceeds from such a taxable disposition to a withholding tax. Non-U.S. holders should consult their tax advisors regarding the potential treatment of the Underlying Fund
        as a USRPHC and/or the notes as USRPI.</div>
      <div style="text-align: justify; margin-top: 6pt;"><font style="font-style: italic;">Section 871(m).</font> A 30% withholding tax (which may be reduced by an applicable income tax treaty) is imposed under Section 871(m) of the Code on certain
        &#8220;dividend equivalents&#8221; paid or deemed paid to a non-U.S. holder with respect to a &#8220;specified equity-linked instrument&#8221; that references one or more dividend-paying U.S. equity securities or indices containing U.S. equity securities. The withholding
        tax can apply even if the instrument does not provide for payments that reference dividends. Treasury regulations provide that the withholding tax applies to all dividend equivalents paid or deemed paid on specified equity-linked instruments that
        have a delta of one (&#8220;delta-one specified equity-linked instruments&#8221;) issued after 2016 and to all dividend equivalents paid or deemed paid on all other specified equity-linked instruments issued after 2017. However, the IRS has issued guidance
        that states that the Treasury and the IRS intend to amend the effective dates of the Treasury regulations to provide that withholding on dividend equivalents paid or deemed paid will not apply to specified equity-linked instruments that are not
        delta-one specified equity-linked instruments and are issued before January 1, 2027.</div>
      <div style="text-align: justify; margin-top: 6pt;">Based on our determination that the notes are not &#8220;delta-one&#8221; with respect to the shares of the Underlying Fund<font style="font-size: 8pt;">,</font> our special U.S. tax counsel is of the opinion
        that the notes should not be delta-one specified equity-linked instruments and thus should not be subject to withholding on dividend equivalents. Our determination is not binding on the IRS, and the IRS may disagree with this determination.
        Furthermore, the application of Section 871(m) of the Code will depend on our determinations made when the terms of the notes are set. If withholding is required, we will not make payments of any additional amounts.</div>
      <div style="text-align: justify; margin-top: 6pt;">Nevertheless, after the date the terms are set, it is possible that your notes could be deemed to be reissued for tax purposes upon the occurrence of certain events affecting the shares of the
        Underlying Fund<font style="font-size: 8pt;">&#160;</font>or your notes, and following such occurrence your notes could be treated as delta-one specified equity-linked instruments that are subject to withholding on dividend equivalents. It is also
        possible that withholding tax or other tax under Section 871(m) of the Code could apply to the notes under these rules if a non-U.S. holder enters, or has entered, into certain other transactions in respect of the shares of the Underlying Fund<font style="font-size: 8pt;">&#160;</font>or the notes. A non-U.S. holder that enters, or has entered, into other transactions in respect of the shares of the Underlying Fund<font style="font-size: 8pt;">&#160;</font>or the notes should consult its tax advisor
        regarding the application of Section 871(m) of the Code to its notes in the context of its other transactions.</div>
      <div style="text-align: justify; margin-top: 6pt; font-style: italic; font-weight: bold;">Because of the uncertainty regarding the application of the 30% withholding tax on dividend equivalents to the notes, you are urged to consult your tax advisor
        regarding the potential application of Section 871(m) of the Code and the 30% withholding tax to an investment in the notes.</div>
      <div style="font-style: italic; font-weight: bold; text-align: justify;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div style="clear: both;">
              <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                  <tr>
                    <td style="width: 50%; vertical-align: top;">
                      <div style="color: rgb(91, 134, 43); font-size: 8pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                    </td>
                    <td style="width: 50%; vertical-align: top;">
                      <div style="text-align: right; color: rgb(91, 134, 43); font-size: 8pt;">TS-<font class="BRPFPageNumber">16</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                  <tr>
                    <td style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 100%;">
                      <div style="color: rgb(91, 134, 43); font-size: 16pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                      <div style="color: rgb(91, 134, 43);">Linked to the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF due April 28, 2028</div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
      </div>
      <div style="text-align: justify; margin-top: 6pt;"><font style="font-style: italic;">U.S. Federal Estate Tax Treatment of Non-U.S. Holders.</font> A note may be subject to U.S. federal estate tax if an individual non-U.S. holder holds the note at the
        time of his or her death. The gross estate of a non-U.S. holder domiciled outside the U.S. includes only property situated in the U.S. Individual non-U.S. holders should consult their tax advisors regarding the U.S. federal estate tax consequences
        of holding the notes at death.</div>
      <div style="text-align: justify; margin-top: 6pt;"><font style="font-style: italic;">FATCA.</font> The Foreign Account Tax Compliance Act (&#8220;FATCA&#8221;) was enacted on March 18, 2010, and imposes a 30% U.S. withholding tax on &#8220;withholdable payments&#8221;
        (i.e., certain U.S.-source payments, including interest (and original issue discount), dividends or other fixed or determinable annual or periodical gain, profits and income, and the gross proceeds from a disposition of property of a type which can
        produce U.S.-source interest or dividends) and &#8220;passthru payments&#8221; (i.e., certain payments attributable to withholdable payments) made to certain foreign financial institutions (and certain of their affiliates) unless the payee foreign financial
        institution agrees (or is required), among other things, to disclose the identity of any U.S. individual with an account at the institution (or the relevant affiliate) and to annually report certain information about such account. FATCA also
        requires withholding agents making withholdable payments to certain foreign entities that do not disclose the name, address, and taxpayer identification number of any substantial U.S. owners (or do not certify that they do not have any substantial
        U.S. owners) to withhold tax at a rate of 30%. Under certain circumstances, a holder may be eligible for refunds or credits of such taxes.</div>
      <div style="text-align: justify; margin-top: 6pt;">Pursuant to final and temporary Treasury regulations and other IRS guidance, the withholding and reporting requirements under FATCA will generally apply to certain &#8220;withholdable payments&#8221;, will not
        apply to gross proceeds on a sale or disposition and will apply to certain foreign passthru payments only to the extent that such payments are made after the date that is two years after final regulations defining the term &#8220;foreign passthru
        payment&#8221; are published. If withholding is required, we (or the applicable paying agent) will not be required to pay additional amounts with respect to the amounts so withheld. Foreign financial institutions and non-financial foreign entities
        located in jurisdictions that have an intergovernmental agreement with the U.S. governing FATCA may be subject to different rules.</div>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt;">Investors should consult their own advisors about the application of FATCA, in particular if they may be classified as financial institutions (or if they hold their notes through
        a foreign entity) under the FATCA rules.</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">Both U.S. and non-U.S. holders should consult their tax advisors regarding the U.S. federal income tax consequences of an investment in the notes, as well as any tax consequences
        arising under the laws of any state, local or non-U.S. taxing jurisdiction (including that of TD).</div>
      <div style="font-weight: bold; text-align: justify;"> <br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div style="clear: both;">
              <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                  <tr>
                    <td style="width: 50%; vertical-align: top;">
                      <div style="color: rgb(91, 134, 43); font-size: 8pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                    </td>
                    <td style="width: 50%; vertical-align: top;">
                      <div style="text-align: right; color: rgb(91, 134, 43); font-size: 8pt;">TS-<font class="BRPFPageNumber">17</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                  <tr>
                    <td style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 100%;">
                      <div style="color: rgb(91, 134, 43); font-size: 16pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                      <div style="color: rgb(91, 134, 43);">Linked to the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF due April 28, 2028</div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
      </div>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt; color: rgb(91, 134, 43); font-size: 20pt;">Canadian Taxation</div>
      <div style="text-align: justify; margin-top: 6pt;">The following is, as of the date hereof, a summary of the principal Canadian federal income tax considerations under the <font style="font-style: italic;">Income Tax Act</font> (Canada) and the
        regulations promulgated thereunder (collectively, the &#8220;Canadian Tax Act&#8221;) generally applicable to a holder who is an individual and who acquires beneficial ownership of a note upon the initial issuance of the note by TD pursuant to this offering
        document or common shares of TD or any of its affiliates on a conversion of a note on a bail-in conversion (if applicable), and who, for purposes of the Canadian Tax Act and any applicable income tax treaty, at all relevant times, is not resident
        and is not deemed to be resident in Canada, and who, for purposes of the Canadian Tax Act, at all relevant times, (i) deals at arm&#8217;s length with, and is not affiliated with, TD, any affiliate of TD, and any Canadian resident (or deemed Canadian
        resident) to whom the holder assigns or otherwise transfers the note, (ii) is entitled to receive all payments (including any interest, principal and dividends, if applicable) made on the note as beneficial owner, (iii) is not, and deals at arm&#8217;s
        length with each person who is, a &#8220;specified shareholder&#8221; (within the meaning of subsection 18(5) of the Canadian Tax Act) of TD and each affiliate of TD, (iv) is not an entity in respect of which TD or any affiliate of TD is a &#8220;specified entity&#8221;
        (as defined in subsection 18.4(1) of the Canadian Tax Act); (v) holds the note or common shares of TD or any of its affiliates as capital property, (vi) does not use or hold and is not deemed to use or hold the note or common shares of TD or any of
        its affiliates in or in the course of carrying on a business in Canada or as part of an adventure or concern in the nature of trade and (vii) is not an insurer carrying on an insurance business in Canada and elsewhere (a &#8220;Non-resident Holder&#8221;).</div>
      <div style="text-align: justify; margin-top: 6pt;">This summary assumes that no amount paid or payable to a Non-resident Holder will be the deduction component of a &#8220;hybrid mismatch arrangement&#8221; under which the payment arises within the meaning of
        paragraph 18.4(3)(b) of the Canadian Tax Act. This summary further assumes that no note or property acquired on settlement of a note will be &#8220;taxable Canadian property&#8221; to a Non-resident Holder for purposes of the Canadian Tax Act at the time of
        its disposition or deemed disposition.</div>
      <div style="text-align: justify; margin-top: 6pt;">This summary is based upon the current provisions of the Canadian Tax Act in force as of the date hereof. On January 29, 2026, the Department of Finance (Canada) released for consultation proposed
        amendments to the Canadian Tax Act (the &#8220;January 29 Tax Proposals&#8221;) that would amend certain provisions of the Canadian Tax Act with respect to &#8220;hybrid mismatch arrangements&#8221; and introduce other consequential amendments. This overview does not take
        into account the January 29 Tax Proposals, but otherwise takes into account all other specific proposals to amend the Canadian Tax Act publicly announced by or on behalf of the Minister of Finance (Canada) prior to the date hereof (the &#8220;Tax
        Proposals&#8221;) and the current administrative policies of the Canada Revenue Agency (&#8220;CRA&#8221;) published in writing by the CRA prior to the date hereof. This summary is not exhaustive of all possible Canadian federal income tax considerations relevant to
        an investment in notes and, except for the Tax Proposals, does not take into account or anticipate any changes in law or CRA administrative policies, whether by way of legislative, governmental or judicial decision or action, nor does it take into
        account or consider any other federal tax considerations or any provincial, territorial or foreign tax considerations, which may differ materially from those discussed herein. While this summary assumes that the Tax Proposals will be enacted in the
        form proposed, no assurance can be given that this will be the case, and no assurance can be given that judicial, legislative or administrative changes will not modify or change the statements below.</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">The following is only a general summary of certain Canadian federal non-resident withholding and other tax provisions which may affect a Non-resident Holder of the notes described
        in this offering document. This summary is not, and is not intended to be, and should not be construed to be, legal or tax advice to any particular Non-resident Holder and no representation with respect to the income tax consequences to any
        particular Non-resident Holder is made. Persons considering investing in notes should consult their own tax advisors with respect to the tax consequences of acquiring, holding and disposing of notes and any common shares of TD or any of its
        affiliates acquired on a bail-in conversion having regard to their own particular circumstances.</div>
      <div style="text-align: justify; margin-top: 6pt;">For the purposes of the Canadian Tax Act, all amounts not otherwise expressed in Canadian dollars must be converted into Canadian dollars based on the single day exchange rate as quoted by the Bank
        of Canada for the applicable day or such other rate of exchange that is acceptable to the Minister of National Revenue (Canada).</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;"><u>Notes</u></div>
      <div style="text-align: justify; margin-top: 6pt;">Interest (including amounts on account or in lieu of payment of, or in satisfaction of, interest) paid or credited, or deemed to be paid or credited, on a note to a Non-resident Holder will not be
        subject to Canadian non-resident withholding tax unless all or any part of such interest is &#8220;participating debt interest&#8221;. &#8220;Participating debt interest&#8221; is defined in the Canadian Tax Act generally as interest (other than on a &#8220;prescribed
        obligation&#8221; described below) all or any portion of which is contingent or dependent on the use of or production from property in Canada or is computed by reference to revenue, profit, cash flow, commodity price or any other similar criterion or by
        reference to dividends paid or payable to shareholders of any class or series of shares of the capital stock of a corporation. A &#8220;prescribed obligation&#8221; for this purpose is an &#8220;indexed debt obligation&#8221;, as defined in the Canadian Tax Act, in
        respect of which no amount payable is: (a) contingent or dependent upon the use of, or production from, property in Canada, or (b) computed by reference to: (i) revenue, profit, cash flow, commodity price or any other similar criterion, other than
        a change in the purchasing power of money, or (ii) dividends paid or payable to shareholders of any class or series of shares of the capital stock of a corporation. An &#8220;indexed debt obligation&#8221; is a debt obligation the terms or conditions of which
        provide for an adjustment to an amount payable in respect of the obligation for a period during which the obligation was outstanding that is determined by reference to a change in the purchasing power of money.</div>
      <div style="text-align: justify; margin-top: 6pt;">In the event that a note is redeemed, cancelled, purchased or repurchased by TD or any other person resident or deemed to be resident in Canada from a Non-resident Holder or is otherwise assigned or
        transferred by a Non-resident Holder to TD or another person resident or deemed to be resident in Canada for an amount which exceeds, generally, the issue price thereof, the excess may, in certain circumstances be deemed to be interest and may,
        together with any interest that has accrued or is deemed to have accrued on the note</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div style="clear: both;">
              <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                  <tr>
                    <td style="width: 50%; vertical-align: top;">
                      <div style="color: rgb(91, 134, 43); font-size: 8pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                    </td>
                    <td style="width: 50%; vertical-align: top;">
                      <div style="text-align: right; color: rgb(91, 134, 43); font-size: 8pt;">TS-<font class="BRPFPageNumber">18</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                  <tr>
                    <td style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 100%;">
                      <div style="color: rgb(91, 134, 43); font-size: 16pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                      <div style="color: rgb(91, 134, 43);">Linked to the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF due April 28, 2028</div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
      </div>
      <div style="text-align: justify; margin-top: 6pt;"> to that time, be subject to Canadian non-resident withholding tax if all or any part of such interest or deemed interest is participating debt interest; unless, in certain circumstances, the note is
        not an indexed debt obligation (described above) and was issued for an amount not less than 97% of its principal amount (as defined in the Canadian Tax Act), and the yield from the note, expressed in terms of an annual rate (determined in
        accordance with the Canadian Tax Act) on the amount for which the note was issued, does not exceed 4/3 of the interest stipulated to be payable on the note, expressed in terms of an annual rate on the outstanding principal amount from time to time.</div>
      <div style="text-align: justify; margin-top: 6pt;">If applicable, the normal rate of Canadian non-resident withholding tax is 25% but such rate may be reduced under the terms of an applicable income tax treaty.</div>
      <div style="text-align: justify; margin-top: 6pt;">Generally, there are no other Canadian taxes on income (including taxable capital gains) payable by a Non-resident Holder under the Canadian Tax Act solely as a consequence of the acquisition,
        ownership or disposition of notes by the Non-resident Holder.</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;"><u>Common Shares Acquired on a Bail-in Conversion</u></div>
      <div style="text-align: justify; margin-top: 6pt;">Dividends (including amounts on account or in lieu of payment of, or in satisfaction of, dividends) paid or credited or deemed to be paid or credited to a Non-resident Holder on any common shares of
        TD or common shares of an affiliate of TD that is a Canadian resident corporation will be subject to Canadian non-resident withholding tax of 25% but such rate may be reduced under the terms of an applicable income tax treaty.</div>
      <div style="text-align: justify; margin-top: 6pt;">A Non-resident Holder will not be subject to tax under the Canadian Tax Act on any capital gain realized on a disposition or deemed disposition of any common shares of TD or common shares of an
        affiliate of TD unless such shares constitute &#8220;taxable Canadian property&#8221; to the Non-resident Holder for purposes of the Canadian Tax Act at the time of their disposition, and such Non-resident Holder is not entitled to relief pursuant to the
        provisions of an applicable income tax treaty. Non-resident Holders should consult their own tax advisors with respect to their particular circumstances.</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div style="clear: both;">
              <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                  <tr>
                    <td style="width: 50%; vertical-align: top;">
                      <div style="color: rgb(91, 134, 43); font-size: 8pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                    </td>
                    <td style="width: 50%; vertical-align: top;">
                      <div style="text-align: right; color: rgb(91, 134, 43); font-size: 8pt;">TS-<font class="BRPFPageNumber">19</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        <div class="BRPFPageHeader" style="width: 100%;">
          <div>
            <div>
              <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                  <tr>
                    <td style="border-bottom: 4px solid #5B862B; vertical-align: top; width: 100%;">
                      <div style="color: rgb(91, 134, 43); font-size: 16pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                      <div style="color: rgb(91, 134, 43);">Linked to the iShares<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MSCI EAFE ETF due April 28, 2028</div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
      </div>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt; color: rgb(91, 134, 43); font-size: 20pt;">Validity of the Notes</div>
      <div style="text-align: justify; margin-top: 5pt; margin-bottom: 1.5pt;">In the opinion of Fried, Frank, Harris, Shriver &amp; Jacobson LLP, as special products counsel to TD, when the notes offered by this term sheet have been executed and issued by
        TD and authenticated by the trustee pursuant to the indenture and delivered, paid for and sold as contemplated herein, the notes will be valid and binding obligations of TD, enforceable against TD in accordance with their terms, subject to
        applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium, receivership or other laws relating to or affecting creditors&#8217; rights generally, and to general principles of equity (regardless of whether enforcement is sought
        in a proceeding at law or in equity). This opinion is given as of the date hereof and is limited to the laws of the State of New York. Insofar as this opinion involves matters governed by Canadian law, Fried, Frank, Harris, Shriver &amp; Jacobson
        LLP has assumed, without independent inquiry or investigation, the validity of the matters opined on by McCarthy T&#233;trault LLP, Canadian legal counsel for TD, in its opinion expressed below. In addition, this opinion is subject to customary
        assumptions about the trustee&#8217;s authorization, execution and delivery of the indenture and, with respect to the notes, authentication of the notes and the genuineness of signatures and certain factual matters, all as stated in the opinion of Fried,
        Frank, Harris, Shriver &amp; Jacobson LLP filed as Exhibit 5.3 to the registration statement on Form F-3 filed by TD on December 20, 2024.</div>
      <div style="text-align: justify; margin-top: 5pt;">In the opinion of McCarthy T&#233;trault LLP, the issue and sale of the notes has been duly authorized by all necessary corporate action on the part of TD, and when this term sheet has been attached to,
        and duly notated on, the master note that represents the notes, the notes will have been validly executed and issued and, to the extent validity of the notes is a matter governed by the laws of the Province of Ontario, or the laws of Canada
        applicable therein, will be valid obligations of TD, subject to the following limitations: (i) the enforceability of the indenture is subject to bankruptcy, insolvency, reorganization, arrangement, winding up, moratorium and other similar laws of
        general application limiting the enforcement of creditors&#8217; rights generally; (ii) the enforceability of the indenture is subject to general equitable principles, including the fact that the availability of equitable remedies, such as injunctive
        relief and specific performance, is in the discretion of a court; (iii) courts in Canada are precluded from giving a judgment in any currency other than the lawful money of Canada; and (iv) the enforceability of the indenture will be subject to the
        limitations contained in the Limitations Act, 2002 (Ontario), and such counsel expresses no opinion as to whether a court may find any provision of the indenture to be unenforceable as an attempt to vary or exclude a limitation period under that
        Act. This opinion is given as of the date hereof and is limited to the laws of the Province of Ontario and the federal laws of Canada applicable thereto. In addition, this opinion is subject to: (i) the assumption that the senior indenture has been
        duly authorized, executed and delivered by, and constitutes a valid and legally binding obligation of, the trustee, enforceable against the trustee in accordance with its terms; and (ii) customary assumptions about the genuineness of signatures and
        certain factual matters all as stated in the letter of such counsel dated December 20, 2024, which has been filed as Exhibit 5.2 to the Registration Statement on Form F-3 filed by TD on December 20, 2024.</div>
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt; color: rgb(91, 134, 43); font-size: 20pt;">Where You Can Find More Information</div>
      <div style="text-align: justify; margin-top: 6pt;">We have filed a registration statement (including a product supplement and a prospectus) with the SEC for the offering to which this term sheet relates. You should read the Note Prospectus, including
        this term sheet, and the other documents that we have filed with the SEC, for more complete information about us and this offering. You may get these documents without cost by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, we, any
        agent, or any dealer participating in this offering will arrange to send you these documents if you so request by calling MLPF&amp;S or BofAS toll-free at 1-800-294-1322.</div>
      <div style="text-align: justify; margin-top: 6pt;">&#8220;Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>&#8221; and &#8220;LIRNs<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>&#8221; are registered service marks of Bank of America Corporation, the parent company of MLPF&amp;S and BofAS.</div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-align: justify;">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div style="clear: both;">
              <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

                  <tr>
                    <td style="width: 50%; vertical-align: top;">
                      <div style="color: rgb(91, 134, 43); font-size: 8pt;">Capped Leveraged Index Return Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
                    </td>
                    <td style="width: 50%; vertical-align: top;">
                      <div style="text-align: right; color: rgb(91, 134, 43); font-size: 8pt;">TS-<font class="BRPFPageNumber">20</font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
      </div>
      <div style="text-align: justify;">
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>exfilingfees.htm
<DESCRIPTION>EXHIBIT 107.1
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Generated by Broadridge Transform (tm) - http://www.broadridge.com -->
<!-- Created: Fri May 01 04:22:00 UTC 2026 -->
<!--?xml version="1.0" encoding="ASCII"?-->
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Tue Mar 04 23:02:01 UTC 2025 -->
<html xmlns:compsci="http://compsciresources.com" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title> </title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc. Document created using Broadridge PROfile 25.1.1.5279 Copyright 1995 - 2025 Broadridge -->



<meta content="text/html" http-equiv="Content-Type"/>
</head>
<body><div style="font-family: Arial; font-size: 9pt; text-align: left; color: rgb(0, 0, 0);"><div>
    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: medium; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; padding-bottom: 20px;">

      <div>
        <div style="text-align: center; font-family: Arial; font-size: 20pt; font-weight: bold;">Calculation of Filing Fee Tables</div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 12pt; font-weight: bold;"><span style="font-size: 10pt;">&#160; </span><br/>
        </div>
        <div style="text-align: center; font-family: Arial; font-size: 20pt; font-weight: bold;"><ix:nonNumeric contextRef="c0" name="ffd:FormTp" id="ixv-32">F-3</ix:nonNumeric></div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 12pt; font-weight: bold;"><span style="font-size: 10pt;">&#160; </span><br/>
        </div>
        <div style="text-align: center; font-family: Arial; font-size: 20pt; font-weight: bold;"><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName" id="ixv-33">TORONTO DOMINION BANK</ix:nonNumeric></div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 12pt; font-weight: bold;"><span style="font-size: 10pt;">&#160; </span><br/>
        </div>
        <div style="text-align: center; font-family: Arial; font-size: 12pt; font-weight: bold;">Narrative Disclosure</div>
        <div style="text-align: center; font-family: 'Times New Roman',serif; font-size: 12pt;"><span style="font-size: 10pt;">&#160; </span><br/>
        </div>

        <ix:nonNumeric contextRef="c0" escape="true" name="ffd:NrrtvDsclsr" id="ixv-26"><div style="text-align: center; font-family: Arial; font-size: 12pt;">The maximum aggregate offering price of the securities to which the prospectus relates is <span style="text-decoration-thickness: initial; float: none; display: inline !important;">$<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ffd:NrrtvMaxAggtOfferingPric" scale="0" unitRef="usd" id="ixv-34">4,431,090.00</ix:nonFraction></span>. The prospectus is a <ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="ffd:FnlPrspctsFlg" id="ixv-35">final prospectus</ix:nonNumeric> for the related offering.</div></ix:nonNumeric><div><br/>
        </div>
      </div>
    </div>
  </div></div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="c0" name="ffd:CombinedProspectusTableNa" id="ixv-38">N/A</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey" id="ixv-39">0000947263</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:FeeExhibitTp" id="ixv-40">EX-FILING FEES</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:OfferingTableNa" id="ixv-41">N/A</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:OffsetTableNa" id="ixv-42">N/A</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:RegnFileNb" id="ixv-43">333-283969</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:SubmissnTp" id="ixv-44">424B2</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" xlink:type="simple"/></ix:references>
<ix:resources xmlns="http://www.xbrl.org/2003/instance"><xbrli:context xmlns="" id="c0">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000947263</xbrli:identifier>
  </xbrli:entity>
<!-- [WMV7][OsW0bZZAZ/De6iFU1ECBVuScuDcIrblZhWMbUe9gAOr+YlhcOvoUdHR+7wVHT6XlMvYP2ZIqgT6aRescUUW5SGi0ok463jXQ43A3tv1prvRzAawSM1PgGqu97QZi1KlCAu39zqOUpUov/P/8dPlAPqmUJ7HsZxxMMe9tNAG3BD9XUGvqnxg6I7isVdXXOQXxA4YMSmVG0reUkKVOCfIewT4fM3XkIWAwCf8P5vaIZ1CpANGRs8GsxrEML+dPYTlHXlpirvG5w0QQpGZGUpJeIbx19qwQBAS8j5d7ZgdKNjmXGcy+aJxI3wCmWngRDF/+vjOVa7zv4SDjeV1aYXcPFpvafXgh32xwDp3w6/Yjm3l7SfbjuCYYZthIa/3bbzq7qo3EKHgyYjYtaztbq+CZbPz6BT5qm86Vu/c=] CSR-->
  <xbrli:period>
    <xbrli:startDate>2026-04-30</xbrli:startDate>
    <xbrli:endDate>2026-04-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:unit xmlns="" id="usd">
  <xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit></ix:resources></ix:header>
</div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !) %$# 2(  A$! Q$!_\0
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MVO/^C5OVD/\ PQWQ._\ F7KL_L+//^A-FO\ X;L7_P#*3U_]2.-/^B0XH_\
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M_%.'_J\O_G//_P >3_-_HK_2 HH_XEG_ .JV_P#-;_\ P\'_ !3A_P"KR_\
(G//_ ,>3_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image1.jpg
<TEXT>
begin 644 image1.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" (F >T# 2(  A$! Q$!_\0
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M-4^PVWA.YGM=;&H1-;O9-$NYBZ, =I7#*PX8$$9KNB.M?,/QY^%6EZ_^T?\
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M !1110 4444 %%%% !1110 AX%)NJKJUK-?Z7=VMO>2:?<31/''=PJK/"Q!
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MU;]H?XE>!O&G@BQ;6KOQ+XT\>?#+3UT;2!\MG)K4TX!NS&/E01Q%I'(P"$-
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M\_9ITF;XJW?Q"NO$E\/&'B;29;J*6VLI;2$3QK"B*# JR-L\O/.W)[U]'_\
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M:G\./B%9^/!:6^HVT-Y:_9],BAF>*3;IS6SF0QQ/Y3*3E&*D$9'!(KT3X%>
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M=<7Q#<^$=0TK3;V=0MRH2_E:&$LCXC8PM&5&>G /!K[EBC$2*B($10%55&
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MK4#_ -LU_P#BJS\T4 7_ /A/(_\ H$ZA_P!^U_\ BJ/^$\C_ .@3J'_?M?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '-?$#_ )%\?]?,'_HQ
M:S6^\?K6E\0/^1?'_7S!_P"C%K-;[Q^M " X.:IZ;H]AHT4L6GV5O91RR--(
MEO&$#N>K''4GUKE_BCXOU'PMIFE6VC);MK6LW\>FV;W8)BB9N2[ =<#M7,:+
MXR\9V/COQ!X=\0W&F7#:=X>.I0S6$!19),L YW'(Z<KTXKSZN*I4ZG)).ZZ]
MKZF,IQB[-'H*>"O#T4TDJ:%IR2R2K.\BVR!C(#D/G'4'G-6X= TRWMKRWCTZ
MU2WO':6YB$0VSNWWF<?Q$]R:\6L/B]XNTSX1Z3XIU=].NKW7I(+;3H[:T?$+
M-NWR2JN2W3(5?I6SX6^)WB2^\->)3?K8I?Z6L;V^K7]K-I]E,C<,6609!0YX
M'7BL(8S#.2BHV;5]OZW1"JPVL>EZ;X5T71KB*?3](LK&>*(P1R6\"HRQDY*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MIFFV=E&S.EM D"LW5@JA03[\59HHKU4DE9'2&B_\CC:_]><G_H2UW%</HO\
MR.-K_P!><G_H2UW%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MW=;*_P#F#ITMVSAOBOX O+W6?B%K5Y=0Z9H^HV&GI;7;L65I89=Q215!(0\
MG&.:E\&:Y/XU^/-MK206*V]MX<:WF.G70N8XW,G"M(H W'' '08KTW4?'_AK
M2X+"2]UFTMXK^,26_G$CS4;HV".%]VP*8WC'POHVL#0QJ%C9ZBWEN+*%-K-Y
MGW&PHP<^M-X:BJRG&HDKIM>>ZZA[.'-=/J='11TS17NG6)I/_(X6/_7M+_-:
M[FN&TG_D<+'_ *]I?YK7<T %%%% !1110 4444 %%%% !1110 4444 %%%%
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M2J^6P(4$GYN/??&_[+WPW^(7BD:_K>@O/>NL*744-Y-#;7RQ$>4+F%&"3A<
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M\*N1RO0D<5UW_"+:+_T"+#_P&3_"N:TG_D<+'_KVE_FM=S0!E_\ "+:+_P!
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M\UKN: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7_PH_P"$BT__ )[/_P!^7_PKTG%&* /-O^$BT_\ Y[/_ -^7_P */^$BT_\
MY[/_ -^7_P *])Q1B@#S_P .7T.H>+K1[<NZI;RAF,;*!DC'45Z#28I: "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ KP3]JO_D,? [_ +*+IW_HBYKWNO _VI?G\2_ N,_</Q LG/U6
MWN2* /?**** "BBB@ HHHH **** "BBB@!N:XC1OC1X0UO1O%6J1ZLMI:^%K
MF>UUK[=&UN]B\2[G,BN 0I7#*V,,""":[<C XKY>^/7PKTO7/VCOANI%U#IO
MC S6OB>QMN+?58K&/[3:K<#'\,@QGC<ORG(XI+5V#979]&>%?$MIXQ\-Z;KF
MGK.+#48$N;?[3 T,AC894LC ,N00<$ \UJDFOB[]I&?PG-\:O$%M\6=7U_1]
M"M= MYO!2Z5<W=O$UYF3SWB^SD![H.(0J/GC& 035&R^*VJ_#S4H)_B?>ZII
M^OZ]\+[:*WA>WF=KS45:;S(T5 1]HP\9*\')]!PF]&_ZZ_Y!K=+^NG^9]OYY
MHR:^?O!'A34?B)^Q%H6B_:;R'6K[PG#Y-PTK+.ET(@T;%LYW!PN<U\VVWCGQ
MOX_U>'Q!'+K=E#\7MG@^WM]LBKI3VC1)/<;?^6>Y1?'=P3\N.E7;WG$E.\5(
M^XKCXM>'[35M/TRYDO+2\O\ 4;C2[6.XLI8_.F@C,DFTE>4VJ2'^ZV.":U_!
M7C/2OB#X6T[Q%H=PUUI6H1^;;RO&T99<D9VL 1R#UKY(T$71^(WAR&0W<T%I
M\2O$4$)G+OY<*Z>ZH 6SA?3M70Z/+>Z?_P $YII+5[FSOH_"]P8W@#)-&V7P
M5QR".U8*=TY%R5I)(^L<T#FOSP_:#\"CP-=> ?#9U:#P_P##:XT>74GO/$U_
MJKV]UK+LI=I)K:02>;L^9%9MG+[5SQ6QKLNFWFG_  TL_CIXOUF]\ MX5EEM
M=:L_[0TR"]U,3G8TVW;,)5M]I028W'<<$FMGU)3O8^]N:S5\06[^(WT01W7V
MM+479D^SOY&PL5P)<;=^1]W.<<XQ7YV_&Z\U76]1\$P:[XHNM$\#IX4AGT/4
MO'G]I6US<7@D</*XL74_:A&(B%DR2IR%R37KC^&?&'C^ZDT"?Q'?7GB23X86
M5W!JT<<UFLVHQ7C213&)\,C,40,& ;!.1S2V7,/K8^R QXXI0:^$/%?C3QY\
M4/@5\1OBQX?34M)FU233]$MX&6=9+33+>11J$ZQIAP3(]QDH-VR,%>U=U^PM
M;26-SXP@TKQAI7B'PF!;M;V.BQZE):V=P0WF%+B]9BQ<;2R*QVD9(&:=KW78
M3T29]:YHYK\X/$VJ:'>>-_BF\&O^)W^,UAXXDC\':?:7=UY0!:'*11+^Z>(C
M?YN\$*/[M-^)4OBV^_:.\43ZQXTL/"?BZS\00P^&HKJ+5IKL6!\OROLL%NWV
M>:.0&0/N1B"7W$8%*/OJ+[_\#_,+[^7]?H?I!DT9KYX^"/@>SU7XZ?%CQ?J+
MZC<ZQINO-IVGF>\F^S6UNUK SB.'=Y?S,22Q!/H17GOQY^*5G\//&/Q[TG5;
M_4[34=<\*VK>'K2"&>1KMUMITD-ML!&Y6QNQ@CJ:71,%J?9))Q7+:[\2M#\+
MR:K_ &O<3Z=;Z9';R7%Y/;2"W_?/LC5)-NUV+8!522,C.,U\8^)OAM#\0E^(
M6KZS?^(OM?ASX=Z-?:3'9:K<VT<-Z+.9_M 6-@'E#*H^;/N.:H_&JV;XA_#W
MXA3>*3J-_:1^$_"&K3!99T"2&5C<2 (0<[2Y;'U(X%-BOV/T%&:=7GOPX7P*
M=7U&3PE>"YO6L+#[2%NII<6PB/V4X<D#*9.1RW5LFO01T%,:%HHHH&%%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !7@G[4?\ R-7P*_['ZT_])KFO>Z\#_:A^;Q;\"4'+'Q[:L!["VN<T >^4
M4F:J3:O96^H6]A+=P1WUPK/#:O*HEE5<;BJYR0,C)'3(H N455BU*UFO)K2.
MXA>ZA56E@60&2,-G:67J <'&>N*L!LTK@.HHHI@%%%% !1110 AIC1@D,0"1
MT)'(J2D-(1')"DNW>BOL.1N .#ZBAH5<JS*KLIRI89P?:I,48H&-5 @ "@ =
M !TIHB7CY%X.1QT-2=JY_4_B%X7T74SINH^)-(T_4!M'V2ZOXHY?F^[\C,#S
MD8XYH W/(3(.Q<@YS@=?6E\I?+V;5V=-N./RIX.: * (Y((Y4"/&CK_=8 BD
MEA29-LB+(N<X8 C-2XH)P*!$<D"3*!)&K@'< R@X-*$^;=@;L8SCG%+N/-*#
MD4#&JBJN% 4>@X%)'"D*!8T6->NU1@9I]*!0(Y7P5\.-(\!SZ_-I@F,FMZI-
MK%T9WWXGE"A]G'RKA!Q72F!&D60HI=>CE1D?0U+TI,&BUE9 -5%5CA0"3DX[
MFD:%'<,R*S 8!(R1GK4GX4G;I0 WR4P1L7!&#\O44AA3!'EI@C:?E'(]/I3P
M: :!C$B2/[B*IP/NC%2"BEH$%%)1FF,6BDI: "BDS1F@!:*3-&: %HII;GI6
M#9?$'POJ.K?V7:>)-(NM3W,GV*&_B>?<OWAL#;LC!R,=J .@HI :6@ HHHH
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M2DG!(_#D=1WQ4^H^.O#VD:3?ZI>:W8P:=8S&VNKEIUV0S @&-CGAP2!MZY-
MCH*1B I)Z#UJEI&L66OZ;;:CIMW#?6%R@DAN;=PZ2*>X(ZU:F&Z)QZJ?Y4@/
M-K'Q1';:+-X]N+36-9%T6BM[+2T:7[/;!C@B+< 2=NYGY/( XXJIX9_:3\(>
M(HM!GF74?#]GKD+W&G7>NVOV2&XC10Q(=FP.&& <$YK?\"Z3Y7PEL=.M26)L
M9(8]YY).X#)_&O(='^ NNMX9^$>GZMI%E=-X;\/ZA8WT4TB2)%<2VZQQ[0>&
MY!&1TI">Y] S>)]'MK];&;5K&*\>,S+;/<H)"@&XL%)SM YSTQS4#^.?#L>E
M6^IOK^EKIEQ)Y4-Z;V,0R/R-JONPQX/ /:OFC_AFOQ;=^ /%=D;>TL_$%]H&
M@V%M=F9'>0V<8^T0;\':K8*Y/!SSQFJU[\!/%3Z5?ZE%X>U,ZO<7]Q/96[7>
MG.L&^V2(FXM6'V8QR%!N$;%P%!Y)(I@CZ3T?XE^'==\3ZMX=MM2A76M-G%O-
M93.$E=O*67,:DY==KK\P&.OI3=<^)OAS0;.2YEU2"Z6._@TR9+%Q.\-Q-((T
M1U4DJ=S#.>G->$M\ ?%U[/>:A<V&EVOB"Z\2:=J#:C8LJ"*&/3U@E:/^)55]
MP"=2*YJ3]G3QUJFE:%96FAVGA631].LM+N;B"\C8ZE-'>1R->#:<E45'<&3$
MA:0C'<J3L..NY]/6/Q)\/:GXUD\*6>HQ7NLQ6KWDL5LPD6)$D6-E=@<*X9A\
MIYI]O\0='N/$^OZ TTEOJ&B6T-Y=BXC*1^1(&*R(QX91L<$CH5(->/? SX6^
M(?"/CG1[O4_"5GH,.D^%CH=QJD%U%(VI7 N$?S0$^;:P5GR^&W.01W.U\>OA
M=XD\7:OI5]X4\E)-2MW\.Z^\LHC*Z7,RN\J?WG0JP"]Q*]4UL)/>YZ%X:^)G
MAWQ3IFBWEIJ4,)UFV%W8VEXPAN9XCDAUB8AB"!D<=*D\(?$70?&WAFSU[3+^
M,6%VB.AN"(G4,2$#*>5+$< ]>U?/'Q)^"'C;5OB1)/HVDC^QX-3TBXT^>RNK
M>WA2UMO+$@FW9F:10K!$3$9#<G.<YWAWX%?$#P_HHT0Z!!.+^?0KF6]COXA'
M:"SG+3*P)W,VW!7:"#T)&*2U_KT&]%H?5]EKVG:C?7=C:ZC:7-[9D"YMH9U>
M2 GH'4'*Y]ZO,X12S= ,FOF;X%? [Q;X'\>:3=ZZL[II$&H13:H;BW$>H&>;
M>I"QKYLG]X^<1M887.<U[S+X?U)O$SZF-?NSIYA,8T<Q1^1NVXW;MN_.>>N*
M.B$<SX#^..E?$2"SO-*T/Q!'H]VKR1:O>6'DVI1206+EL@?*<$BNOB\8:%-9
M7MY'K>G/9V1VW5PMW&8[<X!Q(V<+P1UQUKYP^$?PCUWPC\,1X9O/ ^MVOB!M
M+OK%]3;Q LVG[Y1+M(A^TD!3N7I$,9Z"JW_#._B;1;GP]=V.@64]AI>F>'Q>
M:+#/%&NI36GG":,YPI9?,1E9^&* 9[T7Z?UU&]&>_P#AKXK^'/%<;S:=>A[1
M);B%KR0JD.Z&01OAB>1N(PPR".];!\9Z"NDIJC:YIHTQY/)6]-W'Y+/G&P/G
M:6R",9S7RCJ?[.'C'6]#N(8_#%CI,-U%J8&EB\B*0K<:G!<1QG;\O,:.3C@'
MCFI?B7X2/PN\:WVO:QI=A>^'KS4]2>QT!G1(I?.L;>-9E!&Q7#1NI4X8AR5R
M>#-[+^O(%J[?UU/I[Q3\0-&\(:=IFH7\[FPU"^@T^*YMD\V-9)FV1EBOW4+$
M+NZ D>M1W/Q'T"R\2ZIHEU?I:W.EV<5_?3SGR[>WCE9EC#RMA59BC$*3G'/<
M5Y]\/_AI)XC_ &4O#_@W5[9]*NI] A@,1R'M)@H:,C/.4<*1GGY17$77PG^(
MNI?#ZUU35M-M9?&NK>(8M4U^VL)89988(HC#$MJTQ$19%5&&_@;FQR!5/1B6
MJ/>+;XD:!=^*4T"'4(Y;V2QBU&*12##+#)(T:%)/NL2R-P.:T[OQ3HU@+=KG
M5["V%Q,;>$RW**)90<&-<GYFSQM'-?)'A#]GSXA^&Y]"U2XT1;EM'NX;M; Z
MG%+/(B:G<3^6LAVH6$4RGG:N01QQ3=4_9T^(-[%+<W.FM*FHVFJ6ATFTO+5A
M927%]).DC22@A0R,NYXLNI08!XH&]SZ<\;!_#MS:^*(+J6%;>6*WOH'E/D2V
M[N%)*G@,A?<&&#@$'.1C"^)VD6%IXK^'=Q!8VT,[>(!F6.%5<YMYL\@9K3\;
MZ'L^$DFDWDSS-#:V\,DQ<LSLC1@DL>I)'4]:K?%9O^*D^'(PQ)\0+T!./]'F
MZ^E*6BT!:H]%'4TM(.]+5 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 5X'^TM\_P 2/@'&?N'QEN(]Q9W!%>^5X%^TI_R4WX _]CB?_2*XH ]]
MHHHH 3;1BEHH **** "BBB@ HHHH 0]*^0?VN+6\LOBIX;U'2](O+K5;BV6U
MM[>YTX:AIFME?/86;H!NAD#-G?N Q)GG97U]SBHY+=)61G169#N4LN2IQC(]
M.*2T=QIV/F_Q]\,+Z_\ B?XMU'1-%FM-;\0?#J]LY;U69E-X9$6*'S2<+@9P
MHP.IQWK1^!]I)JGQ*BUG3]*O=)T>P\&V&B7:W=D]KNO4E9C& P!8QKD%@"/F
MP":^@BOH<4;<FGUO_77_ #$]4E_7]:''0CX@#Q(OFCPU_P (_P"><[#<?:O)
M[?[&[]*ROAO(K_$3XI*K LNK6F1GI_H%O7H_:O+?A=:R1?%'XO2L,)+J]EM/
MKC3[?-"WMY?JA-V/"/A=87VE_M0ZOI=AH-\=/D>:34+#6+(&;1Q*UVWVJVOE
M S'*2 %R6(DQGY*NZ/X E\ :78S0>'[NU\+:!\3;[4;BTBMI)6%HT;I'<A,%
MY%$CJVX9/5N<5];K BR-($42, K.!\Q S@$^V3^9I^T^M)]$5)WOY_Y6/$/A
M7I5QHOP/\63ZE;:MIUEJ&H:OJ-G:6<;Q7T-K--(\0B0?,CD'<HX(+#@5H_LV
MOXI'P^O$\<C4?^$QCNI/[0^W-NC(V@PF$CY=GE>7G;_'YF><UZ_@^M,F4F&0
M#D[2 /PI]6Q6. \''5_$/PHT.30=0@T6]EC#B:[M?M2A0QRNP,O)]<\4@\,?
M$O\ Z'K1_P#PGC_\D5?^#$+V_P +_#\4BE)$MR&4]CN-=J.E('N>=_\ ",?$
MO_H>M'_\)X__ "11_P (Q\2_^AZT?_PGC_\ )%>BT4P/.O\ A&/B7_T/6C_^
M$\?_ )(H_P"$9^)7_0]:/_X3Q_\ DBO1#VI#^M(#SO\ X1GXE?\ 0]:/_P"$
M\?\ Y(I?^$9^)7_0]:/_ .$\?_DBO'_$VOZII'C;Q!XFU'6=7U+PW8Z_';IK
M/AS5@%T8 QH;.ZT]\+(OF'#.NYB) 1C QS%G^T9X[\'>!+R6:^M/$VKV7]L:
MQ.!I\C/]E@OI8D1R952"("-AYA8G@*$."2+57"VI]#?\(S\2O^AZT?\ \)X_
M_)%*?#7Q*[^.M'_\)X__ "17COBGXL?$#Q9?)-I&K:9X=TFV\9:1I"0I:/-<
M7$4RPRR"1_,4 'S2NT+R!U%4[#]H[QC'H5Y=V%MH\=EI&F?VM<I=^=-+<YU&
M:V,2N7^0;8\ACNP>,8Z'2[#R1[=_PC7Q*_Z'K1__  GC_P#)%'_",_$KC_BN
MM'_\)X__ "17">&OCCXGU_QQX:!BTB'PUKVMZEHT=DR.+^W%HLG[PMNVL6:,
MDKM&T,O)S3?BEX_UCX1^-_%$:W\]VOBG28W\-VMQ(72+5480-!$OHPDAE(']
MR0TW=6\Q)IG>_P#",_$H?\SUHX_[EX__ "11_P (S\2O^AZT?_PGC_\ )%>.
MZE\;_$?P\UW3_"T<Y\0Z=IE]9>&]0U&6%WE>XEA7=-)=,Z@2[G!$2(_')9:@
M^%_[0WB"V^'&F"^,&IW%K?:%IC75T[//<K=Q(\KL<\R?,=OZYI-I)M]"K.Z1
M[0?#7Q*_Z'K1_P#PGC_\D4'PO\27'/CC1B/?P\?_ )(K@O@=^T!XA^)OB/24
MU#1Q!H^NZ?/J-HZVCV[6?ER*HC+NY^T;E89=%4*P((P0:^@AR*=FMR4[['G?
M_",?$O\ Z'K1_P#PGC_\D4?\(Q\2_P#H>M'_ /">/_R17HM% SSK_A&/B7_T
M/6C_ /A/'_Y(H_X1CXE_]#UH_P#X3Q_^2*]%HH \\\;2:GX?^%&I2:Y>PZO?
MQ;/,N+6V^S*X,R@80LV, COSBI?B5<1P>)?A^))%C,FM;$#'&X_9Y>!ZFIOC
M/;R7?PTUJ&%#)*XA"HO4_ODK"^--I+<^+/A2\:AEA\3J[G/0?99QG]:=DUJ4
MK'J@I:04M(D**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KP+]I+
MYOBA\ 4'+'Q>[ >PLKC->^U\[?M1ZSI_A_XF_ /4-4O[73+"'Q3.9+J\F6&)
M!]AG'+L0!^)H ^B:*XG_ (7A\./^B@>%_P#P<VW_ ,71_P +P^''_10/"W_@
MYMO_ (N@#MJ*XG_A>'PX_P"B@>%O_!S;?_%T?\+P^''_ $4#PM_X.;;_ .+H
M [:BN)_X7A\./^B@>%O_  <VW_Q='_"\/AQ_T4#PM_X.;;_XN@#MJ*XG_A>'
MPX_Z*!X6_P#!S;?_ !=(?CC\./\ HH'A;_P<VW_Q= ';T5\$_'[_ (*A:7\
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M-.BD?NU8I][@?/R30!^B^L:O9:!I5WJ6I7<-CI]I$T]Q=7#A(XHU&69F/
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C %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image2.jpg
<TEXT>
begin 644 image2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" $' 40# 2(  A$! Q$!_\0
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MA_\ ^$'??_+FC_A'/CA_T4/X?_\ A!WW_P N:]6HH \I_P"$<^.'_10_A_\
M^$'??_+FC_A'/CA_T4/X?_\ A!WW_P N:]6HH \I_P"$<^.'_10_A_\ ^$'?
M?_+FC_A'/CA_T4/X?_\ A!WW_P N:]6HH \I_P"$<^.'_10_A_\ ^$'??_+F
MC_A'/CA_T4/X?_\ A!WW_P N:]6HH \I_P"$<^.'_10_A_\ ^$'??_+FC_A'
M/CA_T4/X?_\ A!WW_P N:]6HH \I_P"$<^.'_10_A_\ ^$'??_+FC_A'/CA_
MT4/X?_\ A!WW_P N:]6HH \I_P"$<^.'_10_A_\ ^$'??_+FC_A'/CA_T4/X
M?_\ A!WW_P N:]6HH \I_P"$<^.'_10_A_\ ^$'??_+FC_A'/CA_T4/X?_\
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M=* %HHHH **** "BBB@ HK)\2>)](\'Z+<ZSK^J66B:1:*'N-0U*X2WMX02
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MXR?\\BLH?'2P'_,L^*/_  5/_C5KX4>$;O2K"ZU[74#>)=:<7%V6_P"6*_\
M+.$>@48X]?7 KT$@9Z"N*"KU%S\W+?I:]ETZ[F,?:27->U^ECS3_ (7K8?\
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M%3/<%5 \R0JJJ7;&20H&2>!6E0!\F?%_X(:G9RWEUHD6N>(M3U#2;N]U33I
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M?_\ A>7W_P IJ/\ A(_CA_T3SX?_ /A>7W_RFKU:B@#RG_A(_CA_T3SX?_\
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M6SAUC6"'BBO);>(QK+';%VCM]P9B5CQG/). :[BN]:'0%%%%, HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH \J_:P_P"36?C)_P!B9K/_ *0S5ZH.E>5_
MM8?\FL_&3_L3-9_](9J]4'2@!:*** "BBB@# \<^++3P#X+U[Q-?))-8Z-83
MZC.D."[1Q1M(P4$@9PIQ7Q;X8\*_$37/CA=Z -)M;2-M<L==US2X%,\6GVC7
M;:G',-8)C\QFN3+&+=;,OMB,9=(\7!^T?'/A"S^(/@K7_#&H33P6&M:?/IMQ
M+:LJRI'-&T;%"P8!@&.,@C/4&O&]"\#Z3X+^)$,DO[0FOS^(=7O(K231[^?P
M^KZG):HKFU\M=/23*Q2J6$15PL@.1E30!]"4444 %%%% '+V'_)3=?\ ^P/I
MW_HZ^KJ*Y>P_Y*;K_P#V!]._]'7U=10 4444 %%%% #?3BD8X]JJ:KJEGHEC
M->W]REK:PKODFE8*JCW->527NN_&]VBL&N/#_@C.U[S&RZU)>XC!^Y&?4]??
MD#EJUE3:BE>3V7];(RE-+1:OL7]?^(FI>+=4F\/> Q'//&=E[KLB[K:R]E/2
M23T X^O..A\'^!=&^'.FW5R9?,NG5I]0UB^<>;-CEG=ST4<G&<#KUR:T;>#P
M_P##;PWM+V6@:):*-TT\JPPQY(&7=B!DD@9)R2:X#3X-;^-UWI>K7MOJ/ACP
M&B&9=%OHGM-2OIPUQ;SVVHVLL;(UHZ%'50P9C@GC%12HN_M*KN_P7I_F*,'?
MFEJ_R]!NK>)/$?QEM&TWP8VH>&-!>]GLK[Q6P$%TJ)%'+!=:8KQR174$S-L\
MPD+MW%<D5Z%X2\#:+X$@U.'1;62UCU+4)]5NA)<RSE[F9MTK@R,Q4$\[5PH[
M 5I:3I-CX?TRSTS3+*WT[3K.%;>VL[2)8X8(E 541% "J    , "K]=IL%%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >5?M8?\FL_&3_L3
M-9_](9J]4'2O*_VL/^36?C)_V)FL_P#I#-7J@Z4 +1110 4444 %?$\&DZ'<
M_&7Q!(^K:F=#M?$UA'#>MH\8B0R:U-/-&D_VSS6+:HD-NTI@4*D2HJ.I:=?L
MO4&NA97#64<4EX(V,"7#E(V?'RAF )"DXR0"0.QZ5\-^&]1O-3^-J7>N_#_P
MSH7B1_%0MKO4XO$?B.ZT(,EX2@$2V*Z7)=E#E-\Z/]J=7:-)LQ  ^G/B_P".
MM'T71/$MCXW\,ZS;?#V+2Y9M5\4"[MH[ 0["7BQ'="[+-]S"PX8MC)!KXVU9
M_A/?0ZOJL-SX2LO"6HZ3JT_A[POX9OK6YM='UT16B6:QBU9H4U65$DD00G<"
M76(N5>63]'J* /C#XO?#S4_!'B?7/%":C]NU[Q%H%U<:K::98^3J46GQ6]J+
MT/>^8VZ/,"Q0((P8I+QY 6VG'T3\!?'MK\1/AKI^I6.G:9IEE!)+I\,6AWPO
M=-:.!S$K6EP(XQ+"0HVL$7H1CC->C44 <O8?\E-U_P#[ ^G?^CKZNHKE[#_D
MINO_ /8'T[_T=?5U% !112&@!.U<UXV\=Z5X$TS[9J,Q#R'9;VT0W37#]E1>
MYY'L,\UC^-_B8FA7T>A:):-KGBF<?NK"(_+"#_RTF;^!1UYY/L#FHO!/PTDL
M=3_X2/Q-=#7/%,BX^T,/W-HO_/.!>@ R1NQD\],G/#.LYR=.CJ^KZ+_-F$IN
M3Y(;]^B,G2_!&L?$K4(-:\<)]FTV)O,LO#2-F-/1[@_QOC^'H/;)6NC\<_$G
M1OAW':6#(U_X@O[>ZET?PY9,@O-4:VA\V2*W5V52P3!P2 ,BL_Q)\4([C7KS
MPEX6CFUGQ);7-O9:J;(1L=!2Y@ED@O)TD9 \8\L?*A+'(XK0^&_PXM_ 6E2"
M:;^U-?OYA?ZOJQ5T%[?&&.*6X2)G<0!Q&O[J,A5[#J3M2HQI+35O=O=EQIJ/
MKW.>T?X.6GBS5-7\0^/[>V\4W6JQ/:6VG:C9[;>STMI(IX[*>V,DD$TL<J;C
M.5W$X P!7K%%%=!H%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% 'E7[6'_ ":S\9/^Q,UG_P!(9J]4'2O*_P!K#_DUGXR?]B9K/_I#
M-7J@Z4 +1110 4444 4=3COIM,NTT^Y@M-1:)UMI[J%IXHY,':SQJZ%U!P2H
M=21QN'6OC;0?A3\4/$?Q=M+32?BCI7B;X=V?B3^VO$&B6OA)K+1(KJ.X\^1+
M>[:\EN);G[6IE,22-#'(D@EVX6"3[&UC2;?7](OM,O1*;2]@>WF\B=X)-CJ5
M;;)&5=#@G#*01U!!KSGPO^S3X,\&OI7]D7?C&UM]+,7V2R/CG7)+6-8\;(_(
M>\,;1@*!Y;*5(X((XH ]7HKSKX@>*(!'KFB>(_"'B!O!ITZ634?$=O-;_8Q#
MY9,B;(;G[9G&0=D..>N,FOBC7Q\/;2\\36DMUX;U+P!]@U>Y\(WWAB)(=$&N
MO#9"W@TR*-W1+Y!&Y7RG:1II+AT"%F10#]'**^,/B]\/-3\$>)]<\4)J/V[7
MO$6@75QJMIIECY.I1:?%;VHO0][YC;H\P+% @C!BDO'D!;:<?1/P%\>VOQ$^
M&NGZE8Z=IFF64$DNGPQ:'?"]TUHX',2M:7 CC$L)"C:P1>A&.,T ;NGC_BYF
MO_\ 8(T[_P!'7U=01BN7T_\ Y*9K_P#V!]._]'7U;&LZS9Z!I\]]J%S':6D*
M[I)I6PJC_/;O4MJ*NQ-VU9=9@!DD #O7ENM>/]4\<:G/H'@,JPB;R[[Q$XW6
M]MZK%VDDQZ<?S%+=KGQP?"&X\/>!"<%_N76IK[?W(C^H]<\=_))H'PU\*W$K
MF#1M#TRUEN9"!A8HHU+R/@9+84%B>2>>M</-/%:1?+'OU?IV1SWE5VTCWZOT
M_P ROX'\ Z9X"L7CM%>YO+@[[N_N#OGN7ZEG;ZD\=!GZFN*O/&NI_%W6M8\.
M^"+M;#1=*N1:ZGXK"QW""\@N56\TK[,S)(KM#G_2%^5?,^4EA4,6G7G[1-A8
MWVIHVE_#IIS/!IZR!V\16_\ HUQI^H)<0R)):J'5CY+#<PX< <'V5:[(0C3B
MHQ5DC>,5%62T,7PAX1TOP'X9TOP_HENUII&F6R6EK#)/),R1(,*IDD9G; [L
M2?>MRBBM"@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** /*OVL/\ DUGXR?\ 8F:S_P"D,U>J#I7E?[6'_)K/QD_[$S6?_2&:
MO5!TH 6BBB@ HHHH **** "BBB@ HHHH \O\4>/=,\">.]:N;YWEFGTK3H[6
MS@7?/<2>?>_*B]^HYZ#(]15;1_ >K?$#4;?7O'85+>)A)8^&T;,$'H\W_/1\
M=N@Y^@W[?1;*\^+FIWT]M'-=VFC62P3.N6B#S7F_;Z$[%YZ\>YJAXE^)FHWF
MHW&A>!-*37];2W-RFH73.FBHT=TD-Q;2WD2OLN54R,(MI/R<X&:XI4959WJO
M1;+IZOOZ&+@YRO+;M_F;7B?XBZ5X4N[/3DCN-4U*XO+6Q-CI<)N)+0W!8137
M"H"88,HV96&T8-<MX'^'>K^(/$6F^._B)%:MXHM(E;3-&MRD]OX=E>%H;K[-
M<!$>7SU*EO,!QC"\<GI_ OPVTWP*][<QS7&L:Q?2.;G7-5$4E_/&99)(X'F1
M%+11>:RQJ<[5X]2>QKM-@I*6B@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@#RK]K#_DUGXR?]B9K/_I#-7J@Z5Y7^
MUA_R:S\9/^Q,UG_TAFKU0=* %HHHH **** "BBB@#SWQS\8]/\%R:O9IH7BC
M6M7L;"2^CM-+\-ZA<0W.U"PBCND@: R-C 0.6R<8SQ7R%I?Q-U[QKIWBRWU[
MQOXJTFYT.R\2>((KOR=0T%1>VZV30(L<R1-)!;B:0"W<,A#*948X-??]<OK/
MPS\'^)%@75O"FB:J(+\:I$+W3H9O+O ,"Y7<IQ+@8\P?-[T ?,_Q0O\ XA_#
MWQ!K/BF[\1S6EEX@TJ8PPVNIW-S-80+;6SW$JZ>RBWA-J(KEDG1B99;J%)
M17T;\*O&%IXQ\'P36NGZII1L)9-,N+#6YDFO+>6!O+9994EE61OE!WB1]V<E
MLYK?O?#VF:G<-<7NFV=W/);2632SP([&WD(,D))&2C%5RO0X&1Q4?AKPMHW@
MK1+;1O#VD6.A:/:@B#3],MDM[>$$EB$C0!5R23P.I- 'F/QA\,?$[5=;OO\
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MY\-^'=6U&30H?"&I^*+=K.^TKR;AO)MKU/#WF>28XMN5N7N(T90ZHSJZ_H;
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%44 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image3.jpg
<TEXT>
begin 644 image3.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  J ,D# 2(  A$! Q$!_\0
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M_'O[;?Q0T.VM;75;C3=1U'7K;X)0:IJ4&F-I]BFA"^ENH_&?V.OV3O$OA?\
M:7_:N_X*#:/\!_BQH>BZA^RWX=_9H_9;^$G[1WQ2\?>-/VG/C1X:\#ZWXO\
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MW#1JI_P]B_X)9?\ 22S]@#_Q,C]G7_YXU'_#V+_@EE_TDL_8 _\ $R/V=?\
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MQ]*KE56^J^J9AAL33S"#3W^M9=#%X"Z<*E'ZY]:HU(5\/3O^*W_!;/\ U_\
MP25_[3-_L9_^F/XOU^X-?.?BO]CW]DCQY\7M&_:#\<?LM?LY^,_CWX<NM OO
M#WQO\5_!'X9^(OB]H-[X5=)/"]YHWQ*U?PQ>>,]+NO#;QQOH%Q8ZU!+H[QHV
MG/;E5(^C*,#*^2SE;_>N+.(L9;^3V66<+9%[/^]S?V%]:Y_=M]:]AROV'MJQ
HC7S9M26WU3A?(\#_ -?/:9KQ/G?M?[EO[<^J\GO7^J^VYU[?V5'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image4.jpg
<TEXT>
begin 644 image4.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  I 3\# 2(  A$! Q$!_\0
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MYX4T;QGX2^'VI:K]F\7^.M+\5ZUX5TC[#J4W]J:;X(_L >*+G[?;V<NF6/\
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M$BP,JM/)H?68R>+EAJ<<)]=/OF2\_:C_ &Q_#7[/7QB^#?[24?[)?[+/Q/\
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M%]=_9A\&:%X<O_$G]M:;I6GV'AGXV^.K>RS?7USJ4OV:WL[[F/VW-1OOV?\
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M^!MP(=.^"WPU\*0I\/?"/A&*_P#".L:'XJTWQ=\0G\9?H1X$T?Q+X=\$>#M
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M]O\ _P#%3O\ P5-_^@WH_P"'EG[.O_1.?V__ /Q4[_P5-_\ H-Z^_P"BD!\
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.%?'SQ>-J4?:XRHH__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image5.jpg
<TEXT>
begin 644 image5.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_VP!#  <%!08%! <&!08(!P<("A$+"@D)
M"A4/$ P1&!4:&1@5&!<;'B<A&QTE'1<8(BXB)2@I*RPK&B O,R\J,B<J*RK_
MVP!# 0<(" H)"A0+"Q0J'!@<*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ
M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BK_P  1" &< DL# 2(  A$! Q$!_\0
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M?^!T7_Q5 &U16+_PF?A?_H9-(_\  Z+_ .*H_P"$S\+_ /0R:1_X'1?_ !5
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M^ADTC_P.B_\ BJ/^$S\+_P#0R:1_X'1?_%4 ;5%8O_"9^%_^ADTC_P #HO\
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M77\UH VO[%TO_H&VG_?A?\*/[%TO_H&VG_?A?\*O44 4?[%TO_H&VG_?A?\
M"C^Q=+_Z!MI_WX7_  J]10!1_L72_P#H&VG_ 'X7_"C^Q=+_ .@;:?\ ?A?\
M*O44 4?[%TO_ *!MI_WX7_"C^Q=+_P"@;:?]^%_PJ]10!1_L72_^@;:?]^%_
MPH_L72_^@;:?]^%_PJ]10!1_L72_^@;:?]^%_P */[%TO_H&VG_?A?\ "KU%
M %'^Q=+_ .@;:?\ ?A?\*/[%TO\ Z!MI_P!^%_PJ]10!1_L72_\ H&VG_?A?
M\*/[%TO_ *!MI_WX7_"KU% %'^Q=+_Z!MI_WX7_"C^Q=+_Z!MI_WX7_"KU%
M%'^Q=+_Z!MI_WX7_  H_L72_^@;:?]^%_P *O44 4?[%TO\ Z!MI_P!^%_PH
M_L72_P#H&VG_ 'X7_"KU% %'^Q=+_P"@;:?]^%_PH_L72_\ H&VG_?A?\*O4
M4 4?[%TO_H&VG_?A?\*/[%TO_H&VG_?A?\*O44 4?[%TO_H&VG_?A?\ "C^Q
M=+_Z!MI_WX7_  J]10!1_L72_P#H&VG_ 'X7_"C^Q=+_ .@;:?\ ?A?\*O44
M 4?[%TO_ *!MI_WX7_"C^Q=+_P"@;:?]^%_PJ]10!1_L72_^@;:?]^%_PH_L
M72_^@;:?]^%_PJ]10!1_L72_^@;:?]^%_P */[%TO_H&VG_?A?\ "KU% %'^
MQ=+_ .@;:?\ ?A?\*/[%TO\ Z!MI_P!^%_PJ]10!1_L72_\ H&VG_?A?\*/[
M%TO_ *!MI_WX7_"KU% %'^Q=+_Z!MI_WX7_"C^Q=+_Z!MI_WX7_"KU% %'^Q
M=+_Z!MI_WX7_  H_L72_^@;:?]^%_P *O44 4?[%TO\ Z!MI_P!^%_PH_L72
M_P#H&VG_ 'X7_"KU% %'^Q=+_P"@;:?]^%_PH_L72_\ H&VG_?A?\*O44 4?
M[%TO_H&VG_?A?\*/[%TO_H&VG_?A?\*O44 4?[%TO_H&VG_?A?\ "C^Q=+_Z
M!MI_WX7_  J]10!1_L72_P#H&VG_ 'X7_"C^Q=+_ .@;:?\ ?A?\*O44 4?[
M%TO_ *!MI_WX7_"C^Q=+_P"@;:?]^%_PJ]10!1_L72_^@;:?]^%_PH_L72_^
M@;:?]^%_PJ]10!1_L72_^@;:?]^%_P */[%TO_H&VG_?A?\ "KU% %'^Q=+_
M .@;:?\ ?A?\*/[%TO\ Z!MI_P!^%_PJ]10!1_L72_\ H&VG_?A?\*/[%TO_
M *!MI_WX7_"KU% %'^Q=+_Z!MI_WX7_"D;1=+V_\@VT_[\+_ (5?H- '*?#A
M0O@>Q  "K+<  <8_?R8KJZYCX<_\B+9_]=;C_P!'R5T] !1110 4444 %<OX
M(^YK_P#V'+K^:UU%<OX(^YK_ /V'+K^:T =11110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %!HH- ',?#G_D1+/\ ZZW'_H^2NGKF/AS_
M ,B)9_\ 76X_]'R5T] !12,<4F[GF@!U%-W>U"L3CZ4 .KE_!'W-?_[#EU_-
M:ZBN7\$?<U__ +#EU_-: .HHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MU3D\'-<21SWFJ3375N!]EE\M5\D@YZ#@_C6GIND-8RS3W%TUW<SL"\KJ%X
M  ' X% #-9\1V>A1QM?0WT@D)"BTL9KDCZ^4K8_&N)\(^.](M5UKS+;66\W5
M[B5?+T6[? )&,[8C@^QY%>E;><Y_2N8\$KE=?]M;NAS]10 G_"Q=$_Y]==_\
M$%[_ /&J/^%BZ)_S[:[_ .""]_\ C5=510!RO_"Q=$_Y]M=_\$%[_P#&J/\
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M+W_XU7544 <K_P +%T3_ )]M=_\ !!>__&J/^%BZ)_S[:[_X(+W_ .-5U5%
M'*_\+%T3_GVUW_P07O\ \:H_X6+HG_/MKO\ X(+W_P"-5U5% '*_\+%T3_GV
MUW_P07O_ ,:H_P"%BZ)_S[:[_P"""]_^-5U5% '*_P#"Q=$_Y]M=_P#!!>__
M !JC_A8NB?\ /MKO_@@O?_C5=510!RO_  L71/\ GVUW_P $%[_\:H_X6+HG
M_/MKO_@@O?\ XU7544 <K_PL71/^?;7?_!!>_P#QJC_A8NB?\^VN_P#@@O?_
M (U7544 <K_PL71/^?;7?_!!>_\ QJC_ (6+HG_/MKO_ ((+W_XU7544 <K_
M ,+%T3_GVUW_ ,$%[_\ &J/^%BZ)_P ^VN_^""]_^-5U5% '*_\ "Q=$_P"?
M;7?_  07O_QJC_A8NB?\^VN_^""]_P#C5=510!RO_"Q=$_Y]M=_\$%[_ /&J
M/^%BZ)_S[:[_ .""]_\ C5=510!RO_"Q=$_Y]M=_\$%[_P#&J/\ A8NB?\^V
MN_\ @@O?_C5=510!RO\ PL71/^?;7?\ P07O_P :H_X6+HG_ #[:[_X(+W_X
MU7544 <K_P +%T3_ )]M=_\ !!>__&J/^%BZ)_S[:[_X(+W_ .-5U5% '*_\
M+%T3_GVUW_P07O\ \:H_X6+HG_/MKO\ X(+W_P"-5U5% '*_\+%T3_GVUW_P
M07O_ ,:H_P"%BZ)_S[:[_P"""]_^-5U5% '*_P#"Q=$_Y]M=_P#!!>__ !JC
M_A8NB?\ /MKO_@@O?_C5=510!RO_  L71/\ GUUW_P $%[_\:I&^(FBD<6VN
M_P#@@O?_ (U75,0,9J&6XBC53(ZJ&.U23U-)@<1<>-]-DURVNT@U@VT*LCJ-
M&N]X8C@[/+W8QWQBHY/%>E3:?]D>'5=IN'EDQI5R1L8L< ^7RWS#Y!\PP<C@
MXZ?P_;R"":\E<,UXPEP!]W(Z5D60N!XKFTTRAHHYS=9/7D=/_'JY'+35;B-?
MPE+;S>&;.2R??"5;8VTKD;CV/0^W:MNN5^'*_P#%$69[>;<?^CY*ZJNJ*LK
M@HHHJAA1110 5R_@C[FO_P#8<NOYK745R_@C[FO_ /8<NOYK0!U%%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4449H ,TA8"DSS6!K>I2;D6Q!D6,[YV4CY
M5!Q_.LYSY5<!-<\0266H16EO&',B*^X'D#)W?HM8<4MUKBI;2HWD6MPC'^\V
MYQCZ<$UKZ=X<,&HK<W+&7RLJI<YSE5Y'XEZOZ59&&]U"4@XEF&T$=@.OZ_I7
M%R5*DKO8G5LT+>!+>W2&(;448 K%\A8_'2NJX:2T+,?QQ_2N@Q@FF>4OF^85
M&\#:&[XKKG3O;R*.<^'/_(BV?_76X_\ 1\E=17+_  Y_Y$6S_P"NMQ_Z/DKJ
M*V **** "BBB@ KE_!'W-?\ ^PY=?S6NHKE_!'W-?_[#EU_-: .HHHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<_\ Q% '445R_P#PGEC_ - ?Q%_X([G_ .(H_P"$\L?^@/XB_P#!'<__ !%
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M .$\L?\ H#^(O_!'<_\ Q%'_  GEC_T!_$7_ (([G_XBF!U%%<O_ ,)Y8_\
M0'\1?^".Y_\ B*/^$\L?^@/XB_\ !'<__$4 =117+_\ ">6/_0'\1?\ @CN?
M_B*/^$\L?^@/XB_\$=S_ /$4 =117+_\)Y8_] ?Q%_X([G_XBC_A/+'_ * _
MB+_P1W/_ ,10!U%%<O\ \)Y8_P#0'\1?^".Y_P#B*/\ A/+'_H#^(O\ P1W/
M_P 10!U%%<O_ ,)Y8_\ 0'\1?^".Y_\ B*1O'=D3_P @CQ%T_P"@'=?_ !%
M'4TV1@JY) Y[UR1^(>D;2?LFL A]GE'2I]^?]W;FL?4/$\M]JC7%C::LMLL0
M$@DT^9=C*P()4KQDE>3VR>QK&=5):"N>B]C6/?:W$EO<BW8F6*01\#.&[_UK
M%_X3:+[0DGV:]2$1D/'+:R))NZ@A"-QSVXY[5FIK,0U*&ZETO69+;+ES#I<S
M@R%BW&U3N7YN&'!]:RE4<O=B%SOK6>.Y@6:!]T;<AO6K KAM,\3V^E12QR:?
MJQB>0R0QC3Y6EVGJ3&%W* 1CIW]ZOGQS8#A=.UJ7'!:#2IY%'_ E7&?Y5M3E
MI9[C)O%>I-!9BTMG_P!(E8<#J%JS#(;BXTQ&._$3NQ_VTVK_ .S-7/KXDT[^
MV)=0?3=8N!)@0R0:;-,NW ')52 <CIUIEGXHAM[N.9]/U=X8Q*H$&ESR$,S[
MCD*IQ@;>O?(Z@USWES<W=B.]'2EKEQX\L<?\@?Q%_P"".Y_^(H_X3RQ_Z _B
M+_P1W/\ \17:,ZBBN7_X3RQ_Z _B+_P1W/\ \11_PGEC_P! ?Q%_X([G_P"(
MH ZB@UR__">6/_0'\1?^".Y_^(H/CRQ/']D>(A_W!+G_ .(H 7X<_P#(B6?_
M %UN/_1\E=/7)?#642>!+!PKJ)'G8!U*D?OY.H/0^U=;0 5#=6\=U;/!.@>.
M12KJ>X(J:B@#%B\,Z;&L@D2:Y$L9C/VF=Y=JGJHW$X'TJ;3=%M-,F:6'SI)7
M 4R3SO*VWTRQ.!G/%:F!1B@ Q7+^"/NZ_P#]ARZ_FM=17+^"/N:__P!ARZ_F
MM '44444 %%%% !1110 4444 %%%% !1112N 45F76J&#6+>S"Y63.]O[I[#
M\36ES4J:=_(!:*!THJP"BBB@ HHHH **** "BBB@ HHHH **** "BBD- "TA
M^Z:0DUD:Y>7L4<4.F-']HE8X#^@!/]*B4U%78KFA)=PQ%Q)(H*KN()Z"N6O-
M-D\3W4E[&_EP+'Y<!'\?<Y].3C\*C2WGULV]XJLINF,4^T_=0#:>ON,UU&F6
M":;I\5I&2RQC[S=\FN6+E6>NPMRI)H=K<Z3#93Q_+"ORX/W6QC(_,TSP_IR6
MVEF&:-2R2L,D=<' -;>T#M1M Z"M_913315D8]QI;2:Y'=Q[%C^5I,#DLN['
MZ-C\!63XB>>WOI9H48%(1*K@],!D/Y>8#77;%]*:\,<GWT5N,<CM2G2YHM+0
M#E[::#P]>&%V!-ZZR*3_  @G!_QKJ5.5XKG/$6AOJ6HV\BX$4<;9]CU%6%\0
M(TVF)& ?MJY*YY7C_'-9PDX2<9"V-VBFJ2:=75<84444P"BBDS0 M%5I[Z"U
M8">=(R>@9L4HN$9 XE4@KN!!R,=S4\\;VN!8HJG9:C#?JY@+#80&#K@C(S5L
M9Q33N M1S.$4L3@ $FL_7-0EL;5!;#,\\@AC)Z*Q[FL%KC6=76.T<")D $Y_
MO G'\N:QJ54GRI 2+IL4N@SWPM6\^>0SD9Y(#DK_ ..U?TN*XO=)O1<(86NW
M<@L.S* #6TD2&'RV4;=NTJ.F/2G)$D:A47:J@  =A25)<W,(YV_TAH-!O6FG
M:68J)"PXY4< 5KZ5"\.DVD<JX=(45QZ$"IKZV%U836X.WS$*Y],U,!P.]5&D
MHRYD,Q]=LVE6&6V@#3EBA<#!"E6'7TR0:J)$MOHUY9(%1I)3$H''WL#(_.ND
MQ6)>:&MQJD=\LCB17C;R\\85@345*;O= 7["RBT^U\F$80,2!Z9.<?K6=X8_
MU-^?^GZ0?RK<*BL?P]"88[]&Z_;7/YA33<;2C;H!M#I10**Z "BBB@ H-%!H
M Y?X<_\ (BV?_76X_P#1\E=17,?#G_D1+/\ ZZW'_H^2NGH **** "BBB@ K
ME_!'W-?_ .PY=?S6NHKE_!'W-?\ ^PY=?S6@#J**** "BBB@ HHHH ***"<"
M@ H/2F[J0R8]*5T N['7BFM)M4L2 !USTK'N=3ENW%OI);S!(4DFV95,=?UJ
MLVB7EU-*FH7<CPY 4AL;E(Y'_?6T_A6,JCO:* 2[E2.*XO[AL*+R-2V/NHK#
MFM'3];@OM/:Z#*H4,64GE0"<$_6JNN::P\-&RLHS)@H OJ >:IOH36UTL%MC
MR[R:1I@%X5."!67OQG9;"U+T/B:&YO+>*V4R12KEI1T0X8X/O\IXK;5MR@UE
M7^D1S6*P6J+%B4-\HQ[-^A(JI:ZQ!I>A6ZL&D?;\L8.6/S8_2KC*4?C&=$**
MRQKUHT3O&V[8BN5[X;I6C%*)8U=>589!]16ZDGL ^BC-)FJ 6BDW>E&: %HI
MN[CWI&DV(68@!023Z4GH I8]NE)O^;%8,WB%;BX6TTY6,\C#:SJ0OK_('\JK
M7AOM-:%7N=\UVPA#@<#GL/7%8.JD!U(Z4M065P+NQAN%! E0. ?<9J;-;IW5
MP%I#1FBC<"*XF6"WDE<X5%+'\*Y[1X+K4M0&K7F%781 H/'.1G'TK6U=?-A@
MMR<)<3A'QZ8+?^RU:M;:.TMTAA&V-!@#TK&<>>=GL*Q#IUA'IUFEO#DJN3D]
M\U<Q1BEQ6R5E9#"BBBF 4444 1R*&R#W%<=;Z>?WRVB[I[0,8.>1B:3 _*NR
M;J:P- M3'?:K+)G=]I9<?[).X?\ H5<M:+E)6$S8M;D/9Q2RL 6 W<_Q=,?G
M5@$]ZX::6>?2'MA(R2QW<L@..B("W\R/SKM8"3;QGJ2H.?PJZ53GT[#)<TM-
MS03Q6VP$=Q<);6[SRG$:*68^@%96E:^E\7CGQ!.LA41OP2,\$58U0B:"&%<-
MON(P0#U 8%OT!K.\1V9BDM]5A4,]JP9E]17/4E):Q$+%IR:S?2WM_ I1,Q0K
MNSG#-DG_ #VKGI/[4MVN8\XC@62'9V"%6;/Y+7::2A738=V5+@R$>FXEOZU;
M>".165U!#@AACKFH=%54I;,+7,&>XDT>]DN796@N(QA.ZLJC^=:FFZI;ZI;M
M-:ON57*$D8P?_P!6*?>:9!>M TH.8'#KC^58,VH3:5KUU:K#B&3]XC <9\L
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MU?7?L=\+2./<"F99!G]WGI50Z9=2264:)_H-PBO= <'=M.2?KQ^5<\JSO9(
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M']O>*?\ H3'_ /!G#7444 <O_;WBG_H3'_\ !G#1_;WBG_H3'_\ !G#7444
M<LVN>*&X/@Q\>G]IPUF0'Q!;:DEU#X**[(M@']I0]<]?RKO*2HE",G=@<)=:
MAXD75H-0E\,M!L3RPIOXF#L>W'0^_M3GU_7KK4[9%\-,)809U@%_$?-!!7=N
MZ #/3OGVKI_$ QI$DN,F([P!^7]:I>'8!.3?RJ?,5%MT)&-J*!D?]]9K%Z3Y
M4+J5_P"WO%/_ $)C_P#@SAH_M[Q3_P!"8_\ X,X:ZBBNA#.7_M[Q3_T)C_\
M@SAH_M[Q3_T)C_\ @SAKJ**8'+_V]XI_Z$Q__!G#1_;WBG_H3'_\&<-=110!
MR_\ ;WBG_H3'_P#!G#1_;WBG_H3'_P#!G#7444 <O_;WBG_H3'_\&<-']O>*
M?^A,?_P9PUU%% '+_P!O>*?^A,?_ ,&<-']O>*?^A,?_ ,&<-=110!R_]O>*
M?^A,?_P9PT?V]XI_Z$Q__!G#7444 <O_ &]XI_Z$Q_\ P9PT?V]XI_Z$Q_\
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MB@ HHHH **** "BBB@ H-%!H YCX<_\ (B6?_76X_P#1\E=/7,?#G_D1+/\
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M%&W_ /!LO_QN@#J**Y?^VO%W_0HV_P#X-E_^-T?VUXN_Z%&W_P#!LO\ \;H
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M[_H4;?\ \&R__&Z/[:\7?]"C;_\ @V7_ .-T =117+_VUXN_Z%&W_P#!LO\
M\;H_MKQ=_P!"C;_^#9?_ (W0!U%%<O\ VUXN_P"A1M__  ;+_P#&Z/[:\7?]
M"C;_ /@V7_XW0!U%%<O_ &UXN_Z%&W_\&R__ !NC^VO%W_0HV_\ X-E_^-T
M=117+_VUXN_Z%&W_ /!LO_QNC^VO%W_0HV__ (-E_P#C= '445R_]M>+O^A1
MM_\ P;+_ /&Z/[:\7?\ 0HV__@V7_P"-T =117+_ -M>+O\ H4;?_P &R_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MLGCS_H,^'?\ P43_ /R37444 <O]D\>?]!GP[_X*)_\ Y)H^R>//^@SX=_\
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MZ#/AW_P43_\ R37444 <O]D\>?\ 09\._P#@HG_^2:1K3QYCG6?#N/;2)_\
MY)KJ:#0!R7PU64> ]/\ .96<//O*@J"?.DR0,GBNMKF/AS_R(EG_ -=;C_T?
M)73T %%%% !1110 5R_@C[FO_P#8<NOYK745R_@C[FO_ /8<NOYK0!U%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4&B@T <Q\.?^1$
ML_\ KK<?^CY*Z>N8^'/_ "(EG_UUN/\ T?)73T %%%% !1110 5R_@C[FO\
M_8<NOYK745R_@C[FO_\ 8<NOYK0!U%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4&B@T <Q\.?^1$L_^NMQ_P"CY*Z>N8^'/_(B6?\
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M ;L<:([,JC<^,D#D^E25AZ1?W<>H2:9J92694\V*=%QYJ9P21V.2*VMVT<T
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M3]15RZ$YLY!:E1.4/E[NF[M7'ZCI\NG:A%]IU>;*PF6*XF.?+D!Y&/[IX&*
M%O'TW^QI-6MH9$O+:\C>?S%_?QDL%(..VUN,<&M^V@_M0P7UY!)$4.Z*%GSQ
MV9ATS[<XJ'2+"Z:XFO\ 4O(\VYBC79"&VD+N(9@P!S\W3MBMO.,XX_K0!3U.
M_33;&2ZD!(4\+D#<>@'TK";[+J5U<P:OIY@OWM2L:.0Z,HR<H>QR>>_ ]*;=
MP7PEA76;E9K6^+1SVV/EA],-[>OM4^G:7=7,EG+-?QW5I9N6@E4?O'X*[6/<
M8/4=>* (]*BDU[2XX;I)XK.-0CDL%-P0<8((SMQ[BNF8K'&3T51^0I0 N
M.PK&UK3KV\DEEBOY;:**+,:Q'&Y_]KU'M0!1EU>SU5K7^U+&>&RDEW0RMM:*
M1AD*&]/4<5!96MO/?7FAMI_GVRW9D^8E5A0@$;2.<Y'&/?D56TVTNK_3ULK&
MY@>UN((YYH902;5F 8JI P3WP<8S[UVMO"(H@O4A0"V.30!%I]A;Z=;^3:Q[
M$Z\L6)/J222?Q)JW2 4M !1110 5F:]JATK31,B%F>18E."50L< L1T%1:SJ
M5QIC)*80UHP*O*O)B/9B.X]:YNVEO%\0_9[>9[^&X(2XAN Q1T8$F4'E0!P
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MBV>GW=S<PQXFN)&9W)R1DYP/09J^YVJ6Y)49P.IQ4=\]Q'92/91K).H^1'.
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MI4Y&>M6:* *EA:+8V45LC%Q$H!<]35NC HH ,5";>+[5YY1?-"[0Q["IJ,4
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A#:P+;VL<2G=L4+N/4X&*FHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Apr. 30, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0000947263<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">TORONTO DOMINION BANK<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-283969<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">F-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">424B2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTableNa', window );">Offering Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OffsetTableNa', window );">Offset Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CombinedProspectusTableNa', window );">Combined Prospectus Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CombinedProspectusTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CombinedProspectusTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OffsetTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OffsetTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Apr. 30, 2026 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvDsclsr', window );">Narrative Disclosure</a></td>
<td class="text"><div style="text-align: center; font-family: Arial; font-size: 12pt;">The maximum aggregate offering price of the securities to which the prospectus relates is <span style="text-decoration-thickness: initial; float: none; display: inline !important;">$4,431,090.00</span>. The prospectus is a final prospectus for the related offering.</div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvMaxAggtOfferingPric', window );">Narrative - Max Aggregate Offering Price</a></td>
<td class="nump">$ 4,431,090<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FnlPrspctsFlg', window );">Final Prospectus</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FnlPrspctsFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FnlPrspctsFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvDsclsr">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvDsclsr</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvMaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvMaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>12</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>1</UnitCount>
  <MyReports>
    <Report instance="exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="exfilingfees.htm">exfilingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="10">http://xbrl.sec.gov/ffd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "exfilingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "exfilingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
     ]
    }
   },
   "keyStandard": 12,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 7,
    "http://xbrl.sec.gov/ffd/2025": 6,
    "http://xbrl.sec.gov/dei/2025": 1
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 107,
   "unitCount": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025": 10,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ffd:NrrtvDsclsr",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ffd:NrrtvDsclsr",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001140361-26-018777-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-26-018777-xbrl.zip
M4$L#!!0    ( +->I%Q0U16R, @   ,7   0    97AF:6QI;F=F965S+FAT
M;>U86U?BR!9^GU]1DW/6<6;9,8$@2!J9A2 TK5P44&36/.120&EN5%4@^.MG
M5T@@H'AZNOMQU-6=9._:^]OWJJK\$;D.6F+*B.]=GN3.U!.$/<NWB3>[/*D-
MZNWVR1_57RJ_RC)J80]3@V,;F6MT17W#IL2>832DAL>F/G71;]S]'<EHSGF@
M*\IJM3HSMVQGEN\B64YDU2D6DG34I 1UC#52<T@MZ/F\KJIH-*RCO)HO;MGW
M0$H 4MJ!E&*0TA];T7LPZ[X;#"SR(48 %C"+4,S\D%J8'4$Z##$@I0 3Y35=
M!:2Y%.GYAGW. 29 ]9B>R+R4$CWOZ9 27AOO^"*3.F<,6V<S?ZD 01'24\;I
MU'Z?$0A[C(3YA7RNM&465L8+?#H#1E53$H[M@N@8;PYX/8=X>'QU?[MCY^_S
M[U@5GGK<X! U 4^5U;R<RV>$R&# GJ#4H(_DY,YE]4+6<JD<X'SYP%)!-@V&
M4_:0R7P=8+9=,C68&;.GE#U7"F'V07P2V45E0\RRDH]\[C%N>-862>1\P#R^
M!=P[SD,;5UK,FBN7RTI,W;*R]_A 9$X9=VX'UAR[AOP&"2/_?-5Q/*(.I.HO
M"%7FV+#% SQRPAU<115E\[#Y* KLEEC88U"NW->S;:5)/-!&# <-?"<4P6>?
M4-NSSE##MT(7>QQ9F]I$(8-.D%W;O^]-B8-1_OPL![_G^5(96D&PIF0VYPA0
M0L5N"C>S2-0P_%1<S UD^1X'%9<2QQ%78HOBGB'C14B6EU)]0Y>'D#&2 L6O
M;&RMF+Z]KE9LLD2,KQU\*4V!4YX:+G'6.JI1,.@SBK\Q\HIU5 [X9R24R(9#
M9IZ.'#R%+Y;O^%1'=&;^IGY"XN_WSU(L-W%=1L-[O&A/[<F0N)BA+EZA>]\U
MO),]""ZV2>BFGX1,'7FBXE*D2P-@P_\ T. A-+$C=,L(#DDK+%RNHX*J?@;3
M.,=49H%A0<!VG#X-YE#E.LKONP+RC:;>(9X-_M:1&D3)EVUG$((\_!FMB.VO
M-E)6/K5W>N(U ,5\(;!,K&6<^B]8AA5\GM!7<\)QO"9C?LQL8\NG<?N1^9Q8
M+QYFH(5XA)/W>!(/'J4GX=K2 \,6DTPV?<Y],"8OX$#]Q''>1+J:/._'/>LJ
MJ"%P[4'8WV8;R.8'D3%]QP9U=<.Q0B=&B/PI5)\C:JJ)8;X;IH-91?E^'&_2
M[Q-BF)+I'K1<_ABT"@3%VRNG9(4P1JK^[S^Y(B1711%LU8I)E0S,'T#]3[Q7
M(9$.2=B%OD2)M>D>$;_'4ZA.V*UXABN@3VV]"8DU#"1$8)23:"EK>:G:E+6*
MLB>@^J^W?]C;L'O2KSV8-NM[/"-,= O>!4K&]YI4'?;N>]UA#S5ZG7:WW>NB
MJUKWYM]HO(W&<8A=@XK.ML2H09CE^ PFQ,_UV!&'_0SO[-X_SBG,8+@)]#3$
MV7KN4LJ7#3";T5UBY8M2]6>X&])SCI%K1,0-763,9A3# ,;0GZ< $MIS %#%
M*^+ !YOGD,), =]Q7XPS:QY_#ZC/ FSQD"&*H<,#G3"TY[IO&7-3QS=X.FIM
MP@+'6 NRV*FC7XD;^!2VAP+T?Q-?-JEAQ?/DT)F@B<!XA2TDG 8V>WOA.*Y[
MH2O;?@Q%,+QQ=,>(:K,9[R7V]\%\"4%DA T@-P2LL9*0V9DR+TC5PJ>"EOND
MEM4S54VK.X573?+C# WWO05>,OY?7F313TF$;?DP0YJ>TZ<LL#AK.K,,JG.I
M.H4MKI/1>-AWA/0XA)NXV=O GVVR]TV?BC\>;P*9E^UC*BG^-Y.SVPB+@&]:
MKMCA8@I[7/%,;-B/;9Z_:?#!2=R$3+'[6VOC?477R+CD IJ)4CNTZMMT[-I]
M'2J,&DX;-HS1#5YGY)>EJ@H_Y4(I7WPS<K_=%-@474=S8A*>G>0%5:I>C^5F
M^[;=;:'F]?7@^S6D"?[&187<#[@HD<PP?RLW_X-R8<9ZL&?$73,C%.:KIFER
M_D(K%\O?+WL0FBYAS-OSMBCJ?.$J_U:L<I">%(,S,1Q<6;4BCLHZB\^SH C%
M1V=]3H5.<;ICQVY6Q(,L'LXBT5HVZ\1MP:7$H/4YX@P8*\XH2Y0G-S[O')J/
M7 ]4*_%-@IXX)%VXL1T\$U?MA@7'"9]4].83$<<D,B68HMA._.X%2[U]LU\+
MAXLWK6%?2WQ<__.Q\U#ZZ\\>>U3-R:0V41JX2)JCW'7]ZB$<6&'#:E/3F<P?
M.^8(EV>U'CU]<N96;^F/["_WIZ75PY=A<>QTED_]_*2]F V+$ EFC4:/YX,6
M4?V70E%['M\5M)K&E[F +N]?:\9JT,GU9ZU%6"[=34CNQJG70JW\NNB-@A%8
MTU<N[+Y3ZR_<T=?2%S:)HDX'EWFWUM*N&N7QJ+5<>-&LV"X1]F"/Q[V[<50K
M/'4&[D-+I7CT<O/0JT_;>#4L3#O:^*7]6%O5IQ?]\Z71GN3J0:W;NF<7+1;1
MZ\[MJ=U_&CI?QDY Z+)UOE+O[H+6I#4*ON*V&>7*B]7=56UP\7QNER8S^Z;[
M[(Y;UOK4^!JUM57=??1F]XVF<KI\[CT8I==E8=!XQ@\YXVEL]9O!TIB.9W,M
M'ZT:@;8J*D_/KN:4!E/S.:P_/4WXO&THFFF^+DH+7[N^^3);/ST_<>.5FXO3
M^L3LOQ:OAN<+]Z+X$"K6Y5^H/K@7MQK;Y B@1'Q[+U_B,W8#IDM57+G*:D'6
MU#3P.UIV!?;L(_PI)9,[J<;T/4GJ-,?%Q-Y/<#&Z,XA=;(C]9#6YL-1'@T8J
M*B5M90MA:14F5;=YW0ZN9-;%=S3BRH:[3O5O4$L! A0#%     @ LUZD7%#5
M%;(P"    Q<  !               ( !     &5X9FEL:6YG9F5E<RYH=&U0
52P4&      $  0 ^    7@@

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>exfilingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000947263</identifier>
        </entity>
        <period>
            <startDate>2026-04-30</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <ffd:FormTp contextRef="c0" id="ixv-32">F-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="c0" id="ixv-33">TORONTO DOMINION BANK</dei:EntityRegistrantName>
    <ffd:NrrtvDsclsr contextRef="c0" id="ixv-26">&lt;div style="text-align: center; font-family: Arial; font-size: 12pt;"&gt;The maximum aggregate offering price of the securities to which the prospectus relates is &lt;span style="text-decoration-thickness: initial; float: none; display: inline !important;"&gt;$4,431,090.00&lt;/span&gt;. The prospectus is a final prospectus for the related offering.&lt;/div&gt;</ffd:NrrtvDsclsr>
    <ffd:NrrtvMaxAggtOfferingPric contextRef="c0" decimals="2" id="ixv-34" unitRef="usd">4431090</ffd:NrrtvMaxAggtOfferingPric>
    <ffd:FnlPrspctsFlg contextRef="c0" id="ixv-35">true</ffd:FnlPrspctsFlg>
    <ffd:CombinedProspectusTableNa contextRef="c0" id="ixv-38">N/A</ffd:CombinedProspectusTableNa>
    <dei:EntityCentralIndexKey contextRef="c0" id="ixv-39">0000947263</dei:EntityCentralIndexKey>
    <ffd:FeeExhibitTp contextRef="c0" id="ixv-40">EX-FILING FEES</ffd:FeeExhibitTp>
    <ffd:OfferingTableNa contextRef="c0" id="ixv-41">N/A</ffd:OfferingTableNa>
    <ffd:OffsetTableNa contextRef="c0" id="ixv-42">N/A</ffd:OffsetTableNa>
    <ffd:RegnFileNb contextRef="c0" id="ixv-43">333-283969</ffd:RegnFileNb>
    <ffd:SubmissnTp contextRef="c0" id="ixv-44">424B2</ffd:SubmissnTp>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
